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ABSTRACT
Gene trapping is a random insertional mutagenesis strategy that aims
to identify novel genes and analyse their function. It usually involves the
introduction into embryonic stem (ES) cells of promoterless reporter/selector
gene constructs whose expression can be activated only after integration
downstream of a gene's regulatory elements. Gene trap insertions result in
production of fusion transcripts consisting of the reporter and endogenous
sequences and the mutated genes can be readily identified using PCR-based
methods such as RACE. Furthermore the biological consequences of the
integration event can be assessed after germ-line transmission. One
limitation of conventional gene trapping is that it can only target genes
expressed in ES cells since selection of insertional events relies on the
endogenous promoter's activity to drive expression of the selectable marker
and to circumvent this problem a new class of gene trap vectors called
poly(A) trap vectors was developed. These constructs contain a 3' selectable
marker whose expression is driven by a constitutively active internal
promoter relaxing the requirement for endogenous gene expression. The
selectable marker lacks a polyA signal but incorporates a splice donor (SD)
signal so only integrations upstream of an endogenous gene's splice acceptor
(SA) and polyA sequences can be selected thus eliminating intergenic
background insertions. However, it has been recently demonstrated that
poly(A) trap vectors are biased towards integrations into the 3'most-intron of
their target genes due to the action of an mRNA-surveillance mechanism
called nonsense-mediated mRNA decay (NMD).
The aim of the study presented here was to assess the efficiency of a
series of gene trap vectors that incorporate two novel features in their design:
(i) the presence of an ATG-less, 5' triple fusion between egfp, P-galactosidase
and neomycin/hygromycin resistance genes to function as a reporter/selector
of the trapped gene's expression state and (ii) a 3' poly(A) trap cassette that
contains the previously uncharacterized rabbit (3-globin exon 2/intron 2 SD
junction and an AU-rich element (ARE) derived from the human GM-CSF
gene. Our results provide evidence that the triple fusion functions properly
and can be potentially used as a reporter of trapped locus activity. We also
show that the presence of the ARE appears to improve the performance of
the rabbit (3-globin SD sequence in the context of poly(A) trapping. More
importantly, preliminary data suggest that our vectors may be resistant to
NMD and thus potentially unbiased in their insertional preference.
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1.1 The mouse as a model for studying embryonic development
Embryonic development is an intricate, tightly regulated, process. The
identification of the genes which are involved in the control of this process is
one of the major goals of developmental biology - for this reason, a variety of
model organisms have been employed. Vertebrate development is routinely
studied through the use of Xenopus, chicken, zebrafish and mouse. The
principal invertebrate models include the fruit fly Drosophila and the
nematode worm Caenorhabditis elegans. Although each of these species has its
advantages and disadvantages as a developmental model, the premier
experimental system for dissecting the events behind mammalian
embryogenesis as well as modelling human disease is the mouse. This is
mainly due to the high degree of similarity shared between mice and
humans at a genomic (99% of mouse genes have a direct human counterpart;
Waterston et al., 2002), anatomical and physiological level. Additional
advantages include its small body size, short generation time, knowledge of
its genome sequence and amenability to genetic manipulation. Moreover, the
existence of a large number of well-characterised inbred mouse strains
allows investigators in different laboratories to design experiments on the
same defined genetic background.
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1.1.1 An overview of mouse embryogenesis
Fertilisation of the egg in the oviduct marks the initiation of early
mouse embryogenesis. This leads to the formation of the zygote which then
undergoes consecutive rounds of mitotic divisions to form a cluster of cells
called the morula. At the late morula stage, after establishment of cell
polarity and morula "compaction" (during which the cells of morula are
flattened and cell outlines are not clearly distinguishable), the conceptus
enters the uterine lumen and gives rise to the blastocyst. The latter consists of
a cavity (blastocoel) and two distinct cell populations, the inner cells mass
(ICM) and the trophectoderm (TE). Blastocyst maturation (4.5 days post
coitum or 4.5 dpc) then takes place through shedding of the zona pellucida
(the outer glycoprotein-based shell that surrounds oocytes/preimplantation
embryos) and further differentiation of the ICM into a pluripotent epithelial
layer (the epiblast or primitive ectoderm) and the primitive endoderm
(Figure 1.1). Each of the components of the mature blastocyst possesses a
predefined developmental destiny: the trophectoderm gives rise to extra¬
embryonic structures such as the placenta; the primitive endoderm
contributes to the formation of the visceral and parietal endoderm that lines
the yolk sac and the epiblast generates the embryo proper as well as some
extra-embryonic membranes (Figure 1.1a). Blastocyst maturation is then
followed by implantation of the embryo into the uterine wall which is
facilitated by the attachment of the trophectoderm into the uterine lining.
Shortly after implantation, a cylindrical structure known as the egg
cylinder appears (6 dpc) containing both the now elongated epiblast as well
as the trophectoderm-derived extra-embryonic tissue. The anterior visceral
endoderm (AVE) then initiates induction of the anterior regions of the
embryo (Beddington and Robertson, 1998) and gastrulation begins at 6.5 dpc
with the formation of the primitive streak. During this stage pluripotent
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Figure 1.1 Overview of early mouse development (a) Lineage descendants of the three
lineages of the blastocyst up to the time of gastrulation (from Rossant, 2004). (b) Scheme of
early mouse development showing the link between early cell populations and primary germ
layers (from Keller, 2005).
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epiblast cells are allocated to the three primary germ layers of the embryo
(ectoderm, mesoderm and definitive endoderm) and the extraembryonic
mesoderm of the yolk sac and amnion. The primary germ layers will
eventually produce all foetal tissue lineages (Figure 1.1b). This temporally
and spatially regulated process involves the migration of epiblast cells to the
primitive streak followed by an epithelial to mesenchymal transition that
results in the formation of mesoderm and definitive endoderm. The most
posterior allocated epiblast cells of the primitive streak constitute the basis of
mesoderm which, in turn, gives rise to haematopoietic and endothelial
lineages. The epiblast cells which colonise the primitive streak later and are
located in a more anterior position form cardiac mesoderm, head
mesenchyme, and paraxial mesoderm. The most anterior-positioned within
the primitive streak epiblast cells produce endoderm and axial mesoderm,
whereas anterior, non-primitive streak epiblast cells generate the ectoderm.
By the end of gastrulation the embryo has a distinct head and developing
forelimb buds and organogenesis commences with the formation of heart,
the cranial neural folds, and the appearance of the somites.
1.1.2 Molecular control of mouse embryogenesis
An important aspect of mouse embryonic development is that it is
orchestrated by unique gene expression programs. Egg fertilisation triggers
the degradation of maternal, oocyte-derived transcripts and global zygotic
genome activation (ZGA) occurs, as shown by microarray studies, between
the 2- and 4-cell stages leading to genetic reprogramming (Hamatani et al.,
2004) (Figure 1.2a) This is followed by a second transcriptional wave (mid-
preimplantation gene activation; MGA) which peaks at the 8-cell stage prior
to the morula-to-blastocyst transition (Hamatani et al., 2004) (Figure 1.2a).

















Figure 1.2 Genes governing the development of the preimplantation mouse embryo, (a)
Gene expression during preimplantation embryo development. The diagram depicts the
waves of gene expression that occur in preimplantation embryos, based on microarray
studies. ZGA, zygotic genome activation; MGA, mid-preimplantation gene activation, (b)
Genetic model of lineage decision. Oct4 (dark pink) is expressed throughout the embryo
before the late morula stage. The expression of Nanog (light pink) is specifically induced in
the inside cells of late morulae. Cdx2 (blue) is expressed in the outer layer of cells in late
morulae and is required for the repression of Oct4 and Nanog in the trophectoderm (Tr) of
the blastocyst. Oct4 is crucial for inner cell mass (ICM) formation. Gata6 (green) is
expressed in the primitive endoderm of the late blastocyst, where Oct4 and Nanog are
repressed. Oct4 represses Cdx2 expression, which in turn represses Oct4 expression to
allow segregation of the ICM and Tr lineages of the blastocyst. An antagonism between
Nanog and Gata6 segregates epiblast and primitive endoderm within the ICM. (Figure taken
from Wang and Dey, 2006).
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further governed by the expression of several genes, mainly transcription
factors, which it has been argued may act by "co-occupying a substantial
fraction of their target genes and collaborate to form a circuitry of
autoregulatory and feed-forward loops" (Wang and Dey, 2006; Boyer et al.,
2005). ICM specification, for example, is instructed by OCT4 (encoded by the
Pou5fl gene), SOX2 and NANOG, which prevent the formation of
extraembryonic lineages in a co-operative fashion (Nichols, et al., 1998; Niwa
et al., 2000; Avilion et al., 2003; Mitsui et al., 2003; Chambers et al., 2003)
(Figure 1.2b). Conversely, trophectoderm development is mainly controlled
by the caudal-type homeodomain protein CDX2 (Strumpf et al., 2005) and
the T-box transcription factor Eomes (Russ et al., 2000) (Figure 1.1b) while the
protein products of the Gata4 and Gata6 genes appear to be important in
defining primitive endoderm fate (Fujikura et al., 2002).
Tissue lineage specification is conducted through the activation of
lineage-specific gene expression programs and parallel restriction of
antagonistic developmental pathways ("reciprocal repressive circuitry
among the different molecules"; Rossant, 2004). It is also strongly influenced
by position-specific cell interactions and signalling. It is speculated that
lineage specification might be initiated by allocation of the appropriate
factors to respective precursor cell populations which in turn triggers the
activation of regulatory molecular networks linked to a lineage-specific
transcriptional profile and leads to mature lineage development (Rossant,
2004). Gene deletion/overexpression studies and expression profiling have
provided some valuable insights into the molecular mechanisms that drive
these processes. Although the whole picture is far from complete, these
studies have revealed the important role played by members of the TGF(3
























Figure 1.3 Specification and differentiation of germ layer derivatives in mouse embryos.
Blue, ectodermal derivatives; pink, mesodermal derivatives; orange, definitive endoderm
derivatives; green, signalling pathways and transcription factors (from Loebel et al., 2003).
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the main determinants of germ layer specification/differentiation. Table 1.1
offers some examples of germ layer and lineage-specific genes.
Embryonic differentiation events also appear to be controlled at an
epigenetic level especially through alterations in chromatin structure, nuclear
dynamics and histone modification status. Chromatin structure is an
important regulator of gene function as it influences genome accessibility.
Studies on embryonic stem (ES) cells (see next section) demonstrated that an
undifferentiated cellular state is characterised by an abundance in
euchromatic, gene transcription-permissive regions while the induction of
differentiation is accompanied by an increase in the fraction of highly
condensed, transcription-restrictive heterochromatic foci, (Francastel et al.,
2000; Arney and Fisher, 2004). It is possible that the implementation of gene
expression programs associated with specific developmental stages is carried
out through the "targeted, physical segregation of genes into active and
inactive chromatin domains" (Meshorer and Mistelli, 2006). ATP-dependent
chromatin remodelling factors such as BRG1, SNF5 and SSRP1 probably play
a critical role in this process and gene targeting experiments have already
indicated their importance in embryonic development (Bultman et al., 2000;
Klochendler-Yeivin et al., 2000; Cao et al., 2003). The correlation between
gene expression and chromatin structure/nuclear dynamics has been recently
demonstrated in the mouse embryo for the Hoxb gene cluster during
gastrulation; Hoxbl expression in the posterior primitive streak was found to
be accompanied by chromatin decondensation and subsequent "looping out"
from its chromosome territory (Chambeyron et al., 2005).
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Gene Developmental Role Reference(s)
Bmp4 Mesoderm formation Winnier et al., 1995




Sirard et al., 1998
Wnt-3a Mesoderm formation Yoshikawa et al., 1997
Fgfrl Mesoderm differentiation Ciruna and Rossant, 2001
Set Haematopoietic/endothelial Elefanty et al., 1997; Endoh
specific et al., 2002
Vegf Haematopoietic/endothelial
specific
Carmeliet et al., 1996
Flk1 Haematopoietic/endothelial Shalaby et al., 1995;
specific Shalaby et al., 1997
Nkx2-5 Cardiac differentiation Lien et al., 2002
MyoD Myogenesis Ridgeway et al., 2000
Sox1 Neuroectoderm formation Pevny et al., 1998
Chordin BMP antagonist, anterior
neural differentiation
Bachiller et al., 2000
Noggin BMP antagonist, anterior
neural differentiation
Bachiller et al., 2000
Nurrl Neuronal differentiation Kim et al., 2002
Shh Neuronal differentiation Ye et al., 1998
Sox17 Definitive endoderm
differentiation
Kanai-Azuma et al., 2002
Mix/1 Definitive endoderm
differentiation
Hart et al., 2002
/3-catenin Definitive endoderm
specification




Table 1.1 Examples of genes that are involved in the specification of primary germ layers
and/or resulting lineages. Blue, ectoderm-specific; pink, mesoderm-specific; orange,
definitive endoderm-specific;
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1.1.3 The use of ES cells as a model for embryonic development
ES cells are pluripotent cells derived from the inner cell mass of
blastocyst-stage embryos (Figure 1.1b) (Evans and Kaufman, 1981; Martin,
1981). They possess two key properties that distinguish them from all other
organ-specific stem cells identified to date. First, they can be maintained and
expanded as pure populations of karyotypically normal, undifferentiated
cells for extended periods of time. Second, they are pluripotent and hence
have the capacity to generate every cell type in the body, both in vivo and in
vitro.
The ability of ES cells to differentiate into derivatives equivalent to all
three embryonic germ layers makes them an attractive developmental model
that is easier to manipulate compared to the mouse embryo. ES cell
differentiation in vitro is usually achieved, in a directed manner, through
three alternative approaches: embryoid body (EB) formation in which ES
cells are allowed to aggregate and form three dimensional structures
(Doetschman et al., 1985; Keller, 1995); co-culture with differentiation-
promoting stromal cell lines (e.g. OP9; Nakano et al. 1994); culture on
extracellular matrix proteins (Nishikawa et al., 1998). Figure 1.4 shows a
model comparing, based on our existing knowledge, the early stages of
embryonic and ES/B development.
Another attractive feature of ES cells is their amenability to genetic
manipulation. This characteristic has been greatly exploited for dissecting
gene function, especially in a developmental context. Genetic changes can be
introduced in culture in a directed or random manner and the resulting
phenotype can be assessed both in vitro and, more importantly, in vivo. The
developmental "pluripotentiality" of ES cells can be employed for generating














Figure 1.4 ES/EB development as a tool for modelling early mouse embryonic


















resulting chimaeric animal, after placement back into an embryonic
environment through host blastocyst injection. Furthermore, they contribute
to functional germ cells enabling the transmission of genetic alterations
through the germline (Bradley et al., 1984).
1.2 Mutagenesis strategies in the mouse
The classic route for characterising the function of genes, including
those which are critical in various aspects of mouse development, involves
the use of mutagenesis experiments. One of the main post-genomic goals of
the mouse genetics community is the production of at least one heritable
mutation, in either ES cells or mice, within every gene of the mouse genome
("genome saturation") and the identification of each consequent phenotype.
For this reason, an International Mouse Mutagenesis Consortium (IMMC)
has been established combining the efforts of research groups from all
around the world both from the public and private domains (Nadeau et al.,
2001). Mutagenesis strategies are generally divided into two categories:
forward genetic approaches in which the phenotype is the starting point
towards identifying the affected gene sequence and reverse genetic
approaches which are characterised by the introduction of a change into a
predefined gene sequence followed by assessment of the resulting mutant
phenotype.
1.2.1 Forward genetic strategies
1.2.1.1 ENU mutagenesis
The majority of phenotype-driven mutagenesis regimes utilise the
alkylating agent N-ethyl-N-nitrosourea (ENU) to introduce point mutations
in spermatogonial stem cells (Russell et al., 1979). The resulting animals are
then screened through the use of appropriately designed mating schemes
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and/or under a specific set of conditions according to the biological questions
of the study. Commonly employed screens can often be region-specific,
focusing on mutations that lie on a particular genomic interval or genome-
wide which are considered more useful for dissecting the genetic basis of a
specific biological process (Kile and Hilton, 2005). ENU is a very efficient
mutagen: it induces mutations at single loci in approximately one sperm in
1,000 (Hitotsumachi et al., 1985; Lyon and Morris, 1966), a rate which is
approximately 100-fold higher than the spontaneous mutation rate (Kile and
Hilton, 2005).
Large-scale ENU-based mutagenesis screens are being performed in
several centres world-wide. For example, the German ENU mutagenesis
project involves mating of ENU-treated male mice with wild-type females to
generate F1 founders which are then screened for dominant/semi-dominant
mutant phenotypes or bred further to subsequently study recessive
phenotypes (Hrabe de Angelis et al., 2000;
http ://www.gsf.de/ieg/groups/enu-mouse.html). Similar phenotype-driven
projects are being carried out by the Medical Research Centre at Harwell in
UK (http://www.mgu.har.mrc.ac.uk/research), the RIKEN Institute in Japan
(http://www.gsc.riken.go.jp/Mouse/), and the Centre for Modelling Human
Disease in Canada (http://cmhd.mshri.on.ca/enu_mutagenesis/index.html).
However, despite the fact that mutant generation through ENU is almost
effortless, the identification of the genes affected through this approach by
positional cloning or by a candidate-gene approach remains cumbersome.
Moreover, some loci have been shown to be "immutable" by ENU (Rinchik
and Carpenter, 1999) while the breeding schemes employed for the
phenotypic analysis of the resulting mutants are often costly and time-
consuming.
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1.2.2 Reverse genetic strategies
1.2.2.1 Gene targeting
Gene targeting is the most widely-used genotype-based mutagenesis
approach in mice. It involves the genetic modification of ES cells through the
introduction of exogenous DNA (targeting vector) that contains two
homology arms, specific to the locus of interest and consequent homologous
recombination which facilitates the replacement of the targeted allele with
the exogenous sequence. The modified ES cells can then be used to generate,
after blastocyst injection, chimaeric mice so that mutant phenotypes can be
studied in vivo on a defined genetic background. Gene targeting proved an
extremely useful and popular mutagenesis tool for elucidating gene function
in vivo and providing valuable insights into key biological processes. To date,
this method has facilitated the production of approximately 3,600 mutants
corresponding to a 15% coverage of the entire mouse genome (Skarnes,
2005). However, the need for screening a large number of ES clones in order
to identify a small number of correctly targeted events renders gene targeting
a labour-intensive and time-consuming approach (Skarnes, 2005) and thus
unsuitable for high-throughput experiments. Furthermore, despite recent
technical advances (e.g. with the development of recombineering), the
engineering of targeting vectors is technically challenging, targeting
efficiencies are low, and vectors often integrate at random (Carlson and
Largaespada, 2005).
1.2.2.2 RNAi
RNA interference (RNAi) is used as a means to induce the sequence-
specific down-regulation of target mRNA transcripts through the
employment of a conserved post-transcriptional gene regulatory mechanism.
It can be triggered either by transiently transfected, synthetic 21-23 nt RNAs
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with 2-nt 3'overhangs (small interfering RNAs or siRNAs) or by longer RNA
transcripts (shRNAs or pri-miRNAs) stably expressed from PolII or PolIII-
driven vectors. RNAi is a convenient tool for fast, high-throughput
mutagenesis studies and has been successfully utilised for the construction of
large-scale-arrayed, sequence-verified libraries targeting most known and
predicted genes in the human and mouse genomes (Silva et al., 2005).
However, unlike traditional gene targeting systems it mediates a knockdown
rather than a knockout of target gene expression and hence it might not be
the most appropriate means of generating loss-of-function phenotypes.
Furthermore, there are still some caveats and unresolved issues concerning
RNAi technology itself. The most important issue to be addressed is non¬
specific suppressive activity including the induction of off-target knockdown
silencing and the triggering of the interferon response system. The off-target
effect involves the sequence-specific silencing of non-targeted genes: it has
been shown that expression of a non-targeted transcript with as few as 11
consecutive nucleotide matches with a siRNA sequence can be
downregulated (Jackson et al., 2003). The interferon response is linked to the
non-specific, sequence-independent effect mediated by an innate, immune
response against any exogenous dsRNA (Stark et al., 1998; Grandvaux et al.,
2002). Although siRNAs were generally assumed to be too short for
triggering an interferon response in mammalian cells (Caplen et al., 2001;
Elbashir et al., 2001), two recent reports demonstrated that expression of
shRNAs in mammalian cells can activate the interferon pathway (Bridge et
al., 2003; Sledz et al., 2003).
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1.2.3 Random insertional mutagenesis
1.2.3.1 Insertional mutagenesis using DNA microinjection/retroviruses
Insertional mutagenesis, conceptually, combines the advantages of
both forward and reverse genetic approaches. It involves the random
insertion of mutagenic exogenous DNA into a target genome simultaneously
providing a molecular tag for cloning of the mutated gene. It was first
introduced in 1976 with the report of retroviral DNA insertion into the
mouse germline (Jaenisch, 1976). In 1981 microinjecting exogenous DNA into
fertilized oocytes yielded the first transgenic mice (Constantini and Lacy,
1981; Gordon and Ruddle, 1981; Harbers et al., 1981; Wagner et al., 1981).
However, these initial attempts were characterised by a low probability (5%)
of producing a phenotype (Jaenisch, 1988; Spence et al., 1989; Weiher et al.,
1990) and DNA rearrangements occurring at the mutated locus (Gridley et
al., 1987). For these reasons alternative insertional mutagenesis approaches
were pursued.
1.2.3.2 Transposon-based insertional mutagenesis
Transposon-mediated insertional mutagenesis has attracted much
attention lately due to the development of elements which can be employed
in vertebrate systems. Transposons are naturally occurring mobile genetic
elements that move around within the genome of an organism. In the mouse,
various transposable elements have been identified, including
retrotransposons and DNA transposons. The LINE-1 (LI) family of
retrotransposons (mobile elements that transpose via a 'copy-and-paste'
mechanism which involves reverse transcription of an RNA intermediate)
have been shown to mobilize in cultured mammalian cells (Moran et al.,
1996) and in the mouse germline (Ostertag et al., 2002). This finding renders
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them a potential candidate for use in in vivo insertional mutagenesis.
However, the frequency of their germline transposition was found to be low
(Farley et al., 2004) while their tendency for 5'truncations (Farley et al., 2004)
and promotion of deletions at the site of integration (Gilbert et al., 2002)
complicates their use as effective mutagenic agents.
DNA transposons which mobilize by a 'cut-and-paste' mechanism,
have, so far, proved more efficient as insertional mutagens. The most
successful systems utilize the piggyBac transposon derived from the cabbage
looper moth (Ding et al., 2005) and Sleeping Beauty (SB), a synthetic element
made from defective copies of an ancestral Tcl/mariner fish transposon (Ivies
et al., 1997). piggyBack has been demonstrated to possess the potential to
carry as much as 14 kb of exogenous DNA and it can mobilize efficiently
within human and mouse somatic cells as well as the mouse germline (Ding
et al., 2005). SB has been shown to be active in mouse ES cells (Luo et al.,
1998) and, most importantly, SB transposition can be achieved in the
germline of mice that are transgenic for transposon and SB transposase
(Dupuy et al., 2001; Fischer et al., 2001; Horie et al., 2001). Furthermore, gene-
trap transposons have been successfully mobilized to mutate genes in vivo
(Carlson et al., 2003; Horie et al., 2003). A Mouse Transposon Insertion
Database (MTID) has been established offering to the scientific community a
significant number of mice carrying germline SB insertions into genes or
chromosomal regions of interest (Roberg-Perez et al., 2003;
http://mouse.ccgb.umn.edu/transposon/).
Transposon-based strategies are an attractive tool for performing
rapid forward genetic screens, especially in vivo, since the induction via this
approach of gene mutations and the recovery of resulting mutant
phenotypes occur almost simultaneously (Carlson and Largaespada, 2005).
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However, genome-wide mutagenesis using any transposon system is not
currently feasible due to the relatively low germline transposition frequency
(Carlson and Largaespada, 2005). Furthermore, SB-related transposons are
subject to 'local hopping', a phenomenon in which new integration sites are
linked to the donor locus in 50-80% of the cases (Carlson et al., 2003; Horie et
al., 2003) while they also exhibit a small but significant integration bias
towards genes and their upstream regulatory sequences, although the bias is
much less than that observed with retroviruses (Yant et al., 2005).
1.3 Gene trap mutagenesis
Gene entrapment is one of the most powerful and popular insertional
mutagenesis approaches. It was first employed in Drosophila (O'Kane and
Gehring, 1987) and then adopted as a tool for identifying and mutating
developmentally regulated genes in the mouse (Gossler et al., 1989). It is
based on the random introduction into ES cells (via electroporation or
retroviral infection) of a DNA vector that is designed to signal its presence
via the activation of a reporter gene. The latter mimics the expression of the
endogenous gene (or the activity of a disrupted enhancer/promoter) and
potentially mutates the locus. The "trapped" ES cells can then be selected in
vitro and subsequent germline transmission enables the analysis of the
insertion's in vivo phenotypic consequences. Huge libraries of ES cell clones
bearing random integrations can therefore be rapidly generated and stored
indefinitely enabling the implementation of high-throughput approaches.
Additionally, the sequence of the "trapped" gene/site of integration can be
easily identified using PCR-based techniques such as RACE (Rapid
Amplification of cDNA Ends, Frohman et al. 1988) and inverse PCR (von
Melchner et al., 1990) or plasmid rescue (Hicks et al., 1997).
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1.3.1 Basic entrapment approaches
1.3.1.1 Enhancer trapping
An enhancer-trap vector (Figure 1.5) usually contains a minimal
promoter that requires the vector to insert near a cis-acting enhancer element
in order to activate a reporter fused to the minimal promoter. Enhancer
trapping has been successfully used in Drosophila as a means of detecting
transcriptional regulatory elements (O'Kane and Gehring, 1987) and its
principles have also been applied in the mouse (Gossler et al. 1989; Korn et
al. 1992; Marikawa et al., 2004); data based on reporter expression patterns
both in ES cells and chimaeric embryos (Gossler et al., 1989; Korn et al., 1992;
Marikawa et al., 2004) as well as molecular cloning of integration sites (Korn
et al., 1992; Marikawa et al., 2004) have provided evidence that enhancer trap
vectors possess the potential to tag cellular enhancers active during
embryonic development. However, this type of entrapment has not been
widely exploited mainly due to its low mutagenicity (Korn et al., 1992;
Marikawa et al., 2004). Furthermore, reporter expression in the case of
enhancer trap vectors is likely to be affected by the specific promoter
employed, without necessarily reflecting the activity of the trapped,
endogenous enhancer elements (Marikawa et al., 2004).
1.3.1.2 Promoter trapping
Promoter-trap vectors (von Melchner and Ruley, 1989; Friedrich and
Soriano, 1991; Reddy et al. 1991; von Melchner et al., 1992) consist of a
promoterless reporter gene/selectable marker whose activity is dependent on
vector insertion in the correct orientation and translational frame into an
exon (those vectors can also be classified as exon traps) of an active gene.
This results in the generation of a fusion transcript that comprises upstream
endogenous exonic sequence and the reporter gene (Figure 1.6). The first
21






Figure 1.5 Enhancer trapping. The enhancer-trap vector contains a minimal promoter
upstream of a reporter gene. Insertion of the vector close to the enhancer of gene X leads to
the transcription and translation of the reporter when gene X is active. It should be noted that
in the example given here the vector also contains a constitutive promoter that drives the
expression of an antibiotic resistance gene for selection of integration events. P, promoter;












Figure 1.6 Promoter trapping. The promoter-trap vector consists only of a
reporter/selectable marker. Insertion of the vector into the coding sequence of a
transcriptionally active gene X will activate the reporter/selector resulting in the generation of
a fusion transcript and protein between trapped gene X and the vector's reporter/selector
gene. pA, polyadenylation signal site.
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promoter trap vectors (U3Neo and U3His) to be employed successfully in ES
cells contained a selectable marker (neo or his conferring resistance to
neomycin and L-histidinol respectively) inserted into the U3 region of the
3'long terminal repeat (3'LTR) of a replication-defective Moloney murine
leukaemia virus (von Melchner et al., 1992). It was shown that drug selection
of infected ES cells leads to the isolation of insertional events that represent
as predicted unique fusions between neo/his and upstream sequences of
trapped genes (von Melchner et al., 1992). Locus disruption in two cases was
associated with a homozygous embryonic lethal phenotype after germ-line
transmission. Both affected genes (hnRNP C and fugl) were later found to
play a critical role in postimplantation mouse development demonstrating
the ability of this type of vectors to capture developmentally important genes
(DeGregori et al., 1994; Williamson et al., 2000). The use in a subsequent
study of a similar vector (U3(3geo) consisting of the fusion between the p-
galactosidase and neo genes (j3geo; see next section) resulted in the generation
of mutant mice which carried an insertion within the Prmtl gene (Scherer et
al., 1996). In this case homozygous embryos failed to develop beyond E6.5
indicating that the mutated locus is essential for embryonic development
(Pawlak et al., 2000). In general, promoter trap vectors seem to be highly
mutagenic presumably due to the fact that they integrate directly into exons;
for example 78% of mutant mice carrying U3pgeo insertions were shown to
exhibit an obvious phenotype (Hansen et al., 2003). They can also be used for
trapping single exon genes, a type of genes that cannot be mutated through
the use of SA (splice acceptor)-containing gene trap vectors (see next section)
(Hansen et al., 2003).
The above studies suggest that promoter trapping is an efficient
mutagenesis strategy in the mouse. For this reason U3 promoter trap vectors
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have been employed as tools for the large-scale construction of trapped ES
cell libraries (U3Neo, Hicks et al., 1997; U3(3geo, Hansen et al., 2003).
However, this type of vectors appears to preferentially integrate towards the
5'UTR of their target genes (Hansen et al., 2003) and therefore trapping in
this case is not entirely unbiased. Moreover, it has been recently
demonstrated that the majority (95%) of U3Neo vector insertions occur
within introns and disrupted endogenous transcripts tend to splice in-frame
to a cryptic 3' SA site within the vector's neo gene (Osipovich et al., 2004). It
therefore appears that the mechanism of entrapment by this specific vector is
more similar to the one employed by gene trap constructs (see next section).
1.3.1.3 Gene trapping
Gene trap vectors (Gossler et al., 1989) (Figure 1.7) contain a splice
acceptor site (SA) immediately upstream of a promoterless reporter gene
which is followed by a poly(A) signal. The integration of the vector into the
intron of an expressed gene in the correct reading frame results in splicing
between the reporter gene and the endogenous upstream exon leading to the
generation of a fusion transcript and an active protein that incorporates the
N-terminal portion of the mutated native protein fused to the reporter
protein (Skarnes et al., 1992). Hence reporter expression is controlled by the
regulatory elements of the disrupted locus and should theoretically reflect
the trapped gene's expression status (Skarnes et al., 1992; Friendrich and
Soriano, 1991). This implies that the tagged integration can serve as a tissue-
specific or cell lineage marker. More importantly, the insertional event
generates a truncated version of the disrupted gene's protein product and is
therefore likely to lead to a loss-of-function phenotype. The rest of this
chapter focuses on specific aspects of gene trapping and discusses theoretical
and practical issues associated with this type of mutagenesis.
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Figure 1.7 Gene trapping. The gene-trap vector contains a splice acceptor upstream of
the reporter/selector gene. Integration in an intron leads after splicing between an upstream
endogenous SD and the vector's SA to the generation of a fusion transcript and protein
between the upstream exon of gene X and the reporter if gene X is active. pA,
polyadenylation signal site; SD, splice donor; SA, splice acceptor.
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1.3.2 Vector Designs
1.3.2.1 Basic vector designs
The prototype plasmid gene trap vector (termed pGT4.5) contained a
SA (from the mouse engrailed-2 gene) followed by the ATG-less lacZ gene
which served as a tag of the trapped gene's activity and a poly(A) signal
(Gossler et al., 1989). The vector also included an internal promoter-driven
neo gene for selection of integration events (Gossler et al., 1989). The lacZ
gene was chosen as a reporter because the activity of its protein product, p-
galactosidase, can be easily assayed in ES cells and embryos using the
chromogenic substrate X-gal which yields a blue colour while it can also
tolerate large N-terminal fusions (Friedrich and Soriano, 1991). The use of
this vector provided the first insights into the principles underlying gene
trapping and demonstrated, through the production of abnormal in vivo
phenotypes, the value of this approach as a mutagenesis tool (Skarnes et al.,
1992). A similar design was subsequently adopted in the construction of the
PT1-ATG vector (Hill and Wurst, 1993). In this case, the inclusion of an ATG
upstream of the lacZ gene resulted in a three-fold increase in the number of
[3-gal-expressing clones, probably reflecting the detection of out-of-frame
splicing events (Hill and Wurst, 1993). The inclusion in this class of vectors of
an autonomous promoter driving selection, theoretically offers the potential
to trap genes that are not expressed in undifferentiated ES cells. However
this feature also results in an increased background due to selection of
intergenic integrations and is associated with low trapping efficiency (0.2-
5%) (Niwa et al., 1993; Wurst et al., 1995; Forrester et al., 1996).
The need for a reporter that allows the direct selection of insertion
events combined with the parallel monitoring of trapped locus activity led to
the development of the fdgeo gene (Friedrich and Soriano, 1992). Its
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construction was based on the in-frame insertion of neo into the 3'end of lacZ
(Friedrich and Soriano, 1992). The retroviral vector ROSA/?geo and its
plasmid equivalent pSAj3geo were the first gene trap constructs to
incorporate figeo as a reporter (Friedrich and Soriano, 1992). A wide variety
of /?yeo-containing vectors, both retroviral and plasmid, were subsequently
designed and employed in a large number of gene trapping experiments
mainly due to their high trapping and mutagenic efficiency. Their use
revealed that resistance to G418 is a more sensitive means of isolating gene
trap clones compared to X-gal staining since a fraction of neoR clones are
always negative for (3-galactosidase activity (Friedrich and Soriano, 1992;
Skarnes et al., 1995). The correction of a point mutation that causes reduced
enzyme activity and was found present within the neo component of the
original figeo reporter opened up the possibility to access genes expressed at
low levels (Skarnes et al., 1995).
More recent versions of figeo-based vectors often include an internal
ribosome entry site (IRES) from the encephalomyocarditis virus between the
SA site and the figeo sequence (termed IRES/?geo; Chowdhury et al. 1997) to
facilitate bi-cistronic translation (i.e. the translation of two proteins from one
mRNA). Inclusion of this element enables the reporter gene to be translated
even when it is not fused in-frame to the endogenous, trapped gene. Another
strategy aiming to address the issue of out-of-frame translational fusions
involves the combined, parallel use of pGTl, 2 and 3 gene trap vectors
(SAj3geo-pA). In this case the splice acceptor's exon sequence was modified to
produce three vector derivatives (pGTl, 2 and 3) which can generate fusion
proteins in each of the three reading frames (Wilson et al., 1995; Tate et al.,
1998; Sutherland et al., 2001; Tzouanacou et al., 2005).
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It has been shown that when a conventional JJgeo gene trap vector
integrates within genes that contain an upstream secretory signal sequence,
the resulting j3geo fusion proteins are translocated (providing the insertion
takes place upstream of any endogenous transmembrane domain-encoding
sequence) in the lumen of the endoplasmic reticulum and (3-galactosidase is
abolished (Skarnes et al., 1995). Tagging of this type of genes cannot
therefore be achieved using conventional gene trap vectors and this
limitation was overcome through the design and employment of a vector
(pGT1.8TM) that includes the transmembrane domain of the rat CD4 gene
upstream of the j3geo reporter ("secretory trap"; Skarnes et al., 1995) (Figure
1.8). This novel approach proved to be effective in recovering insertional
mutations within genes that encode secreted and type I membrane proteins
(Skarnes et al., 1995). Vector pGT1.8TM and its modified versions were
subsequently used in a large-scale screen aiming to identify developmental
important genes that belong to this specific class (Mitchell et al., 2001). A
similar strategy employing retroviral gene trap vectors that contain a
reporter fusion between the human CD2 receptor gene which provides a
type II transmembrane domain and the neomycin resistance gene (Ceo) has
been recently reported (De-Zolt et al., 2006).
A substantial number of mouse mutants generated through the use
secretory and classic ftgeo-type gene trap constructs have been described and
some examples are given in Table 1.2. These studies clearly demonstrate the
value of gene trapping in aiding the identification and functional annotation
of genes that are critical in early mouse development.
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Figure 1.8 The secretory-trap vector. The secretory-trap vector uses protein sorting and
the fact that p-galactosidase (P-gal) activity is abolished in the endoplasmic reticulum (ER)
specifically to trap genes that encode secreted and transmembrane proteins that are
expressed in embryonic stem (ES) cells. The pGT1.8TM secretory-trap vector contains a
transmembrane (TM) domain immediately downstream of a splice acceptor (SA) site,
followed by the p-geo reporter with its own polyA site. The TM domain of the secretory-trap
vector sequesters gene-trap fusion proteins that do not have a signal sequence into the ER
lumen, thereby extinguishing p-gal activity. When a fusion protein contains a secretory signal
(SS) sequence, it is translocated into the cytosol where p-gal activity can be assayed. So,
the secretory-gene-trap vector enriches for insertions into genes that encode secreted or
transmembrane proteins by using a modification of blue-white selection (from Stanford et al.,
2001).
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Vector Disrupted locus Phenotype Reference

















pGT1.8geo J3-E- catenin Embryonic lethality
6.5 dpc, defective
implantation
Torres et al., 1997
pGT1,8geo Neuropilin-2 Axon guidance and
lymphatic vessel
defects
Chen et al., 2000;
Yuanetal., 2002
pGT1,8geo Taube Nuss Preimplantation
lethality
Voss et al., 2000




Serafini et al., 1996
PLAP ADAM19 Neonatal lethality,
cardiac defects
Zhou et al., 2004
IRESPgeo Apafl Embryonic lethality
16.5 dpc
Cecconi et al., 1998






pTiPgeo Birc6 Embryonic lethality
11.5-16.5 dpc
Ren et al., 2005
Table 1.2 Examples of characterised mouse mutants generated through the use of
different, representative gene trap vectors and carry insertions within developmentally critical
and tissue-specific genes.
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1.3.2.2 Alternative gene trap vector components
Gene trap constructs that utilize reporter/selection systems other than
the traditional lacZ/neo combinations have also been developed. Hygromycin
and phleomycin are two examples of alternative to neo drug resistance
markers that have been used by gene trappers in their effort to construct
novel vectors (Natarajan and Boulter, 1995; Camus et al. 1996). Alkaline
phosphatase (AP) has been employed as an alternative to p-galactosidase to
monitor expression (Xiong et al. 1998; Leighton et al., 2001). Like (3-
galactosidase, AP activity can also be monitored during in vitro
differentiation protocols as well as in vivo hence providing an excellent
spatiotemporal tag of endogenous gene expression (Xiong et al. 1998).
Furthermore, the property of the human placental AP to label axons, when
expressed transgenically in neurons, has been exploited in the construction of
the PLAP secretory trap vector which can be utilised as a tool for identifying
genes involved in neuronal axon guidance (Leighton et al., 2001).
Reporter systems that allow negative selection have also been
described. Such an example is the galtek fusion between lacZ and the Herpes
Simplex virus thymidine kinase (HSV-tk) (Cannon et al., 1999) whose
inclusion in a gene trap vector (ROSAgaltek) enables the elimination via FIAU
(l-2-deoxy-2-fluoro-(3-D-arabinofuranosyl-5-iodouracil) selection of galtek-
marked cells during in vitro differentiation and hence the function of
expressing cells (and consequently the trapped gene's role) can be elucidated
without requiring any prior knowledge of their identity or anatomical
position (Cannon et al., 1999).
More recent vector designs incorporate fluorescent protein-encoding
genes such as GFP or eGFP as reporter tags of trapped gene expression
(Ishida and Leder, 1999; Lai et al., 2002; Taniwaki et al., 2005; Xin et al., 2005;
Zheng and Hughes, 1999). The use of fluorescent reporters offers the
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advantage of allowing the non-invasive monitoring of expression in living
cells and embryos. Additionally, flow cytometry provides an extra means to
monitor fluorescence easily, in an automated manner making it a useful
system for high-throughput approaches. Some groups have also reported the
successful employment of entrapment vectors that include bipartite reporter
fusions that combine eGFP with selection marker genes such as
nitroreductase (Medico et al., 2001), neo (Chen and Chen, 2004), hygro
(Cobellis et al., 2005) and puro (De Palma et al. 2005). Finally, a recently
described gene trap system uses a p-lactamase reporter enzyme to cleave a
non-toxic fluorogenic substrate, CCF2/AM, which results in a shift in the
emission wavelength from 530 nm (green) to 460 nm (blue), as expression of
the trapped gene increases (Whitney et al., 1998; Scheel et al., 2005). This
enzyme and fluorophore-based combination allows "measurement of small
changes in transcriptional activity through enzymatic amplification of the
transcriptional signal and quantitative ratiometric analysis of gene
expression, making the system less susceptible to variations due to
background fluorescence and cell density" (Zlokarnik et al., 1998; Scheel et
al., 2005).
1.3.2.3 Microarray-coupled gene trap mutagenesis
The ROSA(3geo vector constituted the basis for the development of a
novel microarray-linked gene trap strategy (Chen et al., 2004a). In this case
the ROSAPgeo vector was modified to include a 3'poly(A) trap cassette (see
section 1.3.6) that contained a PGK promoter driving the expression of the
hygromycin resistance gene. The latter lacked a poly(A) signal but
incorporated a splice donor (SD) sequence. Gene trap clones were isolated by
G418 selection using the 5' figeo component while the poly(A) trap module
served as an artificial exon for the cloning of the trapped genes by 3'RACE
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PCR (Chen et al., 2004a). This vector (named ROSAFARY) was used for the
construction of a library consisting of 2,880 individual gene-trapped ES
clones. Trapped transcripts were then employed for the construction of a
cDNA microarray which was used for the expression-based identification of
trapped genes that are induced or repressed by the platelet-derived growth
factor (PDGF) (Chen et al., 2004a).
1.3.2.4 Conditional gene trapping
The current trend in the design of gene trap vectors involves the
generation of constructs that include recombination sites allowing
recombinase-mediated, post-insertional modifications of the gene-trap locus
(Thorey et al. 1998; Araki et al. 1999; Hardouin and Nagy, 2000; Schnutgen et
al., 2005; Xin et al., 2005; Cobellis et al., 2005; Taniwaki et al., 2005). This
allows the utilisation of a trapped gene's promoter elements to drive the
expression of a knocked-in transgene for use in rescue or cell-labelling
experiments as well as the spatiotemporal control of the induced mutations.
These recombinase-mediated cassette exchange (RMCE) strategies have
mainly utilised the Cre/loxP system although recent developments in this
area incorporate other site-specific DNA recombining enzymes such as FLP
recombinase (Cobellis et al., 2005; Schnutgen et al., 2005; Xin et al., 2005).
The Cre/loxP technology was also adopted in the design of a novel
inducible gene trapping strategy that uses an ES cell line modified to respond
to transient Cre expression by permanent drug resistance switching (Chen et
al., 2004b). In the un-induced state the responder ES cells are blasticidin S
resistant while Cre-catalysed recombination using loxP sites engineered
within the responder ES cells renders them resistant to puromycin. When the
responder cells are infected by a retroviral gene trap vector that carries a
promoterless (linked to a splice acceptor) cre gene as a reporter, then the drug
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resistance status of the trapped responder cells reflects the expression state of
the trapped gene, since Cre expression is regulated by the trapped gene's
transcriptional activity. The employment of the above system by Chen et al.
(2004b) enabled the enrichment of integration events that occur within
developmentally regulated genes (85% of the cases) and demonstrated that
the cre reporter is extremely sensitive, a property that can be exploited for
"accessing chromosomal regions that are not detectable by other reporters"
(Chen et al., 2004b).
1.3.2.6 Targeted trapping
A novel approach, termed 'targeted trapping', which combines the
power of gene targeting with the simplicity of gene trapping has recently
been described (Friedel et al., 2005) (Figure 1.9). Targeted trapping is based
on the construction of targeting vectors which consist of a promoterless gene
trap cassette flanked with genomic sequences that serve as homology arms
facilitating via homologous recombination insertion into an intron of a target
gene (Friedel et al., 2005). The vector's reporter gene {/3geo) is expressed only
if correct splicing takes place between an upstream, endogenous splice donor
and the construct's splice acceptor in a manner similar to random gene
trapping (Figure 1.9). Flence antibiotic resistance is dependent on the activity
of the 'trapped/targeted' endogenous promoter and this should theoretically
result in the elimination of most non-specific insertions. A further degree of
enrichment is obtained through the employment of gene trap cassettes that
lack a translational initiation codon to promote the selection of in-frame
integrations. Friedel et al. (2005) demonstrated that a higher targeting
efficiency (50%) compared to conventional gene targeting approaches can be













Figure 1.9 Targeted trapping. Targeted trapping relies on homologous recombination to
introduce a promoterless gene trap cassette into the targeted locus. The trapping cassette is
flanked by genomic sequences of the target locus that act as homology arms. Exons are
depicted by open boxes. SA, splice acceptor; pA, polyadenylation signal. (Figure adapted
from Skarnes, 2005).
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provided that targeted loci are expressed above a certain threshold (1% of the
transferrin receptor gene expression level for the specific vector they used).
1.3.3 Technical issues and limitations
Analysis of mutant mice resulting from gene trapping experiments
has revealed that the expression of a gene trap vector's reporter gene may
not faithfully recapitulate that of the trapped gene in all cases (e.g. Deng and
Behringer, 1995; Pall et al., 2004). A lack of correlation could be caused, for
example, by the insertional disruption of intronic regulatory elements that
are essential for gene activity, often, in a tissue-specific manner (Lothian and
Lendahl, 1997; Haerry and Gehring, 1997) and confirmation of the trapped
gene's expression profile for example by in situ hybridisation is always a
good practice.
Obviously the mutagenic outcome of a gene trap event depends on
the location at which a vector integrates within a transcriptional unit. Some
insertions, particularly those taking place at the 3'end of genes are more
likely to generate hypomorphic rather than null mutations. Although this
type of genetic lesion might still be informative, it usually does not provide
an insight into the trapped gene's function because of the lack of a
phenotype. Another reason for a lack of phenotype is "splicing around"
events. These occur when a gene trap vector's splice acceptor is ignored by
the endogenous splicing machinery resulting in the generation of a wild-type
transcript and lack of a phenotype (Skarnes et al., 1992; Sam et al., 1998;
Faisst and Gruss, 1998; Voss et al., 1998). It is therefore important to confirm
(e.g. by RT PCR or Northern blotting) the existence of a fusion transcript
predicted to result from a gene trap event.
The method of delivery (electroporation or retroviral infection) can be
a critical determinant of a vector's integrational behaviour. Introduction via
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retroviruses might compromise the theoretically random nature of gene
trapping as they tend to insert into a target gene's 5'portion (including the 5'
UTR and first intron) (Harbers et al., 1984; Vijaya et al., 1986; Soriano et al.,
1987). However, this feature might also render them more suitable for the
generation of null mutations. Moreover, the major advantage of retroviral
infection is that it ensures the integration of a single copy of the entire vector.
On the other hand, electroporation-based delivery strategies are considered
to be more random but they often result in tandem vector integrations,
chromosomal deletions and rearrangements and electroporated vectors are
more sensitive to digestion by exonucleases (Friendrich and Soriano, 1991;
Niwa et al., 1993; Forrester et al., 1996; Neilan and Barsh, 1999).
1.3.4 Directed trapping
Gene trapping is mainly employed by investigators whose research
revolves around the genetic dissection of specific developmental pathways.
In vivo gene trapping has been used successfully in the past to identify novel
genes that are expressed either within specific tissues or in spatiotemporal
patterns that may be of interest to the investigator (Gossler et al. 1989;
Friedrich and Soriano, 1991; Skarnes et al. 1992; Wurst et al. 1995). In this
case, "the developmental function of a trapped gene can be elucidated by
breeding transgenic animals that are heterozygous for the gene trap and
analysing homozygous offspring for morphological or physiological defects"
(Baker et al., 1997). However, this strategy is expensive both in terms of
resources and time (since it involves the generation of hundreds of chimeric
embryos from a large 'pool' of trapped ES clones). Thus it is not suitable for
smaller laboratories with specific research interests. An alternative approach
involves the in vitro pre-selection of gene trap events prior to generating
transgenic animals on the basis of a defined set of parameters tailored to an
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investigator's specific biological questions (Baker et al., 1997). Such pre¬
selection strategies demonstrate the potential of gene trapping as both a
reverse and forward genetic mutagenesis strategy, as they can be either
phenotype or genotype-driven.
1.3.4.1 In vitro phenotype-based screens
This type of screens relies on the isolation of insertional events that
give rise to interesting reporter expression patterns in vitro. For example, an
important selection criterion frequently employed in such 'directed' gene
trap screens is the subcellular localisation of the trapped/reporter protein
fusion, which is also theoretically an indicator of the trapped protein's
function. This concept has been successfully implemented in gene trap
studies aiming to identify genes that encode proteins confined to nuclear
compartments (Tate et al., 1998; Sutherland et al., 2001). Furthermore, the
capacity of ES cells to differentiate into various cell types in vitro has been
exploited widely in expression and induction gene trap screens which aim to
identify developmentally important and lineage-specific genes; trapped ES
cell clones are driven to differentiate in vitro (see Section 1.1.3) and the ones
that exhibit reporter expression at the desired developmental stage are
selected for further analysis in vivo.
Expression trap screens have been employed successfully to identify
and mutate genes that are expressed in haematopoietic (Stanford et al. 1998;
Muth et al. 1998; Hidaka et al. 2000) and endothelial lineages (Stanford et al.
1998; Hirashima et al. 2004), cardiomyocytes (Baker et al. 1997), chondrocytes
(Baker et al. 1997), cardiomyocytes (Chen and Chen, 2004), and neurons
(Shirai et al. 1996). Induction screens, (which involve the directed
administration of specific developmental cues) have identified and mutated
genes regulated by retinoic acid (Forrester et al. 1996; McClive et al. 1998;
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Sam et al. 1998; Gajovic et al. 1998; Komada et al. 2000), engrailed homeobox
proteins (Mainguy et al. 2000), WNT-3A proteins (Yamaguchi et al., 2005),
BMP2 (Kluppel et al. 2002) and FGF1 (Tateossian et al. 2004).
An alternative approach aiming to characterise genes of a predefined
developmental and functional profile involves the use of gene trapping in
cell lines other than ES cells. Some examples include the isolation of: genes
activated during programmed cell death by applying a Cre/loxP gene trap
system to interleukin-3 (IL-3)-dependent FDCP1 haematopoietic cells (Russ
et al., 1996; Wempe et al., 2001); genes modulated by the granulocyte-
macrophage colony-stimulating factor (GM-CSF) by employing the GM-
CSF/IL-3 dependent human premyeloid TF-1 cell line (Baghdoyan et al.,
2000); and genes regulated by germ cells and nerve growth factor (NGF) by
using the Sertoli differentiated cell line 15P-1 (Vidal et al., 2001).
1.3.4.2 Genotype-driven pre-selection
Genotype-driven pre-selection of gene trap events is based on the
prior sequence identification of the disrupted locus. These screens were
greatly assisted by the progressive optimisation of RACE protocols in a high-
throughput context (Townley et al., 1997) and the completion of the mouse
genome sequencing. All large-scale gene trap projects predominantly employ
this approach; different gene trap vectors are introduced into ES cells to
construct huge libraries which are then 'screened' at a genomic level through
the generation of RACE tags unique for each gene trap clone. These RACE
sequences which are usually publicly accessible can then be utilised for the
further isolation and analysis (in vitro or in vivo) of gene trap clones that carry
an insertion at a locus of interest.
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1.3.5 The quest for genome saturation
The International Gene Trap Consortium (Nord et al., 2006; website:
http://www.igtc.org/) was established as a subgroup of the International
Mouse Mutagenesis Consortium aiming to generate an international resource
of ES cells with gene trap insertions in every, or most genes in the mouse
genome ("genome saturation"). The Consortium brings together all major
centres that perform large-scale, high-throughput gene trap mutagenesis
such as The Centre for Modelling Human Disease (To et al. 2004;
http://www.cmhd.ca/sub/genetrap.asp), the German Gene Trap Consortium
(Hansen et al., 2003; http://genetrap.de), the Sanger Institute
(http://www.sanger.ac.uk/PostGenomics/genetrap/), and BayGenomics
(Stryke et al. 2003; http://baygenomics.ucsf.edu/) as well as smaller groups,
which employ gene trapping to address more specific biological questions.
An overview of the major gene trap groups is given in Table 1.3. To date, the
IGTC has attained 40% genome coverage in approximately 45,000 gene trap
cell lines (Nord et al., 2006). These clones are freely available to the scientific
community. A similar high-throughput, gene trap mutagenesis-based project
is being carried out independently by the private company Lexicon Genetics
yielding the development of the largest to date sequence-tagged, gene trap
library (Omnibank; www.lexicon-genetics.com/omnibank/) of >270,000
mouse embryonic stem cell clones. These represent mutations in
approximately 60% of mouse genes (Zambrowicz et al., 2003).
The analysis of data obtained from these high-throughput projects
employing a variety of different vectors (both plasmid and retroviral) has
provided some valuable insights into the nature of gene trap mutagenesis.
There is now considerable evidence showing that gene trapping is not as
random as was initially believed. Hansen et al. (2003) (German Gene Trap
Consortium) demonstrated that different vectors have different site
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Research Group Website Comments
The Sanger Gene
Trap Resource


















http://www.genetrap.gsf.de Mainly based on the

















IRBM-TIGEM http://genetrap.tigem.it Use of loxP/FTR
containing gene trap
vectors
EGTC http://egtc.jp Focus on conditional
gene trapping
NAISTrap http://bsw3.naist.jp/kawaichi/naistrap.html Use of RET-based
poly(A) trap vectors





Table 1.3 An overview of all major gene trap groups that carry out large-scale gene trap
projects.
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preferences for integration within the mouse genome. Some of these "hot
spots" were found to be vector-independent whereas some others were
specific to different vectors. A consensus has emerged that the probability of
successfully trapping a gene is influenced by its size and its expression level
although secondary chromatin structure might also be a critical determinant
(Hansen et al., 2003).
Results obtained from the large-scale gene trap mutagenesis project
conducted by Lexicon indicate that the rate of trapping new genes is not
linear but declines after a specific point (Zambrowicz et al., 2003; Skarnes et
al., 2004) (Figure 1.10). This is corroborated by the public gene trap resources
(Figure 1.10); the efficiency of their trapping has now dropped to
approximately 10% (i.e. one novel gene mutated per 10 trapped clones
isolated) (Skarnes, 2005). However, the initial trapping rate was higher for
IGTC compared to Lexicon (Figure 1.10). This may reflect the fact that the
IGTC trapping efforts are based on the employment of a combination of
different gene trap constructs both retroviral and plasmid. Lexicon, on the
other hand, has adopted a less diverse, standardised experimental protocol.
It is now widely accepted that the best route to achieve saturation is only
through the parallel use of different vector types (Hansen et al., 2003; Skarnes
et al., 2004). Interestingly, a similar large-scale project that aimed to identify
and mutate genes essential for embryonic development in zebrafish through
the use of a retroviral gene trap vector yielded the generation ofmutants that
correspond to only 25% genome coverage (Amsterdam et al., 2004). This can
be probably attributed to the fact that only a single trapping approach was
employed, thus providing a further piece of evidence that the use of a
combination of vectors and methodologies is the optimal strategy to achieve















50.000 100,000 150.000 200,000
Sequence tags
Figure 1.10 Comparison of the rates of trapping of the IGTC and OmniBank (Lexicon)
resources (from Skarnes et al., 2004).
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which target fractions of the mouse genome inaccessible to conventional
gene trap vectors would be beneficial.
1.3.6 Poly(A) trapping
Trapping genes that are not expressed in undifferentiated ES cells is a
major challenge for vector designers. Traditional figeo type vectors can lead
to the entrapment of even weakly expressed in ES cells genes since selection
on the basis of resistance to neomycin is more sensitive than X-gal staining
(see Section 1.3.2.1). Hence resistant clones that are (3gal negative are likely to
carry integrations within genes expressed at low levels but still some
minimal degree of transcription is a prerequisite for trapping (Friedrich and
Soriano, 1991; Skarnes et al., 1995). This limitation results in the under-
representation of mutations in many developmentally important genes
which are transcriptionally silent in ES cells; a database search using the
IGTC server shows that many genes required for germ layer/lineage
specification such as Wnt3a, Scl, MyoD, Nkx2-5, Soxl and Soxl7 have not
been trapped to date by any of the gene trap vectors employed by the IGTC
members. It is estimated that approximately 60-70% of all mouse genes are
accessible to entrapment through the use of figeo constructs (Skarnes et al.,
2004; Schnutgen et al., 2005). It is therefore evident that in order to achieve
genome saturation using gene trap mutagenesis, alternative vector designs,
targeting this 'untrappable' 30-40% of the mouse genome, are desirable. For
this reason, a new generation of constructs, termed poly(A) trap vectors,
were developed.
A typical poly(A) trap vector is characterized by the presence of a
constitutive promoter that drives the expression of a drug resistance marker
(Figure 1.11) thus alleviating the need for endogenous trapped gene
expression to select for vector insertions and enhancing the vector's potential
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Figure 1.11 Poly(A) trapping. Schematic representation of poly(A) trapping. PolyA trap
vectors contain a promoter driven selectable marker (e.g. neo) lacking a polyadenylation
signal downstream of a reporter gene (e.g. lacZ). A stable fusion neo transcript and protein
that incorporates downstream endogenous sequences is generated only after insertion into a
gene whose endogenous polyA signal is acquired by the vector via a splice donor site. The
upstream reporter gene acts as a gene trap and allows the monitoring of endogenous gene
expression. P, promoter; pA, polyadenylation signal site; SD, splice donor; SA, splice
acceptor.
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to trap genes not expressed in undifferentiated ES cells. Furthermore, the
selectable marker lacks a poly(A) signal, but includes a splice donor (SD)
sequence and hence a spliced polyA signal (derived via splicing) from an
endogenous gene is required to generate stable selectable marker's mRNA
and, in turn, resistant clones. This feature should theoretically favour the
selection of insertions within transcriptional units and the elimination of
'background' intergenic integrations. In addition, the presence of several
termination codons following the selectable marker prevents the expression
of the 3' trapped exons. The trapped gene's sequence can be determined
through the use of 3'RACE PCR which is more straightforward in
comparison to the technically challenging 5'RACE protocols. It should be
noted that poly(A) trap vectors still employ a 5'SA-reporter-pA component
similar to a traditional (3geo-type construct (Figure 1.11) but in this case the
5'component acts exclusively as a means of monitoring the trapped gene's
expression status and not as a selector of the gene trap event.
1.3.6.1 Evolution of poly(A) trap vector designs
The first polyA-trap vectors (U1 and U2) to be developed (Niwa et al.,
1993) contained a phosphoglycerate kinase (PGK) promoter to drive the
expression of the neomycin resistance gene which lacked a polyA addition
signal. A lacZ reporter was located upstream of PGK promoter-neo and
downstream of a SA allowing for endogenous gene expression to be
monitored. However, the use of these vectors was characterised by large
deletions or rearrangements spanning more than lOkb in the 3'-flanking
region of the vector (Niwa et al., 1993). An improved poly(A) trap vector
(pPAT) was subsequently designed. It incorporated a SD sequence (derived
from the mouse fyn gene exon 3/intron 3 splice junction) which was placed
downstream of the neo gene leading to more efficient poly(A) trapping
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(Yoshida et al., 1995). Although the integrational behaviour of this vector at
the molecular level was not further investigated in depth (only 12 clones
were successfully analysed by 3'RACE PCR), its design constituted the basis
for the construction of the next generation of poly(A) trap vectors. A
modified version of the pPAT vector, which was subsequently employed in a
gene trap expression screen designed to enrich for neuron-specific genes,
was shown to exhibit a high propensity for concatemer formation (Carroll et
al„ 2001).
The first evidence indicating the capacity of poly(A) trap vectors to
target developmentally regulated genes came from the use of a vector
(IRES(3galNeo(-pA)) that consisted of a 5' SA-IRES-(3gal-pA cassette and a
poly(A) trap component which included the /3-actin promoter driving the
expression of the neomycin resistance gene and a SD from the mouse Pax-2
gene (Salminen et al., 1998). This vector appeared to integrate within
transcriptional units that are inactive in undifferentiated ES cells since the
number of the resulting (3-galactosidase positive gene trap clones increased
after in vitro differentiation, suggesting an induction in the expression of
trapped lineage-specific genes (Salminen et al., 1998). However, employment
of the IRES(3galNeo(-pA) vector in combination with an expression screening
strategy showed that the vector's Pax-2 SD does not always function properly
(Hirashima et al., 2004).
The large-scale gene trap project carried out by Lexicon Genetics was
initially based on the use of poly(A) trap vectors (Zambrowicz et al., 1998). In
this case a retroviral poly(A) trap vector (VICTR20) containing a mutagenic
component (SA-IRES-(3geo-pA) and a poly(A) trap module (PGK promoter-
puro-SD) was successfully employed to generate a library of 2,000 gene trap
ES cell lines (Omnibank; Zambrowicz et al., 1998). Most importantly, this
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specific study showed, through RT-PCR-based expression analysis of
trapped genes, that several trapped clones carried vector integrations within
genes that are not expressed in undifferentiated ES cells (Zambrowicz et al.,
1998). However, the VICTR20 poly(A) trap vector was later found to possess
a low trapping efficiency (only 10% of the integrations occurred within
functional genes; Brian Zambrowicz, personal communication).
Consequently, Lexicon focused on the use of a SA-type construct as a tool for
'building' their Omnibank library (http://www.lexgen.com/omnibank/;
Zambrowicz et al., 2003). The new construct they used is similar in design to
the ROSAFARY vector (section 1.3.2.3). It relies on a promoterless selectable
marker ifigeo) to facilitate gene entrapment but it also includes a 3'trapping
component containing a PGK promoter-driven artificial exon (instead of a
selectable marker) and a SD sequence, both derived from the murine Bruton's
tyrosine kinase (Btk) gene (Zambrowicz et al., 2003). The poly(A) trap cassette
in this vector serves as a means of acquiring more informative sequence
(compared to 5'RACE-obtained sequence) from the 3' end of a trapped gene
through 3' RACE.
The most recently developed poly(A) trap vector designs incorporate
(as in the case of modern SA-type vectors) loxP and FRT sites for use in
RMCE-based approaches (Ishida and Ledder; Cobellis et al., 2005; Xin et al.,
2005; Osipovich et al., 2005). This feature is particularly useful for testing and
identifying optimal sequence elements thus bypassing the need to construct
new vectors (Osipovich et al., 2005).
1.3.6.2 Large-scale projects employing poly(A) trapping
A high-throughput gene trap project that employs poly(A) trapping is
being carried out by William Stanford's group in the Centre for Modelling
Human Disease (CMHD) (Table 1.3) (To et al., 2004). Their efforts involve the
49
utilisation of a variety of vectors that contain combinations of different
functional components within their 5'reporter and poly(A) trap modules
(www.cmhd.ca/genetrap/vectors). Moreover, most of these vectors include
loxP sites thus allowing the engineering, through the action of Cre
recombinase, of sequences inserted in individual trapped clones.
Another RMCE-based, poly(A) trapping strategy that has been used
on a large-scale gene trap project (NAISTrap database; website:
http://bsw3.naist.jp/kawaichi/naistrap.html) (Table 1.3) is based on the
employment of a retroviral polyA trap vector called RET (removable exon
trap; Ishida and Leder, 1999) (Figure 1.12). The RET vector employs GFP as
the promoterless reporter of disrupted gene expression. It also includes the
MCI promoter-driven HS\-tk gene for negative selection and a 3'poly(A)
trap component consisting of the RNA polymerase II promoter, neo and a SD
from the mouse hprt gene (exon 8/intron 8 splice junction) (Figure 1.12).
Ishida and Leder (1999) tested successfully the functional components of this
novel vector and 3'RACE analysis of GFP-negative, trapped clones showed
that these clones carry integrations within genes that are not expressed or are
very weakly expressed. In addition, they demonstrated that integrated RET
proviruses can be efficiently removed from the genome of infected cells
using Cre-mediated homologous recombination (Ishida and Leder, 1999).
However, poly(A) trapping using the RET vector was subsequently found to
be non-random due to the vector's tendency for integrations in the last intron
of its target genes (Shigeoka et al., 2005) (see section 1.6.3.4). It is worth
noting that the RET vector has been used to create a gene trap clone library
from human female ES cells and led to the successful development of a
model for studying X chromosome inactivation through the employment of
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Figure 1.12 The RET gene-trap vector. (A) Structure of the RET vector in a packaging cell
line. (B) Structure of the RET provirus in infected cells. (C) Structure of residual provirus
elements following Cre-mediated excision. Diagonally striped black rectangles represent
exons of a trapped gene. En (-): enhancer deletion; P1: MC1 promoter; P2: RNA polymerase
II promoter (short form); X-GFP mRNA: fusion transcript for the 5'-half of the trapped gene X
and the GFP cDNA (from Ishida and Ledder, 1999).
a trapped clone that contained an integration in the X chromosome (Dhara
and Benvenisty, 2004).
The same group (NAISTrap) has also reported the efficient coupling of
poly(A) trapping with microarray technology; a modified version of the RET
vector was used for the generation of a library of 900 trapped ES cell clones
and cDNA fragments derived from the disrupted genes were then utilised
for the construction of DNA arrays to facilitate profiling of the expression
patterns of the trapped loci (Matsuda et al., 2004). This "synergistic coupling"
of poly(A) trapping with DNA arrays enables the rapid screening of a large
number of clones and the consequent identification of mutated
transcriptional units that exhibit expression patterns of interest (Matsuda et
al., 2004).
1.3.6.3 AU-rich elements and poly(A) trapping
AU-rich elements (AREs) are czs-sequence element regulators of
mRNA turnover that reside in the 3' untranslated region (3'UTR) of many
cytokine and oncogene transcripts (Mitchell and Tollervey, 2000a; Zhang et
al., 2002). They are composed of variable numbers of the AUUUA pentamer
or UUAUUUAUU nonamer and are classified into three categories based on
the number and the distribution of the AUUUA pentamer they contain. Class
I AREs (e.g. c-Fos) contain three to five scattered pentamers coupled with a
nearby U-rich region; class II AREs (e.g. GM-CSF, TNF-a, COX-2) include
multiple AUUUA motifs with some overlapping; and class III elements (e.g.
c-Jun) do not contain any pentamers but possess U-rich regions (Zhang et al.,
2002).
AREs have been identified by their ability to mediate decay of the host
mRNA via deadenylation and subsequent degradation (Brewer and Ross,
1988; Wilson and Treisman, 1988; Shyu et al., 1989; Shyu et al., 1991; Xu et al.,
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1997; Ford et al.,1999). However, AREs can also lead to stabilization of an
mRNA transcript. The stability status of ARE-containing mRNAs depends on
the identity and relative levels of ARE-binding proteins which exert their
effects in a redundant/additive or antagonistic fashion (for a review see
Barreau et al., 2005). Examples of proteins that promote ARE-mRNA
degradation include AUF1 (Loflin et al., 1999), TTP (Lai et al., 1999), and
BRF1 (Stoecklin et al., 2002). Furthermore, it has been recently demonstrated
that the enzyme Dicer is involved, in vitro, in the degradation of a reporter
RNA molecule containing the GM-CSF ARE (Takahashi et al., 2006).
Examples of ARE-binding proteins that facilitate ARE-mRNA stabilization
include HuR (Fan and Steitz, 1998; Peng et al., 1998) and NF-90 (Shim et al.,
2002).
The destabilising action of AREs was first demonstrated through the
use of a [3-globin reporter mRNA. When the ARE from the human GM-CSF
was inserted into the 3'UTR of the rabbit (3-globin gene, the otherwise stable
(3-globin transcript was destabilised and reduced to approximately 3% of the
wild-type levels (Shaw and Kamen, 1986). The first and rate-limiting step in
the degradation of ARE-mRNAs is deadenylation, which can proceed either
synchronously (class I and III AREs) or asynchronously (class II AREs) (Chen
and Shyu, 1994; Chen et al., 1994; Chen et al., 1995). mRNA deadenylation is
followed by 5'-3' (in yeast) or 3'-5' (in mammals) degradation which is
carried out in vitro by a large, highly conserved amongst eukaryotes,
multiprotein complex called the exosome. The yeast exosome consists of at
least ten subunits all of which exhibit exonucleolytic and/or RNA binding
activities. Both yeast and human exosome components exhibit sequence
similarity to E. coli RNase PH, RNase D, or RNase R (Allmang et al., 1999;
Mitchell and Tollervey, 2000b). It has been shown that certain ARE-binding
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proteins (e.g. TTP) can physically associate with the exosome and facilitate its
recruitment (Brewer, 1998; Chen et al., 2001) to the target mRNA. RHAU, a
putative DExH RNA helicase that also interacts with the exosome is
considered to be an additional key player in this process (Tran et al., 2004).
5'-3' degradation of ARE-mRNAs might also occur in mammalian cells
(Kedersha and Anderson, 2002; Gao et al., 2001) and it is linked to cellular
entities such as P- or GW bodies (Sheth and Parker, 2003; Kedersha et al.,
2005) which contain mRNA decapping (Dcpl and Dcp2) and degradation
(the 5'-3' exonuclease Xrnl) factors (Kedersha et al., 2005; Ingelfinger et al.,
2002; Eystathioy et al., 2003).
The RNA-destabilising property of AREs was exploited in the design
of poly(A) trap vectors as a means for reducing background due to intergenic
insertions and vector read-through events (Ishida and Ledder, 1999; Matsuda
et al., 2004; Osipovich et al., 2005). For example the RET vector was
engineered to include an ARE from the human GM-CSF gene located
downstream of the vector's SD (Figure 1.12) (Ishida and Ledder, 1999). This
should theoretically result in the destabilisation of neo mRNA transcripts that
arise from direct read-through into the vector's SD intron or target genomic
regions. Conversely, proper splicing events between the vector's SD and an
endogenous SA should result in the removal of the ARE and the consequent
stabilisation of the neo fusion transcripts, provided that 'trapping' of a
functional gene's poly(A) signal occurred. Initial data from Ishida and
Ledder suggest that this approach has a positive effect in enhancing the
efficiency of poly(A) trapping: when HAT resistant, RET vector (+ or -ARE)-
infected NIH 3T3 tk(-) cells (HAT selection was used to isolate all infection
events) were selected in neomycin, the percentage of G418 resistant colonies
that contained integrations with the ARE-containing version of the RET
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vector was found to be 13% compared to 26% which was obtained after
infection with the non-ARE vector (Ishida and Ledder, 1999). Although this
reduction is likely to reflect an enrichment in the fraction of desired
intragenic integrations, the comparison between the +ARE and the -ARE
versions of the RET vector was not accompanied by the corresponding
3'RACE PCR data. Therefore further investigation is required in order to
define the role (especially in molecular terms) of an ARE as an enhancer of a
poly(A) trap vector's performance.
1.3.6.4 Limitations of poly(A) trapping
Despite the advantages that poly(A) trapping theoretically offers, the
performance of constructs that utilise this strategy has so far been quite
inconsistent. Some of the limitations associated with the use of poly(A) trap
vectors include inefficient 3'splicing due to poor SD performance (Hirashima
et al., 2004; Zambrowicz et al., 2003) as well as high background due to a
tendency for integrations outside functional genes (Zambrowicz et al., 2003)
probably through promiscuous employment of poly(A) signal sites. Several
investigators have tried to address these issues by testing various
combinations of different internal promoters, selectable markers and splice
donor sequences (Zambrowicz et al., 2003; Matsuda et al., 2004; Shigeoka et
al., 2005; Osipovich et al., 2005).
The most serious caveat of poly(A) trapping is the recent
demonstration that poly(A) trap vectors tend to integrate into the last
(3'most) intron of their target genes, a bias that jeopardises the theoretically
random nature of poly(A) trapping and, most importantly, its mutagenic
potential (Shigeoka et al., 2005). Shigeoka et al., observed that the 88% of
gene trap insertions, generated by their large scale gene trap project
employing the RET poly(A) vector, exhibited this 3'-most intron bias. The
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same tendency was demonstrated for the poly(A) trap constructs employed
by the CMHD gene trap group (Shigeoka et al., 2005). This bias is believed to
be caused by an mRNA surveillance mechanism called nonsense-mediated
mRNA decay (NMD) (Shigeoka et al., 2005). The role of NMD consists of
preventing the production of truncated proteins that could function in a
dominant-negative fashion by eliminating abnormal transcripts that
prematurely terminate translation (for a review see Maquat, 2004). NMD
induces the degradation of transcripts in which a termination codon (TC) is
placed more than 55-60 nt 5' to the last exon-exon junction and hence is
recognised by the NMD surveillance machinery as a premature TC (PTC)
(Shigeoka et al., 2005).
It was hypothesised that the TC of the poly(A) trap cassette's neo
resistance gene is recognised as a PTC when vector insertion occurs into one
of the upstream introns (other than the last one) of a trapped gene (Shigeoka
et al., 2005). This subsequently leads to the degradation of the resulting neo-
trapped gene fusion transcript due to the action of NMD (Shigeoka et al.,
2005) (Figure 1.13a). In contrast, vector insertion into a gene's last intron
would result in the generation of an NMD-immune fusion transcript because
the distance between the neo TC and the last exon-exon junction is probably
too short to efficiently elicit an NMD response (Shigeoka et al., 2005). This
has been proposed to account for the over-representation of poly(A) trap
insertions in the last intron of target genes (Figure 1.13b). Consequently, an
improved poly(A) trap vector, termed UPATrap, was developed (Shigeoka et
al., 2005). Its structure is similar to that of the RET vector apart from the fact
that it incorporates an IRES sequence which is flanked by two loxP sites and
is positioned between the neo cassette's TC and the SD sequence (Shigeoka et
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Figure 1.13 Proposed model for the biased selection of the vector integration sites in
poly(A) trapping, (a) Vector integration within an intron other than the last one places the
termination codon (TC) of the vector's neo cassette at a distance greater than 60 nt from the
last exon-exon junction causing the degradation of the resulting fusion transcript through
NMD since the TC of the neo coding sequence is recognised as a PTC. (b) Vector
integration within a target gene's last intron results in resistance to NMD since the distance
between the neo TC and the last exon-exon junction is shorter than 60 nt. It should be noted
that only the vector's poly(A) trap component is shown. TC, termination codon; IC, initiation
codon; P, promoter; pA, polyadenylation signal; SD, splice donor; NMD, nonsense mediated
mRNA decay. (Adapted from Shigeoka et al., 2005).
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the selectable-marker mRNA and permit the trapping of transcriptionally
silent genes without a bias in the vector-integration site (Shigeoka et al.,
2005). The authors postulated that the presence of the IRES probably blocks
the NMD initiation stages either by "displacing the exon-exon junction
complexes (EJCs) from downstream exon-exon junctions" or by promoting
the formation of a complex secondary structure at the RNA level (Shigeoka et
al., 2005).
The biased nature of poly(A) trapping is likely to contribute to the fact
that the in vivo mutagenic capacity of poly(A) trap vectors has proved so far
unconvincing. The tendency of this type of vectors to integrate within the last
intron of genes is likely to result in the generation of hypomorphic mutations
that do not generate a phenotype. The few published examples of mutant
strains generated through the employment of poly(A) trap vectors seem to
support this prediction; there is only one reported example of a poly(A) trap
vector-generated mutation that is linked to an obvious (not lethal) phenotype
(Tarrant et al., 2002; vector insertion in this case took place within an intron
closer to the 5'end of the gene) while the majority of the reported mutants
showed no abnormalities (Tsukahara et al., 2000; Tsukahara et al., 2001;
Carroll et al., 2001; Hirashima et al., 2004).
1.4 Project overview
This thesis reports the characterization of a series of novel gene trap
vector constructs. The novel features of these vectors include: (a) a 5'tripartite
reporter fusion between the eGFP, (3-galactosidase and neomycin or
hygromycin resistance genes and (b) a 3'poly(A) trap component that
contains a SD sequence derived from the rabbit jSglobin gene and an ARE
from the human GM-CSF gene. The project's experimental design aimed to
assess the function of each of these components. We provide evidence that
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the triple fusion functions properly and can be potentially used as a reporter
of trapped locus activity. We also show that the presence of the ARE appears
to improve the performance of the rabbit figlobin SD sequence in the context
of poly(A) trapping. More importantly, preliminary data suggest that our





2.1 Molecular Biology Methods
2.1.1 Plasmid Vector Construction
Plasmid gene trap vectors pEGeo2, pEGeo2puroSD2 and
pEHygro2neoSD2 (Figure 2.1) were constructed by Dr. Joshua Brickman and
Dr. Elena Tzouanakou at the Institute of Stem Cell Research (ISCR). Vector
pEGeo2 consists of the mouse En-2 splice acceptor and a triple fusion
between egfp, [3-galactosidase and neomycin resistance genes followed by
the SV40 polyA signal site. Vector pEGeo2puroSD2consists of the mouse En-
2 splice acceptor and a triple fusion between egfp, (3-galactosidase and
neomycin resistance genes followed by the SV40 polyA signal site and a 3'
cassette that contains the human (3-actin promoter driving the constitutive
expression of the puromycin resistance gene and the rabbit (3-globin exon
2/intron 2 splice donor junction. Vector pEHygro2neoSD2 consists of the
mouse En-2 splice acceptor and a triple fusion between egfp, [3-galactosidase
and hygromycin B resistance genes followed by the SV40 polyA sequence
site and a 3' cassette containing the constitutive human [3-actin promoter, the
neomycin resistance gene and the rabbit [3-globin exon 2/intron 2 splice
donor junction. It should be noted that in all cases a glycine hinge domain (16
glycine codons) was inserted at both ends of the egfp sequence in order to
confer flexibility to the tripartite fusion protein (Bronchain et al., 1999) while













Figure 2.1 Gene trap vectors employed. Schematic representation of the linearised
versions of plasmid gene trap vectors pEGeo2, pEGeo2puroSD2and pEHygro2neoSD2 . En-
2, engrailed-2; pA, polyA; SA, splice acceptor; SD, splice donor; P, promoter; neo, neomycin
resistance gene; (3geo, fusion between |3-galactosidase and neomycin resistance genes;
Phygro, fusion between p-galactosidase and hygromycin resistance genes.
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2.1.2 Construction of pEHygro2neoSD2 (+ARE) gene trap vector
Gene trap vector pEHygro2neoSD2 (+ARE) (Figure 2.2) is identical to
plasmid pEHygro2neoSD2 but it also includes a 50 bp AU-rich RNA
destabilising element (ARE)
(TAATATTTATATATTTATATTTTAAAATATTTATTTATTTATTTATTTAA
) from the human GM-CSF gene (Xu et al. 1997). The map of the plasmid is
given in Appendix 1. The construction of the vector involved the following
steps:
(i) Plasmid pBKnSDARE (30 pg) which contains the constitutive human
P-actin promoter, the neomycin resistance gene, the rabbit p-globin
IVS2 splice donor (exon 2/intron 2 splice donor junction) and the ARE
was digested at 37»c with restriction endonucleases AscI and PacI
(New England Biolabs) (70 U of each) and the resulting 2404 bp
fragment predicted to include the P-actin P/neo/SD cassette was
excised and gel-purified using the Qiaquick® Gel Extraction kit
(Qiagen) following the manufacturer's guidelines.
(ii) Gene trap vector pEHygro2neoSD2 (Figure 2.1) was also doubly
digested with AscI/PacI and the resulting 10085 bp fragment
(SA/egfp/phygro/pA cassette) was excised and gel-purified.
(iii) The purified 10085 bp fragment was dephosporylated by incubating
together with 2 pi of Shrimp Alkaline Phosphatase (USB Corporation)
at 37°C for 15 minutes and then at 65°C for 15 minutes and then
ethanol-precipitated by adding 1/10 of the total reaction volume
(1/10V=3 pi) of 3M sodium acetate (pH 5.2) and 2 volumes (=60 pi) of
100% ethanol, freezing for 5 minutes at -140 °C and spinning at 13,000
rpm for 20 minutes in a tabletop microcentrifuge (Biofuge 13,
Heraeus, Sepatech). The precipitated pellet was washed twice with
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Figure 2.2 Schematic representation of the linearised version of plasmid gene trap vector
pEHygro2neoSD2 +ARE. En-2, engrailed-2; pA, polyA; SA, splice acceptor; SD, splice
donor; P, promoter; neo, neomycin resistance gene; (3hygro, fusion between (3-galactosidase
and hygromycin resistance genes.
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70% ethanol and after air-drying in a laminar flow sterile hood for 5-
10 minutes it was resuspended in 20 pi of distilled H2O.
(iv) The 2404 bp fragment generated from the double AscI/PacI digestion
of plasmid pBKnSDARE and the 10085 bp fragment produced from
the double AscI/PacI digestion of plasmid vector pEHygro2neoSD2
were mixed together at various different molar ratios (also included
vector- and insert-only controls) in the presence of 2 U of T4 DNA
ligase (Roche) and 2 pi lOx ligation buffer (660 mM Tris-HCl, 50 mM
MgCb, 50 mM DTT, 10 mM ATP, pH 7.5 at 20°C-final reaction
volume=20 pi). The ligation reactions were left at 16°C overnight.
(v) 3 pi of each ligation reaction were added into 40 pi aliquots of MAX
Efficiency ® DH5a™ chemically competent cells (Invitrogen) and the
mixtures were left on ice for 40 minutes followed by heat-shocking at
42°C for 45 s. After heat-shock the cells were transferred onto ice and
left for 10 minutes. S.O.C medium (2% Tryptone; 0.5% Yeast Extract;
10 mM NaCl; 2.5 mM KC1; 10 mM MgCh; 10 mM MgSCU; 20 mM
glucose-Invitrogen) was then added and the tubes were shaken
horizontally (200 rpm) at 37 °C for 1 hour and 20 minutes. The
transformants were spread on pre-warmed ampicillin-containing
(100 pg/ml) LB agar plates, which were then incubated overnight at
37 °C. Approximately 30 ampicillin-resistant clones were obtained
and plasmid DNA was isolated from each of them using the QIAprep
Spin Miniprep Kit (Qiagen). The success of the ligation reactions was
determined by a combination of diagnostic restriction enzyme
digests, PCR and sequencing of the resulting DNA minipreps.
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2.1.3 Nucleic Acid Manipulation and Cloning
2.1.3.1 Transformation of Bacterial Cells
lpl of plasmid DNA was added into a 75 |J,1 aliquot of chemically
competent, subcloning efficiency DH5a bacterial cells. After mixing gently,
cells were incubated on ice for 15 minutes and then heat-shocked at 42°C for
2 minutes. The transformation mixture was then immediately transferred
onto ice and after a further 5-10 minute incubation, 1ml of pre-warmed Luria
Broth (LB) culture medium was added and the tube containing the mixture
was left shaking (200 rpm) horizontally at 37°C for 1 hour in an orbital
shaker. Finally, transformed cells were spun at 3,000 rpm for 3 minutes in a
table-top microcentrifuge (Biofuge 13, Heraeus, Sepatech) and 50 pi of the
resuspended cell pellet (volume of approximately 100 pi) were spread on a
prewarmed LB agar plate with 100 pg/ml ampicillin as selection. The plate
was left at 37°C overnight until visible colonies appeared. Glycerol stocks of
transformed cells were made by inoculating 5 ml of selective LB medium
(100 pg/ml Ampicillin) with a single transformed colony picked with a sterile
yellow Gilson tip from a fresh plate. The culture was grown at 37°C for about
8 hours with shaking to reach log phase and then cells were centrifuged at
4,000 rpm for 5 minutes and the pellet was resuspended in LB containing
15% sterile glycerol. Cells were then dispensed into 500 pi aliquots in pre-
chilled screw capped eppendorf tubes and stored at -80°C.
2.1.3.1 TA Cloning of PCR Products
Purified PCR products were cloned using the TOPO TA Cloning® Kit
for Sequencing (Invitrogen) following the supplier's guidelines. Briefly,
direct insertion of the purified PCR products into the linearised pCR®4-
TOPO® plasmid vector (Invitrogen), which contains overhanging 3'
deoxythymidine (T) residues, was performed by incubating 4 pi of purified
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PCR product with 1 pi pCR®4-TOPO® vector and 1 pi salt solution (200 mM
NaCl; 10 mM MgCh) provided by the kit at room temperature for
approximately 5 minutes. 2 pi of the TOPO® Cloning reaction were then
added into a vial of One Shot® TOPIO Chemically Competent E. coli cells
(Invitrogen) and cells were incubated on ice for approximately 10 minutes.
The ice incubation was followed by heat-shocking of the cells for 30 seconds
at 42°C after which the tubes were immediately transferred onto ice and 250
pi of room temperature S.O.C medium (2% Tryptone; 0.5% Yeast Extract; 10
mM NaCl; 2.5 mM KC1; 10 mM MgCh; 10 mM MgS04; 20 mM glucose-
Invitrogen) was added. Tubes were capped tightly and shaken horizontally
(200 rpm) at 37°C for 1 hour. 50 pi from each transformation were spread on
a pre-warmed ampicillin-containing (100 pg/ml) LB agar plate, which was
then incubated overnight at 37°C. The resulting colonies were picked for
subsequent plasmid DNA isolation and sequencing (see below).
2.1.3.2 DNA Isolation
2.1.3.3.1 DNA plasmid minipreps
A single colony was picked with a sterile yellow Gilson tip and used
for inoculation of 5 ml of ampicillin-containing (100 pg/ml) LB medium. The
culture was incubated at 37 °C overnight with shaking. Bacterial cells were
harvested by centrifugation at 4,000 rpm for 5 minutes (CENTRA-3, IEC).
Plasmid DNA extraction was then carried out using the QIAprep Spin
Miniprep Kit (Qiagen) according to the manufacturer's instructions. The
bacterial pellet was resuspended in 250 pi of Buffer PI (Resuspension Buffer-
50 mM Tris-Cl, pH 8.0; 10 mM EDTA; 100 pg/ml RNase A) and transferred to
an eppendorf microcentrifuge tube. Buffers P2 (Lysis Buffer-200 mM NaOH;
1% SDS) and N3 (high salt-containing buffer) were then added sequentially
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(250 pi and 350 pi respectively) to facilitate alkaline lysis of the cells, lysate
neutralization and precipitation of proteins and chromosomal DNA. The
tube was centrifuged for 10 minutes at 13,000 rpm in a table-top
microcentrifuge (Biofuge 13, Heraeus, Sepatech) and the supernatant was
applied by pipetting to a QIAprep spin column (contains a silica membrane
for selective adsorption of plasmid DNA in the presence of the high-salt
buffer N3) which was then centrifuged for 1 minute at 13,000 rpm. After
discarding the flow-through the column was washed first by adding 0.5ml
Buffer PB and centrifuging for 1 minute at 13,000 rpm and then by adding
0.75 ml Buffer PE (ethanol-containing) and centrifuging twice for 1 minute at
13,000 rpm. Elution of DNA was performed by adding 35 pi of buffer EB to
the centre of the column (placed in a clean 1.5 ml eppendorf microcentrifuge
tube), letting it stand for 1 minute and centrifuging at 13,000 rpm for 1
minute.
2.1.3.3.2 DNA plasmid maxipreps
For the preparation of higher amounts of plasmid DNA the HiSpeed
Plasmid Maxi Kit (Qiagen) was employed following the manufacturer's
instructions. A single colony was picked with a sterile yellow Gilson tip and
used for inoculation of 150 ml of ampicillin-containing (100 pg/ml) LB
medium. The culture was incubated at 37°C overnight with shaking (200
rpm). Bacterial cells were harvested by centrifugation at 6000 rpm for 15
minutes at 4°C (SLA-1500 rotor, RC5C, Sorvall Instruments, Du Pont). All
buffers were provided in the kit unless otherwise stated. Briefly, the pellet
was resuspended in 10 ml buffer PI and cells were lysed in 10 ml of buffer
P2. The lysate was then neutralized by addition of chilled buffer P3 (3 M
potassium acetate, pH 5.5) and poured into the barrel of a QIAfilter Cartridge
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where it was left for 10 minutes at room temperature. After debris
precipitation the cleared lysate was loaded onto a HiSpeed Maxi Tip (an
anion-exchange resin that was pre-equilibrated by applying 10 ml of buffer
QBT-750 mM NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol; 0.15% Triton®
X-100) by gravity flow. The HiSpeed Maxi Tip was then washed with 60 ml
of medium-salt buffer QC (1 M NaCl; 50 mM MOPS, pH 7.0; 15%
isopropanol). The plasmid DNA was eluted from the HiSpeed Maxi Tip
using 15 ml of high-salt buffer QF (1.25 M NaCl; 50 mM Tris-Cl, pH 8.5; 15%
isopropanol) and precipitated using 10.5 ml of isopropanol. The precipitated
plasmid DNA was then applied to the QIAprecipitator Module using the
syringe provided in the kit and washed with 2 ml of 70% ethanol. The final
step involved the elution of the plasmid DNA into a microcentrifuge tube
using 500 pi of buffer TE (10 Mm Tris-Cl, pH 8.0; 1 mM EDTA). Plasmid
DNA concentration for both minipreps and maxipreps was determined by
UV spectrophotometry at 260 nm.
2.1.3.3.3 Preparation of genomic DNA for Southern Blotting
Gene trap ES cell clones were plated on a 96-well plate and grown to
confluency. Each well was washed, after aspirating the medium, with 100 pi
of PBS and 50 pi of Lysis Buffer (10 mM Tris, pH7.5; 10 mM EDTA; 10 mM
NaCl; 0.5% Sarcosyl; lmg/ml Proteinase K) was added. The plate was then
sealed with parafilm and left overnight at 55°C. After the incubation, 200 pi
of 95% ethanol/75 mM NaOH was added to each well and the plate was left
at room temperature overnight. The ethanol/NaOH mixture was then
removed and the wells were washed three times with 70% ethanol and left to
dry at room temperature. 30 pi of Xbal (10 U, Roche) restriction digest
cocktail (also containing lXBuffer H, 1 mM Spermidine, 100 pg/ml BSA, 100
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pg/ml RNase A) was added to each well followed by an overnight incubation
at 37°C. The next day DNA loading buffer was added directly to the wells
and the samples were ran overnight at 25 V on a 0.7% TAE agarose gel.
2.1.3.4 Vector preparation prior to electroporation
Plasmid vectors pEGeo2, pEGeo2puroSD2and pEHygro2neoSD2
were digested using the restriction endonuclease Hindlll (New England
Biolabs) for 4 hours by incubation at 37°C. Approximately 180pg of each
vector were digested using 10 units of enzyme per pg of plasmid and IX the
supplier's recommended optimal buffer (NEBuffer 2). Once complete
linearisation was confirmed by gel electrophoresis plasmids were
precipitated by adding 1/10 of the total reaction volume (1/10 V) of 3M
sodium acetate (pH 5.2) and 2 volumes of 100% ethanol, freezing for 5
minutes at -140 °C and spinning at 13,000 rpm for 20 minutes in a tabletop
microcentrifuge (Biofuge 13, Heraeus, Sepatech). The precipitated pellet was
washed twice with 70% ethanol and after air-drying in a laminar flow sterile
hood for 5-10 minutes it was resuspended in PBS to obtain a final
concentration of 1 pg/pl.
The modified version of vector pEHygro2neoSD2 (+/-ARE) without
the cryptic SA was generated by double digestion of approximately 40 pg of
DNA with restriction endonucleases Hindlll and Mfel (New England
Biolabs) using IX the supplier's recommended buffer for digestion with Mfel
(NEBuffer 4), 1 U of Mfel/pg of plasmid and 2 U of Hindlll/pg of plasmid all
present in the same reaction mixture. Digestion was performed at 37°C
overnight. The largest restriction fragment (size of 9501 or 9551 bp
depending on the vector used) was then excised and purified from the gel
slice using the QIAEXII gel purification kit (QIAGEN) following the
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manufacturer's instructions. In brief, the gel slice was transferred into a
microcentrifuge tube and weighed. Three volumes of buffer QX1 (high salt-
containing, solubilisation buffer), two volumes of H2O and 70 pi of QIAEXII
suspension (consists of silica-gel particles) were then added to the tube
containing the gel slice and the mixture was incubated at 50°C for 10
minutes. The sample was centrifuged for 30 s and the supernatant was
removed by pipetting. The pellet was then washed once with 500 pi of buffer
QX1 to remove residual agarose and three times with ethanol-containing
buffer PE to remove salt contaminants and air-dried in a laminar flow sterile
hood for 15 minutes until it became white. DNA elution was performed by
adding 20 pi of PBS (pH 7), incubating at 50°C for 5 minutes and centrifuging
for 30 s.
2.1.3.5 RNA Isolation
Total RNA was isolated from gene trap embryonic stem (ES) cell
clones grown either on 6-well plates or 25 cm2 flasks using the mono-phasic
phenol/guanidium isothiocyanate TRIZOL® reagent (Invitrogen) according to
the manufacturer's instructions. In summary, cells were lysed by adding 1 ml
(6-well plates) or 2.5 ml (25 cm2 flasks) of TRIZOL reagent, transferred into a
1.5 ml RNase-free Eppendorf microcentrifuge tube and then incubated for 5
minutes at room temperature. 0.2 ml of chloroform per 1ml of TRIZOL
reagent was then added and the tube was shaken vigorously by hand for 15 s
and incubated at room temperature for 2 to 3 minutes. After incubation the
sample was centrifuged at 11,000 rpm for 15 minutes at 4°C (Centrifuge 5415
C, Eppendorf). Following centrifugation the RNA-containing upper aqueous
phase was transferred to a fresh tube and RNA was precipitated using 0.5 ml
of isopropanol per 1ml of TRIZOL reagent used for the original
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homogenization. The sample was then incubated for 10 minutes at room
temperature and centrifuged at 11,000 rpm for 10 minutes at 4°C. After
removal of the supernatant by decanting, the gel-like RNA pellet was
washed with 75% ethanol by adding 1 ml of 75% ethanol per 1ml of TRIZOL
reagent used for the original homogenization, mixing by vortexing and
centrifuging at 9,000 rpm at 4°C. Finally, the RNA pellet was air-dried for 5-
10 minutes, resuspended in 40 or 80 pi of RNase-free water (Ambion) and
incubated for 10 minutes at 55°C. The RNA sample concentration was
determined by spectrophotometry and RNA integrity was assessed by
agarose gel electrophoresis. RNA samples were stored at -80°C.
2.1.3.6 DNase-treatment of total RNA samples
Contaminating genomic DNA was removed from total RNA samples
by employing the TURBO DNA-free™ kit (Ambion) in accordance with the
supplier's guidelines. All reagents were provided in the kit unless otherwise
stated. In brief, 3 U of TURBO DNase and 0.1 volume 10X TURBO DNase
buffer were added to an RNA preparation followed by incubation at 37°C in
a water bath for 30 minutes, a further addition of 3 U of TURBO DNase and a
further 30 minute incubation at 37°C. Removal of the DNase as well as
divalent cations was performed at the end of the second incubation by
adding 0.2 volumes of DNase Inactivation Reagent and incubation for 2
minutes at room temperature during which the sample was mixed
occasionally. RNA was recovered in the supernatant of the reaction after
centrifugation at 13,000 rpm for 1.5 minutes (Biofuge 13, Heraeus, Sepatech),
transferred into a fresh, RNase-free microcentrifuge tube and stored at -80°C.
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2.1.3.7 polyA+ RNA Isolation from total RNA
polyA+ mRNA was isolated from total RNA preparations using the
Oligotex mRNA Spin-Column kit (Qiagen) following the supplier's
guidelines. Approximately 10 pg of total RNA was transferred into an
RNase-free 1.5 ml microcentrifuge tube and the volume was adjusted with
RNase-free water to 250 pi. 250 pi Buffer OBB (20 mM Tris:Cl, pH 7.5; 1 M
NaCl; 2 mM EDTA; 0.2% SDS-pre-warmed at 37°C) and 15 pi of Oligotex
Suspension (10% Oligotex particles in 10 mM Tris-Cl, pH 7.5; 500 mM NaCl;
ImM EDTA; 0.1% SDS; 0.1% NaN3) were then added to the RNA preparation
and the sample was incubated for 3 minutes at 70°C in a heating block and
then at room temperature for 10 minutes. It should be noted that the Oligotex
suspension consists of polystyrene-latex particles of uniform size that are
covalently linked to dCioTso oligonucleotides designed to promote binding of
polyadenylic acids. The OligotexrRNA complex was pelleted by
centrifugation for 2 minutes at 13,000 rpm (Biofuge 13, Heraeus, Sepatech)
and, after removal of the supernatant by pipetting, resuspended in 400 pi of
wash buffer OW2 (10 mM Tris:Cl, pH 7.5; 150 mM NaCl; 1 mM EDTA). It
was then transferred onto an RNase-free small spin column placed in a 1.5
ml microcentrifuge tube and centrifuged for 1 minute at 13,000 rpm. After
centrifugation the spin column was transferred into a new 1.5 ml
microcentrifuge tube, washed for a second time with 400 pi of buffer OW2
and centrifuged for one minute at maximum speed. Finally, the spin column
was transferred into a new 1.5 ml microcentrifuge tube and polyA+ mRNA
was eluted by applying 20 pi of buffer OEB (5 mM Tris:Cl, pH 7.5-pre-heated
at 70°C) and centrifuging for one minute at 13,000 rpm. A second elution step
with another 20 pi of buffer OEB and a centrifugation was performed. The
resulting samples were stored at 80°C.
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2.1.4 Polymerase Chain Reaction (PCR)
All PCR reactions were performed using the Peltier Thermal Cycler
PTC-200 (MJ Research). dNTPs were supplied by ABgene (Advanced
Biotechnologies). All primers were obtained by MWG Biotech unless
otherwise stated.
2.1.4.1 5' Rapid Amplification of cDNA ends-PCR (5' RACE-PCR)
5'RACE-PCR was performed by employing the GeneRacer™ kit
(Invitrogen) following the manufacturer's guidelines. An overview of the
strategy employed is shown in Figure 2.3. In brief, polyA+ mRNA samples
were treated with Calf Intestinal Phosphatase to eliminate truncated mRNA
and non-mRNA species, then treated with Tobacco Acid Pyrophosphatase to
remove the 5'cap structure from intact, full length mRNA and finally
5'ligated to the GeneRacer™ RNA Oligo. cDNA synthesis then followed
using a gene trap vector-specific primer. Finally, the first-strand cDNA was
amplified using a reverse gene trap vector-specific primer and a primer
homologous to the GeneRacer™ RNA Oligo (the GeneRacer™ 5' Primer). A
second round of PCR using nested primers was also performed. The
resulting 5'RACE-PCR products were gel purified and cloned using the
TOPO TA Cloning® Kit as described in Section 2.1.3.2. All reagents used were
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Figure 2.3 Overview of the 5'RACE PCR strategy employed. Red box, trapped gene's
sequence; Blue/green box, gene trap vector's reporter gene sequence; Yellow box,




7 pi (50-250 ng) of polyA+ mRNA was dephosphorylated using 1 pi
Calf Intestinal Phosphatase (10 U/pl in 25 mM Tris-HCl, pH 7.6; 1 mM MgCh;
0.1 mM ZnCh; 50% glycerol), 1 pi 10XCIP Buffer (0.5 M Tris-Cl, pH 8.5; 1 mM
EDTA) and 1 pi RNaseOut™ (40 U/pl in 25 mM Tris-Cl, pH 8; 50 mM KC1; 0.5
mM EDTA; 8 mM DTT; 50% glycerol). The 10 pi reaction was set up in a 1.5
ml microcentrifuge tube and after mixing gently its components by pipetting
it was incubated at 50°C in a heat block for 1 hour. After incubation the tube
was centrifuged briefly and placed on ice. Dephosphorylation was followed
by RNA precipitation. 90 pi RNase-free water and 100 pi
phenol:chloroform:isoamyl alcohol (25:24:1) were added and the reaction
was vortexed vigorously for approximately 30 seconds followed by
centrifugation for 5 minutes at 13,000 rpm at room temperature (Biofuge 13,
Heraeus, Sepatech). The top aqueous phase was then transferred to a new
sterile microcentrifuge tube and 2 pi of mussel glycogen (10 mg/ml), 10 pi of
Sodium Acetate (3M, pH 5.2) and 220 pi of 95% ethanol were added
sequentially to it. The mixture was frozen on dry ice or at -140°C for 10
minutes and then centrifuged at 13,000 rpm for 20 minutes at 4°C. The
resulting RNA pellet was washed by the addition of 500 pi 70% ethanol and
centrifugation at 13,000 rpm for 2 minutes at 4°C. After removal of the
ethanol by pipetting the pellet was air-dried for 5 minutes and resuspended
in 7 pi of RNase-free water.
(ii) Removal of the mRNA cap structure
The dephosphorylated RNA (7 pi) was then treated with lpl tobacco
acid pyrophosphate (0.5 U/pl in 10 mM Tris-HCl, pH 7.5; 0.1 M NaCl; 0.1
mM EDTA; 1 mM DTT; 0.01% Triton® X-100; 50% glycerol) to remove the 5'
cap structure from intact, full-length mRNA. The reaction mixture also
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included 1 pi 10XTAP Buffer (0.5 M sodium acetate, pH 6.0; 10 mM EDTA;
1% p-mercaptoethanol; 0.1% Triton® X-100) and 1 pi RNaseOut™. Incubation
took place at 37°C in a water bath for an hour.
(iii) Ligation to the RNA Oligo
The now decapped RNA was precipitated as described before and the
resuspended RNA pellet (7 pi) was transferred to a microcentrifuge tube
containing the pre-aliquoted, lyophilized GeneRacer™ RNA Oligo (0.25 pg,
provided in the kit), which was resuspended by pipetting up and down
several times. The tube was placed at 65°C in a heat block for five minutes
and then chilled on ice for 2 minutes. The ligation reaction mixture was then
set up by adding 1 pi of lOXLigase Buffer (330 mM Tris-Acetate, pH 7.8; 660
mM potassium acetate; 100 mM magnesium acetate; 5 mM DTT), 1 pi ATP
(10 mM), 1 pi RNaseOut™ and 1 pi T4 RNA Ligase (5 U/pl in 50 mM Tris-
HC1, pH 7.5; 0.1 M NaCl; 0.1 mM EDTA; 1 mM DTT; 0.1% Triton® X-100; 50%
glycerol) to the tube containing the RNA sample and the GeneRacer™ RNA
Oligo. Incubation took place at 37°C in a water bath for one hour. Finally,
RNA was again precipitated as before and the resulting pellet was
resuspended in 10 pi of RNase-free water.
(iv) cDNA synthesis
10 pi of the now dephosphorylated, decapped and ligated mRNA was
mixed in a microcentrifuge tube with 1 pi of primer GSP2 or lacZRT2, 1 pi of
dNTP mix (10 mM) and 1 pi of RNase-free water and the tube was incubated
at 65°C in a heat block for 5 minutes and then chilled on ice for a minute. The
reaction volume was then made up to 20 pi by the addition of 4 pi 5X First
Strand Buffer (250 mM Tris-HCl, pH 8.3; 375 mM KC1; 15 mM MgCh), 1 pi
DTT (0.1 M), 1 pi RNaseOut™ and 1 pi Superscript™ III Reverse
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Transcriptase (200 U/pl in 20 mM Tris-HCl, pH 7.5; 100 mM NaCl; 0.1 mM
EDTA; 1 mM DTT; 0.01% Nonidet P-40; 50% glycerol). The reagents were
mixed by retro-pipetting and then cDNA synthesis took place at 55°C for 45
minutes. The reverse transcription reaction was inactivated by heating at
70°C for 15 minutes followed by the addition of 1 pi of RNase H (2 U/pl in 20
mM Tris-HCl, pH 7.5; 100 mM KC1; 10 mM MgCl2; 0.1 mM EDTA; 0.1 mM
DTT; 50 pg/ml BSA; 50% glycerol) to the reaction mix and incubation at 37°C
for 20 minutes.
(v) Amplification of cDNA ends
The 1st round PCR mix included 1 pi of cDNA as the template together
with 3 pi of the GeneRacer™ 5' Primer (10 pM-homologous to the
GeneRacer™ RNA Oligo, provided in the kit), 1 pi of the reverse gene trap
vector-specific primer GSP5 or lacZ-RACE-1 (12.5pM), 1 pi of dNTP mix
(lOmM), 1 pi MgClz (50mM), 5 pi of 10X PCR Buffer (200 mM Tris-HCl, pH
8.4; 500 mM KC1), 0.5 pi of Platinum™ Taq DNA polymerase (Invitrogen-5
U/pl in 20 mM Tris-HCl, pH 8.0; 40 mM NaCl; 2 mM Sodium Phosphate; 0.1
mM EDTA; 1 mM DTT; 50% glycerol) and 37 pi of H2O. The reaction took
place in a 0.5 ml tube. The thermal cycling parameters employed were: 94°C
for 2 minutes; 94 °C for 30s, 72 °C for 2 minutes (X5); 94°C for 30s, 70°C for 2
minutes (X5); 94 °C for 30s, 68 °C for 30s and 72 °C for 2 minutes (X20).
Nested PCR was then performed using 1 pi of the 1st round PCR product
(undiluted or diluted X50) as a DNA template and 3 pi of the GeneRacer™ 5'
Nested Primer (10 pM, provided in the kit) and 1 pi of the vector specific
primer GSP5 (if the lacZ-RACE-1 primer was used for the 1st round PCR) or
GSP7 (12.5 pM). The rest of the reaction reagents as well as the cycling
parameters were identical to the ones used in the first round PCR. The
resulting PCR products were analysed by agarose gel electrophoresis, and
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bands over 300 bp were excised, transferred to a S.N.A.P™ column placed on
a sterile microcentrifuge tube and centrifuged at 13,000 rpm for 1 minute at
room temperature. The purified PCR products were then either cloned using
the TOPO TA Cloning® Kit (see Section 2.1.3.2) or stored at -20°C overnight.
(vi) Primer sequences (5'to 3')
1) GeneRacer™ RNA Oligo:
CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA
2) GeneRacer™ 5' Primer:
CGACTGGAGCACGAGGACACTGA








2.1.4.2 3' Rapid Amplification of cDNA ends-PCR (3' RACE-PCR)
3' RACE-PCR was also performed using the GeneRacer™ kit
according to the manufacturer's instructions. An overview of the strategy
employed is shown in Figure 2.4. In brief, polyA-i- mRNA was reverse
transcribed at 50°C as described above using the GeneRacer™ Oligo dT
primer (provided with the kit). Two rounds of PCR were then performed
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using the same reagents and conditions as in 5'RACE apart from the DNA
template and the sets of primers. The first round employed the cDNA
synthesized with the GeneRacer™ Oligo dT primer as a template and
primers NeoA (12.5 pM-specific to the gene trap vector) and GeneRacer™ 3'
Primer (10 pM-homologous to the GeneRacer™ Oligo dT primer, provided in
the kit). For the second round PCR the nested primers NeoB (12.5 pM, vector-
specific) and GeneRacer™ 3' Nested Primer (10 pM, provided in the kit) were
used in combination with 1 pi of undiluted 1st round PCR product. The PCR
cycling parameters employed were identical to the ones used for 5'RACE-
PCR. The PCR products were visualized by agarose electrophoresis and
prepared for sequencing using the PCR Product Pre-Sequencing kit (USB
Corporation) according to the manufacturer's instructions. In brief, 5 pi of
PCR amplification mixture was mixed with 1 pi of Exonuclease I (10 U/pl)
and 1 pi of Shrimp Alkaline Phosphatase (2 U/pl) and incubated at 37°C for
15 minutes followed by incubation at 80°C for 15 minutes. Incubations were
performed using a thermocycler.
Primer sequences (5'to 3')















GeneRacer Oligo dT primer
GeneRacer Oligo dT primer
GeneRacer 3' Primer
(TTTTTTTT)24 ' ' PCR amplification of cDNA ends
^BeneRacer 3' Nested Primer
Figure 2.4 Overview of the 3'RACE PCR strategy employed. Red box, trapped gene's
sequence; Brown box, gene trap vector's neomycin resistance gene sequence; Light blue
box, GeneRacer oligo dT primer.
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4) GeneRacer™ 3' Primer
GCTGTCAACGATACGCTACGTAACG
5) GeneRacer™ 3' Nested Primer
CGCTACGTAACGGCATGACAGTG
2.1.4.3 Reverse Transcriptase PCR (RT-PCR)
cDNA synthesis was performed as described above using either
primer GSP2 or GeneRacer™ Oligo dT primer depending on the sample. To 2
pi of the first strand cDNA reaction was added: 5 pi 10X PCR buffer (200
mM Tris-HCl, pH 8.4; 500 mM KC1); 1.5 pi MgCb (50mM); 1 pi primer X
(12.5pM): 1 pi primer Y (12.5 pM); 1 pi dNTP mix (10 mM); 0.5 pi Platinum™
Taq DNA polymerase (Invitrogen-5 U/pl in 20 mM Tris-HCl, pH 8.0; 40 mM
NaCl; 2 mM Sodium Phosphate; 0.1 mM EDTA; 1 mM DTT; 50% glycerol)
with water added to 50 pi final volume. PCR amplification was carried out
using one cycle of 94°C for 2 minutes and 30-35 cycles of 94°C for 30 s; 55°C
or 58°C for 30 s; 72°C for 2 minutes. All sequences of the primers used are
given in Appendix 2.
2.1.5 Sequencing
Purified 5'RACE PCR and RT PCR products were TOPO-TA cloned
and then the ligations were used for subsequent transformation of TOP10
chemically competent cells as described in Section 2.1.3.2. Plasmid DNA was
isolated from the transformants (about 10 clones analysed per PCR product,
see Sections 2.1.3.2 and 2.1.3.3) and 5 pi were used as a template for the
sequencing reaction together with 1 pi of primers T3 or T7 (0.1 pg/pl in TE
buffer, pH 8). 3'RACE PCR products were directly sequenced without TA
cloning and after treatment with Exonuclease I and Shrimp Alkaline
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Phosphatase (described in Section 2.1.4.2). Again 5 pi of the final PCR
mixture (after the second, nested 3'RACE PCR round) were used as a
template for the sequencing reaction together with 1 pi of primers T2 or
SDEX. Plasmid pEHygro2neoSD2 was sequenced in detail using 1 pi of
plasmid maxi-prep as a template and a variety of different primers listed in
Appendix 2. The sequencing reactions were carried out using the BigDye
Terminator Cycle Sequencing ready Reaction Kit (Perkin Elmer) either by the
I.C.A.P.B. Sequencing Facility Core (Ashworth Laboratories, University of
Edinburgh) or by the sequencing service in MRC, Human Genetics Unit.











20 pg of plasmid pdlEGFP-Nl (Clonetech) were doubly digested
using 200 units of restriction endonuclease Hindlll (Roche) and 100 of
restriction endonuclease Ncol (Roche) in the presence of lxSure/Cut buffer H
(from a lOx stock-500 mM Tris-HCl, 1 M NaCI, 100 mM MgCL, 10 mM
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Dithioerythritol, pH 7.5 at 37°C) and by incubating at 37°C overnight to
release a 716 bp eGFP fragment. The latter was gel-purified after agarose gel
electrophoresis using the Qiaquick® Gel Extraction kit (Qiagen) following
the manufacturer's instructions and DNA quantification was carried out by
UV spectrophotometry at 260 nm and agarose gel electrophoresis.
Approximately 50-100 ng of probe (in 11 pi of H2O) were heated at 100°C for
5 minutes and then mixed with 4 pi of High Prime (Roche) and 5 pi of
redivue 32P-, 33P-Nucleotides (Amersham Biosciences) on ice. The mixture
was incubated at 37°C for 1 hour. Removal of unincorporated radioactive
precursors was performed by column chromatography using Sephadex G-50
(see Current Protocols in Molecular Biology, Vol 1). The now purified
radioactive probe was incubated at 100°C for 5 minutes.
(ii) DNA Transfer
The agarose gel with the digested genomic DNA samples (see Section
2.1.3.3.3) was placed in a clean glass dish containing 250 ml of 0.25 M HC1
and left shaking for 15 minutes. HC1 was then replaced by 250 ml of
denaturation solution (0.5 M NaOH, 1.5 M NaCl) and the gel was left
shaking in it for 45 minutes. Finally the gel was transferred into 250 ml of
lOxSSC and shaken for a further 15 minutes. DNA transfer onto a Hybond-
N+ membrane (Amersham Biosciences) was carried out overnight by
upward capillary action using the Whatman 3MM filter paper wick method
(see Current Protocols in Molecular Biology, Vol. 1). The next day the
membrane was washed briefly in 2xSSC and air-dried at room temperature
after which it was wrapped in cling film and exposed to UV light on a UV




The membrane was rolled and placed in a prewarmed hybridisation
cylinder glass bottle (DNA side facing inwards) and 10 ml of ExpressHyb
(Clontech) solution (pre-warmed at 65°C) were added. The bottle was left
rolling at 65°C in an oven for 30 minutes and then the purified radioactive
probe was added into it. Hybridisation took place overnight with rolling at
65°C.
(iv) Washes
After hybridization and removal of the ExpressHyb solution the
hybridization bottle was rinsed with 50 ml of 2XSSC/1% SDS solution which
was subsequently replaced with prewarmed 2XSSC/1%SDS and the blot was
left rolling for 15 minutes at 65°C. This wash was repeated and followed by
two washes with 0.2XSSC/1%SDS for 30 minutes at 65°C. Finally the
membrane was wrapped in cling film, placed in a cassette with X-ray film
(Kodak) and left to expose for 2 days at -80°C. The film was developed using
an automatic processor (SRX-101A, Konica).
2.2 Bioinformatics
DNA sequence traces were handled using the Chromas Lite software
(Technelysium Pty Ltd.). RACE tags were determined by aligning 5' and 3'
RACE PCR sequences against the respective gene trap vector sequences
using the bl2seq program (NCBI,
http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi). Vector integrations
were determined by performing BLAST analysis of the RACE tags using the
NCBI (blastn, http://www.ncbi.nlm.nih.gov/BLAST/), Ensembl Mouse Blast
View v.36 Dec 2005 (http://www.ensembl.org/Mus_musculus/blastview) and
UCSC (http://genome.ucsc.edu/index.html?org=Mouse) databases. Analysis
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of sequences and data mining also employed the International Gene Trap
Consortium (IGTC) databases (http://www.genetrap.org/), databases from
other gene trap groups (accessed through the IGTC website), Expasy
Proteomics Server (http://ca.expasy.org/) and the JavaScript DNA Translator
1.1 (http://www.bioinformatics.vg/bioinformatics_tools/JVT.shtml). Primers
were designed using the Oligonucleotide Properties Calculator software
(http://www.basic.northwestern.edu/biotools/oligocalc.html). Restriction
enzyme target sites within DNA sequences were determined using
Restriction Mapper version 3 (http://www.restrictionmapper.org/).
2.3 ES Cell Culture and Manipulation
The feeder-independent mouse ES cell line E14 derived from the
inbred mouse strain 129/Ola (Hooper et al., 1987) was used in all
experiments. All ES cell manipulations were performed in laminar flow
sterile hoods under strictly sterile conditions that included wiping of all
surfaces and spraying of all items entering the hoods with 70% ethanol. ES
cells were incubated at 5% CO2 at 37°C in a humidified incubator (Galaxy S,
Wolf Laboratories). Cells were maintained in ES cell medium consisting of
IX Glasgow Minimal Essential Medium (Gibco) supplemented with 20%
fetal calf serum; 0.25% sodium bicarbonate (Gibco); 0.1% non-essential
aminoacids (Gibco); 2mM L-glutamine (Gibco); ImM sodium pyruvate
(Gibco); 0.1 mM (3-mercaptoethanol (Sigma); 100 U/ml Leukaemia Inhibitory
Factor (LIF). LIF was obtained as culture supernatant from COS-7 cells
transiently transfected with a murine LIF expression plasmid (pDRlO)
(Smith, 1991). Serial dilutions of the supernatant were tested on CP1 ES cells
(Bradley et al., 1984) and lOOx the minimum concentration required to keep
the cells undifferentiated was generally used as the working concentration.
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All flasks and plates were gelatinized (5 minutes with 0.1% gelatin in PBS)
prior to addition of ES cells. All stock solutions were prepared by Aileen
Leask at the JHBL.
2.3.1 Thawing ES Cells
Frozen ES cell cryovials were thawed at 37°C and the cell suspension
was transferred using a plugged pasteur pipette into a 15 ml tube containing
pre-warmed ES cell medium to a final volume of 10 ml. Cell were then
centrifuged at 1200 rpm for 3 minutes (Mistral 1000 centrifuge, MSE) and the
resulting cell pellet was resuspended in 10 ml of ES cell medium. Cells were
finally transferred into a 25cm2 flask and fresh medium was added after 24
hours to remove cell debris and traces of freezing medium.
2.3.2 Passage and Expansion of ES Cells
Cells were normally passaged every two days. Culture medium was
aspirated off the culture flask and the cell monolayer was washed once by
adding 5 ml PBS. Removal of PBS was then followed by the addition of 1 ml
of trypsin solution (1% trypsin; 1% chick serum; EDTA in PBS) and cells were
placed at 37°C for 5 minutes. 7 ml of ES cell medium was added to the
resulting single cell suspension and cells were centrifuged at 1000 rpm for 5
minutes. The medium/trypsin were then aspirated and the cell pellet was
resuspended in 8 ml of fresh culture media. The cell number was determined
using a haemocytometer and 1X106 cells in 8 ml of ES cell medium were
transferred into a new gelatinized 25cm2 flask.
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2.3.3 Freezing ES Cells
ES cells were frozen at 1 cryovial per 25cm2. Cells were trypsinised as
described above and centrifuged at 1000 rpm for 5 minutes. The resulting cell
pellet was then resuspended in 2 ml of freezing medium consisting of 10%
dimethyl sulphoxide (DMSO-Sigma) in ES cell medium, transferred into a
cryovial and placed at -80°C and finally at -140°C for long term storage.
2.3.4 Generation of gene trap clones
ES cells grown in 225 cm2 flasks were harvested and after
centrifugation the resulting pellet was resuspended in 20 ml of PBS. Cells
were then counted using a haemocytometer, centrifuged and pre-chilled PBS
was added to give a concentration of 107cells/ ml PBS. 0.8 ml (i.e. 8,000,000
cells) of the cell suspension were transferred into an electroporation cuvette
(0.4 cm, Bio-Rad) where they were mixed with 8 |ig of the vector plasmid
DNA to be electroporated and left on ice for 5 minutes. The cuvettes were
then placed on the GenePulser™ (Bio-Rad) and electroporation was
performed by applying a single pulse at 250 V and capacity of 500 pF aiming
for a time constant between 7 and 10. After electroporation the cuvettes were
placed onto ice and after 10 minutes cells from each cuvette were transferred
into pre-chilled 15 ml Corning tubes containing approximately 4.5 ml of ES
medium and incubated on ice for a further 10 minutes. Finally, cells were
plated on gelatinized 10 cm2 plates (the contents of one 15 ml Corning tube
split into two plates) containing 8 ml of pre-warmed ES medium and placed
into the incubator. The next day the medium was replaced by fresh medium
into which the appropriate antibiotic was added (hygromycin B obtained
from Roche at a concentration of 150 pg/ml or G418 obtained from Gibco at
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180 pg/ml). Antibiotic selection lasted for approximately 5-7 days for
hygromycin and 8-10 days for G418) after which individual resistant colonies
were picked (after replacing ES medium with PBS) using a yellow Gilson tip
and transferred onto gelatinized 96-well or 24-well plates. Once the clones
reached confluency they were replica plated in 24-well plates: one set of
plates was frozen to serve as a backup (the ES medium was replaced by 200
pi of freezing medium and plates were sealed and transferred first at -20°C
and eventually at -80°C), one set was employed for FACS analysis of eGFP
expression, a third set was used for analysis of lacZ ((3-galactosidase)
expression by X-gal staining, and another set was further expanded until
cells were consequently plated on 6-well plates or 25 cm2 flasks that were
utilised for RNA isolation (see Section 2.1.3.5).
2.3.5 Analysis of lacZ expression by X-gal staining
(3-galactosidase expression was detected (both in the presence of LIF
and after RA induction) by staining with X-gal (5-bromo-4-chloro-3-indonyl-
(3-D-galactopyranoside-Sigma) in 24-well plates. Briefly, cells were washed
twice in PBS and then fixed in 0.2 % gluteraldehyde, 5 mM EGTA, 2 mM
MgCh, and 100 mM Na2HPC>4 for 5 minutes. After fixation, cells were
washed 3 times for 5 minutes each in wash buffer (2 mM MgCh, 0.02% NP-40
and lOOmM NazHPCh). X-gal staining solution contained 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 2mM MgCh, 0.02% NP-40, and 1
mg/ml X-gal. Stocks were made in dimethyl formamide (DMF) and stored in
the dark at -20°C. X-gal staining was carried out overnight at 37°C and then
staining solution was replaced with wash buffer and plates were kept at 4°C.
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2.4 Analysis of eGFP expression by flow cytometry
All flow cytometry analyses were performed by Kay Samuel (John
Hughes Bennett Lab). Briefly, cells were harvested, washed twice in PBS
(supplemented with 0.1% BSA and 0.1% sodium azide), counted and finally
resuspended at 2 x 106 cells/ ml for use. Where possible data for 40,000 cells
was acquired using a FACSCaliber bench top cytometer equipped with a 488
nm laser (Becton Dickinson) without compensation. eGFP expression was
detected in fluorescence 1 channel (FL1). Data was also acquired in the
fluorescence 2 channel (FL2) to allow detection of changes in
autofluorescence. Samples were only considered positive for eGFP
expression if there was an increase in fluorescence in FL1 over that detected
in controls and no change in FL2. Data was analysed using Cellquest
software (Becton Dickinson). Controls included were mock transfected cells
and non-electroporated wild-type cells. Relative eGFP expression between
positive samples was quantified by comparison of peak channel valves
derived from histogram plots. An electronic gate was drawn around eGFP
positive events on the FL1 / FL2 dot plot. Data for these events was imported
into a FL1 histogram plot to generate peak channel value data (Figure 2.5).
2.5 Microscopy
Cells were routinely examined with a Leitz Labovert light microscope.
For analysis of eGFP expression cells from the gene trap clone to be
examined were normally plated at a low density on a gelatinized 10 cm2 plate
and once distinct colonies appeared the ES medium was replaced by PBS and
fluorescence was visualized using the Zeiss Axiovert 25 fluorescence
microscope with UV light through Zeiss filter set 44. Cells were
photographed with an AxioCam digital camera using AxioVision 3.1
software.
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Figure 2.5 Analysis of eGFP expression by flow cytometry, (a) Dot plot diagram depicting
the forward and side scatter profiles used to exclude dead cells from acquisition obtained by
the employment of an electronic gate, (b) Dot plot representation of flow cytometry data
showing the electronic gate around eGFP positive events. Data from eGFP positive events




3.1 Vector design and objectives
A series of plasmid gene trap vectors were constructed as tools to
entrap developmentally regulated genes (Figure 3.1). Their novel features
include:
• an ATG-less tripartite reporter fusion combining the egfp, lacZ and
either the neomycin (y3geo) or hygromycin (fliygro) resistance genes
present within a 5'SA module - a stretch of glycine (Gly) codons was
inserted upstream of the egfp gene (Figure 3.2) in order to provide a
flexible hinge between eGFP and upstream sequences and prevent
steric hindrance or folding interference (Bronchain et al., 1999);
• the rabbit jB-globin exon 2/intron 2 splice donor (SD) junction which is
contained within a 3'poly(A) trap cassette that also includes the
human /3-actin promoter driving the constitutive expression of the neo
gene - this poly(A) trap module is part of the egfpphygro-containing
vector;
• an ARE from the human GM-CSF gene (Xu et al., 1997) cloned into the
fi-globin intron, approximately 120 nt downstream of the SD
exon/intron junction.
A series of experiments were performed aiming to characterise each of these
novel components and assess their potential for use in a gene trapping
context.
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SA egfp phygro pA PactinP SD
pEHygro2neoSD2
(+ARE)
Figure 3.1 Schematic representation of the gene trap constructs employed. En-2,





....ccctttctcctccatgacaaccag G TCC CAG GTC CCG AAA ACC AAA GAA GAA
SQVPKTKEE
GAA CGC AGA TCT GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA
E R R S G G G G G G G G G G
GGA GGA GGA GGA GGA GGA GTG AGC AAG GGC GAG GAG CTG
G G G G G G V S K G E E L
eGFP
Figure 3.2 Nucleotide and predicted amino acid sequences of the En-2 SA-gly-egfp
junction present in both the egfpfigeo and egfpfihygro triple fusions. The mouse Engrailed-2
SA is shown in pink with the intron in lower case letters and exon in uppercase letters. The
glycine bridge is shown in blue and the beginning of eGFP in green. En-2. engrailed; SA,
splice acceptor.
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3.2 Characterisation of the triple reporter fusion
3.2.1 Experimental strategy
To test the function of the triple reporter fusion, linearised vectors
pEGeo2, pEGeo2puroSD2 and pEHygro2neoSD2 (equivalent to vector
pEHygro2neoSD2 (+ARE) shown in Figure 3.1 but without including the
ARE) were introduced independently by electroporation into ES cells (Figure
3.3); the egfpfigeo fusion was tested in the context of gene trap vectors pEGeo2
and pEGeo2puroSD2 whereas the egfpfihygro fusion was characterized as the
5'component of vector pEHygro2neoSD2. After neomycin or hygromycin
selection, depending on the construct used, individual gene trap clones were
isolated, expanded and replicated into three sets of 24-well plates (Figure
3.3). One set was frozen, another was used for analysis of egfp expression by
flow cytometry and fluorescence microscopy, and the last set of replica
plates was X-gal stained in order to determine P-galactosidase expression
levels. Some selected clones were further expanded 5'RACE-PCR analysis.
The latter was employed as a means of characterising the molecular nature of
the gene trap integrations.
3.2.2 Reporter expression analysis provides evidence that the triple
fusion is functioning
Electroporations with the two different egfplj3geo-containing constructs
yielded similar numbers of neomycin resistant colonies per electroporation
plate. 65 pEGeo2-electroporated and 159 pEGeo2puroSD2-electroporated
neoR gene trap ES clones were picked and analysed for reporter expression
(Table 3.1). 49 % and 39 % of the total number of neoR clones tested by X-gal














Figure 3.3 Schematic representation of the experimental strategy adopted for the








































Table 3.1 Summary of the results obtained after analysis of gene trap clones for (3-
galactosidase (X-gal staining) and eGFP (flow cytometry) expression. Numbers in
parentheses indicate percentages relative to the total number of clones analysed.
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respectively. These percentages are within the range of values representing
the proportion of (3-galactosidase positive, G418-resistant gene trap clones
that have been reported by investigators employing similar Pgeo-containing
constructs e.g. 24-37% (Bonaldo et al., 1998) or 60% (Skarnes et al., 1995). The
number (n=32) of hygromycin resistant gene trap clones generated after
electroporation with the pEHygro2neoSD2 construct was considerably lower
probably due to the stringent nature of hygromycin selection (Table 3.1). 56%
of these were found to express |3-galactosidase (Table 3.1).
The resulting lacZ expression patterns varied both in terms of staining
intensity and cellular distribution (Figures 3.4). Some of the trapped clones
that we tested were characterized by restricted (3-galactosidase activity which
was confined to a few isolated cells (Figure 3.4a) or larger cell
subpopulations (Figure 3.4b). Others showed a more widespread cellular
distribution of lacZ expression which was often localised in speckles within
most cells (Figure 3.4h), or it appeared as diffuse, intense staining present
within the majority of cells (Figure 3.4e). Different, distinct patterns of
subcellular localization e.g. nuclear or cytoplasmic were also observed
(Figures 3.4i and k respectively). This variation in (3-galactosidase activity
indicates that a wide range of genes expressed at varying levels in ES cells (as
reflected by the diversity of the expression patterns observed) are accessible
to entrapment by our triple fusion-containing vectors.
eGFP expression analysis of the clones by flow cytometry was carried
out taking into account two parameters: (i) the percentage of fluorescent cells
within the clone and (ii) the fluorescence intensity of the positive cell
subpopulations as estimated by peak channel value data relative to
untransfected/mock-transfected controls. Based on these criteria 23% and












Figure 3.4 Representative p-galactosidase expression patterns of hygromycin
and neomycin resistant gene trap clones. Various different X-gal staining patterns
were obtained e.g restricted (a-b), faint/diffuse (c), widespread/intense (e), spotty
(h). Also note the different subcellular localisations of the lacZ reporter protein e.g.
nuclear (i) or cytoplasmic (g and k). Objective x20, scale bar=80 pm (a-f) and x40,
scale bar= 30 pm (g-k).
pEGeo2puroSD2 vector insertions respectively were found to be eGFP
positive by flow cytometry (Table 3.1). This percentage was slightly higher
(34%) for the pEHygro2neoSD2-electroporated, hygroR gene trap clones
(Table 3.1). Some examples of eGFP positive clones as determined by flow
cytometry are given in Figures 3.5 and 3.6.
Gene trap clones expressing eGFP were also detected by fluorescence
microscopy (Figures 3.7 and 3.8). However, this was possible only in the case
of clones that were found by flow cytometry to be high eGFP expressors. It
was found that the higher the percentage of eGFP-expressing cells within a
gene trap clone (as determined by flow cytometry) the higher the probability
of detecting the presence of eGFP within the same clone by fluorescence
microscopy. Moreover, we were unable to detect by microscopy less bright
clones that were defined as eGFP positive based on their flow cytometric
profile. This finding probably reflects a 'lowest sensitivity limit' for the eGFP
detection potential of the specific microscope that was employed during this
study.
3.2.3 Assessing the correlation between the eGFP and lacZ
proteins
Approximately half of the p-galactosidase positive clones resulting from
all three electroporations were found to be fluorescent (Table 3.1). To get an
idea of the extent of correlation between the eGFP and (3-galactosidase
reporter proteins, all gene trap clones were categorized into four groups on
the basis of their [3-galactosidase expression profile:
• (-) group, this includes clones that showed no lacZ expression; (+/-) in
which clones exhibited a small degree of lacZ expression mainly
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Figure 3.5 Flow cytometry profiles of two representative eGFP expressing, hygromycin
resistant clones, (i) Dot plot of forward and side scatter profiles of each clone used to gate
"live" events (R1) before further analysis (ii) Flow cytometry data from analysis of E14
control sample (iii) Plots showing gating of fluorescent positive events (R2) (iv) Histogram
plot showing the log increase of the peak channel log shift of eGFP expressing cells (green
line) relative to the control cells (filled bar).
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Figure 3.6 Flow cytometry profiles of two representative eGFP expressing, neomycin
resistant clones, (i) Dot plot of forward and side scatter profiles of each clone used to gate
"live" events (R1) before further analysis (ii) Flow cytometry data from analysis of E14
control sample (iii) Plots showing gating of fluorescent positive events (R2) (iv) Histogram
plot showing the log increase of the peak channel log shift of eGFP expressing cells (green
line) relative to the control cells (filled bar).
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Figure 3.7 eGFP expression of representative neomycin resistant clones. The names of the
clones and their lacZ expression profiles are also shown. Percentages indicate the fraction of
fluorescent cells within each clone as determined by flow cytometry. Objective x20 (clones 1A1,









Figure 3.8 eGFP expression of representative hygromycin resistant clones. Corresponding lacZ
expression profiles are also shown. Percentages represent the fraction of fluorescent cells within
each clone as determined by flow cytometry.
• (+), which consists of clones that showed widely distributed [3-
galactosidase (Figure 3.9);
• (++), which contains clones that are strongly (3-galactosidase positive
in terms of intensity and cellular distribution (Figure 3.9).
This grouping was empirical based on subjective observational criteria. The
percentage of the eGFP expressing cells (as determined by flow cytometry)
present within each clone was then plotted against its corresponding lacZ
expression group (Figure 3.10).
Predictably, the clones with the highest levels of (3-galactosidase
activity were clones that also possessed the highest eGFP positive cell
populations (Figure 3.10). This correlation is obvious for all three
electroporations with the members of the (++) lacZ expression group
containing the highest fractions of fluorescent cell populations (values up to
88.2% of the total in the case of vector pEGeo2). It should be noted that some
clones belonging to the (+/-) and (+) lacZ expression groups and possessed
relatively low to minimal fluorescent cell populations (0.48-5%) were
classified as eGFP positive because they were found by flow cytometry to be
considerably brighter than the control samples. The employment of
fluorescence microscopy revealed that the expression pattern of eGFP, in
general, correlates well with that of [3-galactosidase both in terms of cellular
distribution and intensity (Figure 3.11).
Interestingly, flow cytometry also revealed the presence of two lacZ
negative clones (clones 3D4 and H3-17 from electroporations with vectors
pEGeo2puroSD2 and pEFIygro2neoSD2 respectively) that possessed
surprisingly high populations of fluorescent cells (depicted as red data points
in Figure 3.10) (Figure 3.12). The pEHygro2neoSD2-electroporated, lacZ (-),
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Figure 3.9 p-galactosidase expression patterns indicative of the three lacZ expression (+/-




















Figure 3.10 Analysis of the degree of correlation between eGFP and (3-galactosidase
reporter proteins. Percentages of fluorescent cells as determined for each clone by flow
cytometry were plotted against corresponding lacZ expression groups for gene trap clones
resulting from electroporations with all three vector constructs. Green data points correspond
to clones that are defined as eGFP positive. Red data points correspond to lacZ (-) clones
that were found by flow cytometry to contain high numbers of eGFP expressing cells.
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Figure 3.11 Examples of correlation in the expression of (3-galactosidase
and eGFP proteins. Note the similar expression patterns of the two reporters
in terms of intensity and cellular distribution.Both neomycin (3B2,1D5) and
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Figure 3.12 Flow cytometry profiles of lacZ-/eGFP+ clones 3D4 and H3-17.
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5B1 pEGeo2 4 Rnu17d (non-protein
coding)
1A1 pEGeo2 1 Gas5 (non-protein
coding)
5C1 pEGeo2 5 Ubc (5'UTR)
1B3 pEGeo2 1 Bat2d (EST transcript)
1A6 pEGeo2 3 EST transcript
ENSMUSESTT0000002342"
1B2 pEGeo2 5 Expressed sequence
AI506816 (EST transcript)
Table 3.2 Results of BLAST analysis of the 5' RACE sequence tags generated from
clones electroporated with vectors pEGeo2 and pEHygro2neoSD2.
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Some selected fusion transcripts were confirmed by RT-PCR using RACE
product- and vector-specific primers (Figure 3.13). In all the cases examined
the En-2 splice acceptor junction was utilized by the splicing machinery in the
predicted manner to give rise to a fusion transcript consisting of endogenous
trapped sequence and the vector's triple fusion coding sequence. All
integrations occurred within distinct loci. The sequences and detailed analysis
of all the 5' RACE tags are given in Appendix 3.
3.2.4.1 Overview of integrations
3.2.4.1.1 egfpfihygrovector integrations
5' RACE analysis of clone H3-10 generated two different, properly
spliced transcripts termed H3-10-1 and H3-10-2. Both products were found
by BLAST analysis to be homologous to adjacent mouse genomic regions on
chromosome 18. H3-10-1 transcript was found to be identical to the last 137
bp of the first exon (157 bp in total) of Fbxol5 gene (Ensembl gene ID:
ENSMUSG00000034391) (Figure 3.14). H3-10-2 product showed homology to
a genomic area approximately 380 bp upstream of H3-10-1 that has not been
reported to be part of an exon. The existence of both fusion transcripts was
confirmed by RT-PCR analysis (Figure 3.13). To eliminate the possibility that
H3-10-2 represents a PCR artifact, the RT-PCR product that was generated
using a vector-specific egfp primer and a primer designed on the H3-10-2
sequence and corresponded to the expected 400 bp size (Figure 3.13) was
cloned and sequenced and it was found to be identical to transcript H3-10-2.
The above data indicates the trapping of two alternatively spliced transcripts
and suggests that integration of vector pEHygro2neoSD2 took place in the
first intron of Fbxol5 which consists of 10 exons in total (Tokuzawa et al.,
2003) (Figure 3.12). Fbxol5 encodes an F-box containing protein and was
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Figure 3.13 RT PCR confirmation of some of the fusion transcripts cloned after
5' RACE PCR analysis of gene trap clones. In all cases a vector-specific (egfp)
primer called GSP5 was used in conjunction with primers that were complementary


















induce a null mutation
RACE product possibly


















Figure 3.14 Overview of some of the gene trap insertions predicted by 5'RACE PCR
analysis of egfpfihygro and egfppgeo triple fusion-containing gene trap clones. White arrows
indicate the intron at which vector insertion occurred. Numbers in parentheses refer to the
total number of reported exons present within the trapped loci. Note that the F-box domain in
the case of clone H3-10 is encoded by exons 3-5. Dark blue boxes, 5' or 3' UTR exons;
Light blue boxes, protein coding exons; red boxes, regions of homology to corresponding
cloned RACE products. Only exons adjacent to the site of integration are shown.
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found to be a target of Oct3/4 (Tokuzawa et al., 2003). The gene trap event
represented by RACE product H3-10-1 is an in-frame fusion between the
egfpfdhygro reporter sequence and the Fbxol5 coding sequence. The resulting
chimaeric protein is predicted to incorporate the first 8 N-terminal
aminoacids of the FBX015 protein and is translated from the trapped gene's
ATG (Appendix 3). This integration is likely to induce a null mutation in the
Fbxol5 gene due to the severity of the truncation that is introduced (Figure
3.14).
BLAST analysis of the 84 bp RACE product H3-1 indicates that vector
insertion in this case took place upstream of the first 5'UTR reported exon
(Futterer et al., 2005) of the Dido (Death inducer-obliterator) locus on
chromosome 2. Dido gives rise to at least three splice variants with distinct
roles in apoptosis (Garcia-Domingo et al., 1999) and tumour suppression
(Futterer et al., 2005). The H3-1 transcript is homologous to a region that is
adjacent to a predicted Dido exon
(http://www.ensembl.org/Mus_musculus/exonview?db=core;transcript
=ENSMUST00000037764). The RACE product's homology with two EST
sequences (Accession numbers: AK051426 and AK036185) which also include
the predicted Dido exon, the existence of identical 5'RACE tags generated by
other groups (gene trap cell lines M029F04 and W068C04) and RT-PCR-based
evidence (Figure 3.15a) indicate that the trapped H3-1 transcript is probably
derived from the predicted exon. This finding is also supported by the fact
that the sequence of the H3-1 RACE product is highly conserved between
mouse and rat (3.15b).
The transcript generated from clone H3-17 was found to be highly
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Figure 3.15 (a) Genomic organisation of Dido locus and RT-PCR strategy adopted for
analysis of RACE transcript H3-1. Reported Dido exons are shown as open boxes. The
predicted Dido exon is depicted by a black box. The region homologous to EST AK051426 is
depicted by a red line. The primer combinations employed include EST1F which was
designed within the predicted Dido exon and vector-specific GSP5 (expected product
size=944 bp) or primers EST1F and EST-H3-1R which is a RACE product-specific primer
(expected product size=570 bp). Note that the RACE product is homologous to a region
within the EST sequence. Yellow box, En-2 SA; Green box, egfp coding sequence; Red box,
RACE transcript H3-1. (b) The H3-1 RACE transcript sequence is conserved among mouse
(chromosome 1) and rat (chromosome 3). The RACE product's sequence is shown in red.
The rat sequence is shown in black letters. (Information obtained from the UCSC genome
server).
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recently identified gene called erythroid differentiation regulator or erdrl
(Dormer et al., 2004). The latter has been involved in the induction of
haemoglobin synthesis and it is speculated to have a more general role in cell
survival and growth control (Dormer et al., 2004). The EST has an ORF that
theoretically gives rise to a 145 aminoacid polypeptide. The integration event
is predicted to give rise to an ATG-containing fusion protein between 51
aminoacids of the trapped gene and the vector's reporter protein (Appendix
3). However, the frame of translation of the fusion protein is different to the
one employed for the generation of the endogenous protein. It should be
noted that H3-17 is the only one of the clones analysed by 5'RACE PCR that
was found to be lacZ(-)/eGFP (+).
Analysis of the RACE product isolated from clone H4H-1 indicates
that in this case the vector landed within a GAPDH-related pseudogene.
BLAST analysis of transcript H4H-1 yielded multiple high homology hits
that corresponded to ESTs and genomic DNA regions located at various
different chromosomes throughout the mouse genome. All hits were related
to a sequence that is present in pseudogenes belonging to the glyceraldehyde
3-phosphate (GAPDH) multigene family. The latter includes a single
functional gene that encodes the glycolysis enzyme GAPDH and more than
300 retroprocessed pseudogenes which are dispersed throughout the mouse
genome (Garcia-Meunier et al., 1993).
3.2.4.1.2 egfpJ3geo vector integrations
The neomycin resistant clone 5B1 carries an integration within the
Rnul7d locus, which is located on chromosome 4. Rnul7d is a non-protein
coding gene that consists of three exons. Its transcript gives rise to intron-
located small nucleolar RNAs (snoRNAs) of the H/ACA-box class (Pelczar
and Filipowicz, 1998). BLAST analysis revealed that vector insertion took
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place within the second intron of Rnul7d (Figure 3.14). The generation of a
fusion transcript incorporating Rnul7d and vector reporter sequences was
confirmed by RT PCR (Figure 3.13). Similarly, clone 1A1 was found to
contain a vector insertion within another snoRNA host gene called gas5
(Smith and Steitz, 1998). Like Rnul7d, gas5 has little protein-coding potential
(Smith and Steitz, 1998). The 1A1 RACE transcript was found to be
homologous to gas5 exons 1 and 2 (12 in total) indicating that the pEGeo2
vector landed within intron 3 (Figure 3.14).
Molecular analysis of clone 5C1 revealed that the affected locus in this
case is the polyubiquitin C gene (Ubc) on chromosome 5. The latter consists
of a short 5'UTR exon and a long exon containing tandem ubiquitin coding
regions (Perelygin et al., 2002). The gene trap construct inserted into the only
intron of the gene hence trapping the short 5'UTR exon (Figure 3.14).
BLAST analysis of the RACE transcript from clone 1B3 suggests that
vector insertion occurred within an EST gene (Bat2d; Ensembl transcript ID:
ENSMUST00000046646) that is positioned on chromosome 1 and is predicted
to encode a protein containing a BAT2 domain. The predicted genomic
model of the gene includes 23 exons. The gene trap vector integrated within
the 3'UTR between exons 21 and 22 since the 1B3 RACE product's sequence
was found to be identical to the last 76 bp of exon 21 (Figure 3.14). The
existence of the fusion transcript within clone 1B3 and consequently the
vector's site of integration were confirmed by RT PCR (Figure 3.13).
Clone 1B2 carries a vector insertion within another EST gene which is
called "expressed sequence AI506816" and is located on chromosome 5. The
integration in this case took place upstream of the transcript's ATG which is
positioned at the start of the longest ORF. However, in silico translation of
RACE transcript 1B2 indicates that a translational event initiating at an ATG
112
present within the cloned RACE tag theoretically yields a fusion protein that
is composed of 12 aminoacids encoded by the trapped sequence and the
triple reporter fusion (Appendix 3). This finding suggests that reporter
protein translation in this case occurred at a different translational frame
from the one employed for the production of the disrupted predicted
protein.
The 5'RACE product which was derived from clone 1A6 was found to
be 100% homologous to a genomic region that lies on the 4th intron of an EST
transcript ENSMUSESTT00000023421 (transcript's predicted genomic model
was retrieved from the Ensembl genome server) which is located on
chromosome 3. The EST transcript is predicted to consist of five exons and
vector integration probably took place within intron 4. The translated RACE
product sequence suggests the presence of an ORF compatible with reporter
protein expression (Appendix 3) although no ATG was present either within
the trapped, cloned sequence or directly upstream of it. It is likely that
transcript 1A6 corresponds to an exon that has not been identified using in
silico approaches. Evidence in support of this hypothesis comes from the fact
that the boundary between the 3' end of the trapped sequence and the
downstream genomic sequence on chromosome 3 exhibits sequence
characteristics typical of a consensus splice donor (Fig. 3.16a). Furthermore,
the RACE product's sequence exhibited considerable similarity to an EST
(Accession: BY727029) and a RACE sequence tag obtained from another gene
trap group (gene trap cell line ID: AD0233). It was also found to be highly
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Rat GGTCTCTGGAATAGAGAGCAAGGAAGGAGAGGAGAAGTGTTTCTGCCCTG
Mouse CTTTGGAGGGAGAAGAACCCGGCAGCCATGTGAGGTCTCTGGAGGAGCTG
Mi: MINIMI I I I I I I I I I I I I I I I I I I I INI I! II
Rat CTTTGGAAGGAGAAGAACACAGCAGCCATGTGAGGTCTCAGGAGAAGATG
Mouse GAGCCTGTGGCCACTATTACAG
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Rat GGG-CTGTGGCCACTACTACAG
Figure 3.16 (a) The boundary between RACE transcript 1A6 and the downstream
genomic sequence on chromosome 3 exhibits sequence characteristics of a splice donor
site. The consensus splice donor sequence (nearly invariant nucleotides in bold) is also
given and compared with the genomic sequence at the site of vector integration in clone
1A6, along with a putative branch point sequence present within an intron between a 5'and a
3'splice site. The 3'end of the trapped (and potentially exonic) sequence is shown in red.
Sequence was retrieved from the Ensembl mouse genome server:
http://www.ensembl.org/Multi/blastview. (b) The 1A6 RACE transcript sequence is conserved
among mouse and rat. The RACE product's sequence is shown in red. The rat sequence is
shown in black letters. (Information obtained from the UCSC genome server). SD, splice
donor; BP, branch point; R, purine; Y, pyrimidine; N, any nucleotide
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3.2.4.2 Southern blot analysis reveals the presence of multiple vector
copies
A common characteristic shared by a considerable fraction (5/11 or
45%) of the cloned RACE sequence tags is the presence of stop codons in the
same translational frame as the triple fusion's coding sequence (transcripts
H3-10-2, H3-1, 5B1, 1B3, 1A1; see Appendix 3). The cloning of RACE
transcripts that are incompatible with the translation of the vector's reporter
is surprising because the gene trap clones from which those transcripts were
obtained exhibited strong reporter expression despite the fact that no ATG
was present in the egfp component of the triple fusion. RT PCR analysis of 4/5
of these RACE transcripts (H3-10-2, H3-1, 5B1 and 1B3) indicates that the
stop codon-containing RACE products were genuine, constituting parts of
actively transcribed mRNA species (Figure 3.13) and in the case of transcript
H3-10-2 the resulting RT PCR fragment's sequence was determined and
found to be identical to that of H3-10-2 thus confirming the authenticity of
the specific RACE transcript.
It is possible that in the case of clone H3-10 reporter expression is
facilitated by transcript H3-10-1 and the generation of H3-10-2 is the result of
alternative splicing. It is also likely that the clones from which the stop
codon-containing RACE products were isolated contain more than one
vector copies and hence reporter expression is enabled by unidentified fusion
transcripts originating from different integration events within the same
clones. Indeed, Southern blot analysis (using an EGFP-specific probe) of four
reporter positive gene trap clones electroporated with vector
pEHygro2neoSD2 suggests that multiple vector insertion (2-3 copies)
occurred in all cases examined (Figure 3.17). Two of the clones analysed (H3-
1, H3-10) belonged to the group of clones that yielded stop codon-containing
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Figure 3.17 Southern blot analysis of hygromycin resistant clones H3-1, H3-10, H4H-1
and HygroC2 using an EGFP-specific probe. Genomic DNA samples were digested with
Xbal which cuts within vector pEHygro2neoSD2 only once at position 7973 nt. Theoretically
probing of digested DNA should reveal a fragment or fragments of a minimum size around
7973 bp provided that an intact vector insertion occurred directly downstream of an
endogenous Xbal restriction site. Lane 1, clone H3-1; lane 2, clone H3-10; lane 3, clone
H4H-1; lane 4, clone HygroC2. A wild type E14 negative control was also included (not
shown). SA, splice acceptor; SD, splice donor.
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clones appear to contain degraded vector copies as they gave rise to
fragments of considerably smaller size than the minimum expected one
(approximately 7973 bp) which corresponds to an intact vector insertion
event (Figure 3.17). These truncations appear to affect both the 5' and 3'
integrity of the vector as some of the resulting bands were found to be as
small as 2000 bp; the distance of the egfp gene from the vector's linearised 5'
end is 1776 bp. Hence this is the largest 5' vector portion that can
theoretically be degraded allowing at the same time the detection of the
intact egfp gene (Figure 3.17). It is also likely that more complex integration
events associated with vector/flanking DNA rearrangements as well as
concatemer formation might have occurred. For example, the insertion of
two intact vector copies in tandem and in a head-to-tail orientation would
theoretically yield a band of 12439 bp (the total size of the vector); the
occurrence of such an event could potentially explain the existence of the top
band resulting from analysis of clone H3-1 (Lane 1 in Figure 3.17) whose size
is approximately 12000 bp.
3.3 Characterisation of the poly(A) trap cassette
3.3.1 Experimental strategy
To assess the performance of the novel poly(A) trap cassette we
employed plasmid vectors pEHygro2neoSD2 and pEHygro2neoSD2 (+ARE).
In brief, linearised vectors were introduced by electroporation into ES cells
and, after selection in G418, resistant clones were picked into 24-well plates
and replicated. One set of replica plates was frozen and the other expanded
for RNA isolation and subsequent analysis by 3'RACE PCR.
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3.3.2 3'RACE analysis of pEHygro2neoSD2-electroporated clones
reveals the presence of a cryptic SA site and problematic SD
function
In a pilot experiment, electroporation of the Hindlll-linearised
pEHygro2neoSD2 vector into wild type E14 ES cells gave rise to an average
of 70 neomycin resistant colonies per electroporation plate. We picked 100
colonies of which 50 were further propagated for subsequent 3'RACE PCR
using neo-specific primers. Sequences of fusion transcripts were successfully
generated from 43 G418 resistant ES cells clones (43/50, 86%).
Ideally, the proper function of the [3-globin SD in conjunction with an
endogenous, downstream SA and poly(A) signal should yield a 3'RACE
product whose sequence is homologous to the splice donor's exonic
sequence followed by endogenous mouse exonic sequence since the splice
donor's j3-globin intron 2 should, theoretically, be removed upon splicing
(Figure 3.18). However, analysis of the resulting transcripts revealed that no
proper SD function took place in approximately half (21/43, 49%) of the
clones analysed. The sequence of 9 (9/43, 21% of the total) RACE products
consisted of the neo coding sequence followed directly by mouse genomic
sequence of different length and chromosomal origin in each case. The
remaining 12 (12/43, 28%) transcripts contained unspliced SD sequence
indicating that SD read-through took place in these cases (Table 3.3).
In 22 (51%) of the obtained RACE sequences the pglobin exon 2/intron
2 junction was utilised in the predicted manner since the splice donor's
Pglobin exonic sequence was followed by a properly spliced sequence.
However, the spliced sequence originated from the vector's backbone and it
was located directly downstream of the /3-globin SD intron 2 suggesting that
cryptic splicing within the vector occurred (Figure 3.19a) (Table 3.3). This
intra-vector splicing event employed the poly(A) trap's SD and the cryptic
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neo SD trapped exon N+2
exon
3' RACE PCR
Figure 3.18 Poly(A) trapping with the pEHygro2neoSD2 vector. Efficient SD usage should
result after splicing into an endogenous exonic sequence in the generation of a fusion
transcript that consists of neo, figtobin SD exon and trapped exon N+2. Transcript
stabilisation should occur through the employment of the trapped gene's poly(A) signal.
Open boxes, trapped gene's exons.
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SA site present within the vector backbone resulting in the generation of a
fusion transcript between neo, the SD's exonic sequence and vector backbone
sequence. The "trapped" sequence originating from the vector backbone had
a constant length of 90 nt in all cases and consisted of a 5' 53 bp-segment,
which was found by BLAST analysis to be homologous to the beginning of
the rabbit /3-globin exon 3, and an additional 37 bp stretch of downstream
vector backbone sequence followed by a stretch of A's. This stretch of A's
found at the end of the transcripts indicates that a proper polyadenylation
event took place.
3.3.3 The inclusion of an ARE improves the vector's SD function
To address the intra-vector splicing problem associated with the use of
the Hindlll-linearised vector we adopted a strategy that involved the
construct's double digestion with the restriction enzymes Hindlll and Mfel.
A unique Mfel target site is present within the 3'end of the splice donor's
intron and upstream of the backbone's cryptic splice acceptor (Figure 3.19a).
Hence this strategy is predicted to result in the removal of the vector
backbone including the cryptic SA. Both pEHygro2neoSD2 and
pEHygro2neoSD2 (+ARE) plasmid vectors were digested with Hindlll and
Mfel giving rise to a 9501 bp or 9551 (in the case of the +ARE construct)
fragment that corresponds to the functional vector and a 2938 bp fragment
that corresponds to the cryptic SA-containing vector backbone (Figure 3.19b).
The "functional vector" fragment was then gel-purified following agarose gel
electrophoresis of the digestion mixture and used for electroporation into
wild type ES cells.
G418 selection following transfection with the pEHygro2neoSD2
(+ARE) vector resulted in approximately 1.7-fold reduction in the number of
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Figure 3.19 (a) Schematic representation of vector pEHygro2neoSD2 (+ARE) showing
the target sites of Hindlll and Mfel restriction enzymes relative to the cryptic SA site within
the vector backbone. Vector pEHygro2neoSD2 has the same structure but lacks the ARE.
(b) Agarose gel analysis of the products generated after double digestion of vector
pEHygro2neoSD2 (+ARE) with Hindlll and Mfel (lane 3). Lane 1: gel-purified fragment (9551
bp) that corresponds to the functional vector after the double digestion. Lane 2: Hindlll-
linearised vector (12489 bp). Lane 4: DNA size markers.
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neomycin resistant clones (40 resistant clones per electroporation plate)
compared to the number obtained when the ARE-less pEHygro2neoSD2
construct was used (67 resistant clones per electroporation plate). This result
might indicate a reduction in the fraction of clones that acquired neomycin
resistance through read-through events and employment of cryptic poly(A)
signal sites and therefore a decrease in the "background".
45 pEElygro2neoSD2- and 43 pEHygro2neoSD2 (+ARE)-
electroporated gene trap clones were analysed by 3' RACE PCR. Our double-
digestion approach appeared to be successful in addressing the intra-vector
splicing issue; the cryptic SA was used in only six pEHygro2neoSD2-
containing clones (6/45, 13%) and in none of pEHygro2neoSD2 (+ARE)-
containing clones (Table 3.3). We postulate that this small fraction of intra-
vector splicing events observed in pEHygro2neoSD2 clones is likely to
represent contamination by Hindlll-only digested vector during the gel
purification process.
The figlobin SD functioned efficiently in most of the pEHygro2neoSD2
(+ARE) clones (33/43, 77%). This is evidenced by the succesfull generation of
fusion transcripts which incorporated endogenous mouse sequences
correctly spliced into the splice donor's exon while the figlobin intron 2 was
successfully removed during the splicing process (Table 3.3). Seven (7/43,
16%) of the RACE transcripts cloned were indicative of read-through into the
splice donor's intron (Table 3.3) while in two cases (2/43, 7%), RACE product
sequences consisted of neo coding sequence followed by endogenous
genomic sequence. Only 5 3'RACE transcripts (5/45, 11%) isolated from
pEHygro2neoSD2 clones were indicative of proper SD function (Table 3.3).
The SD was not used appropriately in the majority (34/45, 76%) of the



















Table 3.3 The ARE enhances the figlobin splice donor's performance while the vector's
double Hindlll/Mfel digestion reduces the incidence of splicing events that employ the
vector's backbone cryptic SA (defined as intra-vector splicing). Percentages corresponding
to RACE products consisting of neo sequence followed by endogenous mouse genomic
sequences are not shown. N=43 for pEHygro2neoSD2 (Hindi 11); N=45 for pEHygro2neoSD2
(Hindlll/Mfel); N=43 for pEHygro2neoSD2 (+ARE) (Hindlll/Mfel).
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the cases (Table 3.3). These data suggests that the presence of an ARE has a
positive effect on the figlobin SD performance.
3.3.4 Analysis of trapped transcripts
The properly spliced trapped sequences generated from 3' RACE PCR
analysis of the clones were examined using the BLAST (or BLAT) algorithm
and the NCBI (http://www.ncbi.nlm.nih.gov/BLAST/), Ensembl
(http://www.ensembl.org/Mus_musculus/index.html) and UCSC
(http://genome.ucsc.edu/index.html?org=Mouse) mouse databases. All
sequence tags (resulting from electroporations with both + and -ARE vectors)
and details of their BLAST analysis are given in Appendix 4. Results are
summarized in Tables 3.4 and 3.5.
Depending on the quality of the generated sequence and the site of
integration, fusion transcripts were often found to incorporate a poly(A)
signal site and a terminal (A)n tail. This indicates that the vector's poly(A)
trap cassette functioned in the predicted manner by capturing endogenous
poly(A) signals for stabilisation of the vector's neo transcript. Gene trap
events were distributed among 14 chromosomes with chromosomes 4 and 6
containing the highest number (n=4) of vector insertions (Figure 3.20).
Of the 38 properly spliced RACE transcripts isolated from both
pEHygro2neoSD2 and pEHygro2neoSD2 (+ARE) clones, 15 (40%) matched
reported transcribed sequences (Figure 3.21). Of these, 8 (22%) matched
exons of known genes, and 7 (18%) were found to be homologous to EST
transcripts (Tables 3.4 and 3.5; Figure 3.21). One of the RACE transcripts
(from clone 2) that matched exons of known genes was found to be
homologous to the reverse strand of the trapped gene (Rfx4).
A substantial fraction (8/38, 22%) of the RACE products did not align
with any known/EST transcripts but overlapped with regions that were
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Clone Chromosome Details
N2 ? Mouse ETn LTR
N19 7 Phlda2 (exon)
N23 6 Unknown
N29 ? Mouse ETn LTR
N34 5 Ccdc18 (intron)
Table 3.4 Identities of trapped sequences obtained after 3'RACE PCR analysis of clones
electroporated with the Hindlll/Mfel pEHygro2neoSD2 vector and in which the rabbit J3globin
splice donor functioned in the predicted manner.
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Clone Chromosome Details
1, 6, 7, 30, 32, 33, 35 ? Mouse ETn LTR
2 10 Rfx4(exon)
4 18 GENSCAN000000402318













22 3 D3Wsu161e gene (intron)
23 12 GENSCAN00000387185














1C6 18 Tcergl (exon)
3C4 2 Cds2 (exon)









Table 3.5 Identities of trapped sequences obtained after 3'RACE PCR analysis of clones
electroporated with the Hindlll/Mfel pEHygro2neoSD2 (+ARE) vector and in which the rabbit
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Figure 3.20 Chromosomal distribution of poly(A) trap events resulting from analysis of
properly spliced 3'RACE transcripts. RACE products were isolated from neomycin resistant










Figure 3.21 BLAST hit distribution of 3'RACE transcripts derived from both
pEHygro2neoSD2 (+ARE) and pEHygro2neoSD2-electroporated, neomycin resistant clones.
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located within ab-initio predicted transcripts determined using the
GENSCAN program (Table 3.5; Figure 3.21; information obtained from the
Ensembl mouse genome server). The latter is designed to identify
exon/intron structures of vertebrate genes with an accuracy of 75-80% (Burge
and Karlin, 1997). Some of the RACE transcripts that were found
homologous to GENSCAN transcripts also exhibited splicing patterns i.e.
different segments of their sequence were found to be homologous to
different adjacent genomic regions indicating the trapping of different exons
(e.g. clone 19; see Appendix 4). Many of the GENSCAN transcript-
homologous 3'RACE sequences were also found to be highly conserved
between different organisms (e.g. clones 4, 13, 19, 23 and 44: Appendix 4).
These observations suggest that some of the RACE products are likely to
represent insertions in bona fide novel genes. Two (5%) RACE transcripts
(from clones N34 and 22) matched the reverse strands of sequences located in
introns of known genes and one (2%) transcript matched a region without
any known or predicted genes in the vicinity but had a splicing pattern
(Appendix 4). Again, some of these sequences might indicate the existence of
genes not predicted by other means.
A significant percentage (23%) of the 3'RACE products corresponded
to a sequence from the 3' LTR (long terminal repeat) present in the repetitive
ETn (early transposon) family of sequences which are highly dispersed
within the mouse genome (200 copies; Tanaka and Ishihara, 2001). The same
ETn sequence has also been trapped repeatedly by other vectors that include
a poly(A) trap cassette (Yoshida et al., 1995; Chen et al., 2004a). Finally, three
clones (8, 29 and 1A4; 8%) yielded RACE transcripts that matched other
repetitive sequences on specific chromosomal locations (Table 3.5; Appendix
4). In general, the nature and the percentages of BLAST matches obtained for
129
our 3'RACE transcripts reflect findings of other studies employing poly(A)
trap constructs (Matsuda et al., 2004; Osipovich et al., 2005).
3.3.5 Our poly(A) trap vectors do not appear to exhibit a bias in
their integration site preference
It has been recently demonstrated that one of the major limitations
associated with poly(A) trapping is the tendency shown by this type of
vectors to insert into the last intron of their target genes presumably due to
the action of nonsense-mediated mRNA decay (NMD) (Shigeoka et al., 2005;
see also relevant section in the Introduction). Examination of some of our
3'RACE products that match exons of transcripts whose genomic structure is
well defined indicates that our poly(A) trap vectors do not appear to suffer
from this bias (Table 3.6). None of the RACE transcripts analysed was
indicative of vector integration into a gene's last intron (Table 3.6). In 4/7
cases vector insertion took place within the first intron, two approximately in
the middle (closer to the 3'end) of the gene and one in the intron before the
last (Table 3.6). These RACE products appear to represent poly(A) trapping
events that evaded NMD.
Interestingly, the termination codon (TC) of the pEHygro2neoSD2
vector's neo coding sequence is located 362 bp upstream of the splice donor's
splice junction. This distance significantly exceeds the "60 nt from the last
exon-exon junction" limit for evasion of NMD. Hence any fusion transcript
between neo and downstream trapped endogenous sequences should
theoretically constitute a default target for NMD irrespective of the site of the
vector's integration since in any case the neo's termination codon is always
further than 60 nt from a target gene's last exon-exon junction and would
therefore be recognised as a potentially premature termination codon.










Ylpml NM_178363 22 2
Rfx4 AY342003 18 8
Pnrc2 AK077403 3 2
Tmem57 BC037192 11 10
Tcergl BC040284 22 8
Cds2 AK170888 13 12
ENSMUSESTT00003795807 AK140938 5 4
Table 3.6 Overview of vector insertion sites within trapped genes. Only RACE sequences
that were homologous to exons of well-defined transcripts were used for the analysis. Genes
consisting of two exons were excluded. The number of trapped exons corresponds to the
number of exons downstream of the vector integration site.
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fide neo fusion transcripts derived from clones electroporated with vectors
pEHygro2neoSD2 and pEHygro2neoSD2 (+ARE) suggests that somehow our
vector is immune to NMD and this might also explain the absence of a bias
towards integrations into the 3'most intron of the vector's target genes.
3.3.6 Overview of disrupted genes
Many of the known genes trapped by our vectors have been shown to
possess distinct roles in mouse embryonic development and exhibit
restricted, developmentally regulated expression patterns. For example, the
Phlda2 gene which is trapped by vector pEHygro2neoSD2 in clone N19
exhibits restricted expression in the lateral mesoderm and the most posterior
extent of the primitive streak as well as in extra-embryonic tissues
(Dunwoodie and Beddington, 2002). Knockout studies suggest that this locus
probably plays a role in regulating placental growth (Frank et al., 2002). The
Rfx4 gene (clone 2) encodes a 735 aa winged helix transcription factor which
appears to be essential for early brain development (Blackshear et al., 2003).
Another example of a developmentally regulated gene that has been trapped
by our vectors is Tmem57 (or C61; clone 28), a neuronal-specific gene whose
expression is upregulated in the telencephalic cortical plate and mitral cells
in the olfactory bulb after day E14.5 of embryonic development
(Kuvbachieva et al., 2005).
Interestingly, one of the clones (2C4) gave rise to a fusion transcript
that was homologous to the histone gene Histlh2bh'r histone-encoding genes
are known to lack introns and a poly(A) tail ending instead in a highly-
conserved between metazoans stem-loop sequence (Marzluff et al., 2002).
The same Histlh2bh-related sequence has also been captured by other groups
(CMHD cell lines CMHD-GT_150D12-3 and CMHD-GT_238E5-3 and
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FHCRC cell line FHCRC-GT-S19-5A1; information obtained from
www.igtc.org) using constructs that incorporate a poly(A) trap component. It
is likely that in this case the trapped gene's single exon contains a cryptic SA
site that was activated upon the vector's integration upstream of the gene
giving rise after cryptic splicing to a fusion neo/Histlh2bh transcript that is
stabilised in the same manner as the native Histlh2bh transcript.
A combination of direct (RT-PCR; Figure 3.22) and indirect evidence
(published literature, EST databases) shows that all the known genes trapped
by the pEHygro2neoSD2 (+/-ARE) vectors are expressed at various levels in
undifferentiated ES cells. A search of the IGTC database revealed that 7/8 of
these genes have been trapped by conventional SA-type gene trap constructs
which is another indication that these genes are expressed in ES cells.
Interestingly, the Phlda2 gene (clone N19) has only been trapped by poly(A)
trapping (CMHD cell line CMHD-GT_222A12-3) despite the fact that is
highly expressed in ES cells (3.21; Dunwoodie and Beddington, 2002). This
could suggest that poly(A) trap vectors target a unique set of genes that are
not accessible to entrapment by other vector types.
Since our sample size is quite small for assessing the above
speculation we expanded our analysis to gene targets of other poly(A) trap
constructs. We examined all IGTC genes that have been trapped by poly(A)
trap vectors employed by the CMHD. We found that, to date, poly(A) trap
vectors have trapped 1025 genes which correspond to 6.2% mouse genome
coverage (the total number of IGTC trapped ENSEMBL genes, to date, is
6644 representing 40.36% of genome coverage). Half of these genes (513 or
50%) have only been trapped by means of poly(A) trapping while the rest
(512) have been trapped by both poly(A) trap and promoter/SA-type vectors
(Figure 3.23a). Interestingly, 27 of 513 the genes mutated exclusively by
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Figure 3.22 RT-PCR analysis of wild type undifferentiated E14 ES cells using primer







Genes trapped by both
poly(A) and other gene
trap vectors
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I I =genes trapped only by poly(A) trap vectors
=genes trapped by both poly(A) and
promoter/SA-type vectors
Figure 3.23 (a) Chart depicting the "accessibility" of 1025 genes targeted by poly(A) trap
vectors to entrapment by conventional SA-type constructs, (b) Chromosomal distribution of
the above genes (N=1025).
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poly(A) trapping are expressed on undifferentiated ES cells based on existing
EST data.
The chromosomal distribution of the poly(A)-trapped genes is shown
in Figure 3.23b. The highest number of poly(A)-trapped genes (96) were
located on chromosome 11. In general, the number of genes present in a
chromosome appeared to correlate with the number of genes trapped by
poly(A) trap vectors suggesting that poly(A) trapping events occur more
frequently in chromosomes with a high gene density (Figure 3.24). A similar
preference has also been reported for SA and promoter entrapment vectors
(Hansen et al., 2003). Furthermore, the highest density of exclusive poly(A)
trapping gene targets was found on chromosomes 7 and X; in these
chromosomes the number of genes trapped only by poly(A) trap vectors was
considerably higher (2- and 5.5-fold for chromosomes 7 and X respectively)
(Figure 3.23b). We also observed the existence of insertional "hot spots" that
were specific to the poly(A) trap vectors employed; some loci were trapped
up to 20 times (Pacrg) by different poly(A) trap constructs but not by any
other class of vectors (Table 3.7). Analysis of the vector integration sites for
180 of the 513 poly(A) trapping-specific genes that contain more than two
exons and whose exon/intron structures are well defined revealed that the
majority of vector insertions (approximately 75%) occurred within the 3'-
most intron of the genes (Figure 3.25). This observation is in agreement with
the findings of Shigeoka et al., (2005) and demonstrates the biased nature of
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Figure 3.24 Correlation between the number of poly(A) trapped genes and the number of
known/novel Ensembl genes per chromosome.










Table 3.7 Genes that have been multiply disrupted exclusively by poly(A) trap vectors and











Figure 3.25 Distribution of vector insertion sites within poly(A) trapping-specific genes. To
identify the insertion sites, 180 genes that contain more than two exons and whose genomic
structure is well defined were analysed. Introns near the 5'and 3'ends were defined as being
located 5'and 3' to the middle exon or intron of a gene, respectively.
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3.3.7 Reporter expression of trapped clones
To examine whether the 5' triple reporter fusion within our poly(A)
trap vectors recapitulates the expression of the poly(A)-trapped genes we
determined the (3-galactosidase activity of 100 undifferentiated (+LIF) neoR
including ones that were found by 3'RACE PCR to contain vector insertions
within genes that are expressed in ES cells and therefore should theoretically
be X-gal positive (Section 3.3.6). 15 of these 100 clones were also subjected to
hygromycin selection for analysis of the reporter's hygromycin resistance
component. Unexpectedly, none of the clones examined appeared to be lacZ
positive or hygromycin resistant.
We hypothesised that the absence of reporter gene expression in
pEHygro2neoSD2 (+ARE)-electroporated neoR clones may be associated with
an increased sensitivity to deletions in the vector's 5' functional segment
induced upon electroporation while the poly(A) cassette remained
unaffected resulting in the generation of neomycin resistant clones. We
analysed by Southern blotting four neoR clones (1A4, 2A4, 3C4, 2C4)
electroporated with vector pEHygro2neoSD2 (+ARE) using a reporter-
specific probe (EGFP). Two of these clones (3C4, 2C4) yielded 3'RACE
products that are indicative of a vector insertion within genes that are
expressed in ES cells. Our results demonstrate that at least one copy of the
triple fusion's eGFP component is present within all clones (Figure 3.26). 2/4
clones (1A4, 2A4) were found to contain more than one vector copies (Figure
3.26). Furthermore, all clones examined appeared to contain degraded vector
fragments as they gave rise to bands of a smaller size than the minimum
expected one (approximately 7973 bp). The extent of deletions does not
appear to be as great as in the case of the hygromycin selected clones
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Figure 3.26 Southern blot analysis of neomycin resistant clones 1A4, 2A4, 3C4 and 2C4
using an EGFP-specific probe. Genomic DNA samples were digested with Xbal which cuts
within vector PEHygro2neoSD2 (+ARE) only once at position 7973 nt. Theoretically probing
of digested DNA should reveal a fragment or fragments of a minimum size of approximately
7973 bp provided that an intact vector insertion occurred directly downstream of an
endogenous Xbal restriction site. Lane 1, clone 1A4; lane 2, clone 2A4; lane 3, clone 3C4;
lane 4, clone 2C4; lane 5; wild-type E14 ES cells.SA, splice acceptor; SD, splice donor.
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analysed by Southern blotting (Figure 3.17). In the cases of clones 2A4 (lower
band) and 3C4 the degradation-indicative bands (size=approximately 6000
bp) could correspond to 5' truncations that have only affected the En-2 splice
acceptor and this fact could explain the absence of reporter expression in the
case of clone 3C4 (Figure 3.26). Clone 2C4 yielded a smaller fragment of
approximately 5 kb which suggests that in this case the vector was degraded
at both 5' and 3' ends (Figure 3.26). However, clone 2C4 should contain a
functional 3' poly(A) trap cassette as it was found to be neo resistant. It is
possible that this clone also includes a second vector integration that lacks
completely the 5' egfp component (and hence cannot be detected by Southern
blotting using an EGFP-specific probe) but has retained an intact 3' poly(A)
trap module. Unfortunately, efforts to analyse the same clones using a neo-




4.1 Characterisation of novel gene trap vector components
This Thesis describes experiments aiming to test a series of gene trap
vectors that were developed as tools for trapping developmentally regulated
genes. One of the novel features of these vectors is the presence of a 5' triple
reporter fusion that incorporates the egfp, lacZ and neomycin or hygromycin
resistance genes (egfpj3geo and egfpj3hygro respectively) placed downstream of
the En-2 SA. The inclusion of eGFP in this reporter system provides an extra
molecular tag directly reflecting the protein levels of the trapped gene in
addition to the enzymatic amplification-based lacZ marker. Moreover, the
presence of eGFP offers a noninvasive means of monitoring trapped gene
expression in living cell populations and permits the rapid screening of a
trapped cell library by flow cytometry thus offering the potential for more
high-throughput approaches. The combination of antibiotic resistance
(provided either by figeo or phygro) and eGFP expression can be also
exploited for enriching reporter-expressing cells during in vitro
differentiation and, consequently, facilitating lineage selection (Li et al.,
1998).
The other novel feature of our vectors is the presence of a 3'poly(A)
trap cassette that includes the previously uncharacterized rabbit ft-globin
exon 2/intron 2 splice donor (SD) junction and a 50 bp mRNA instability
signal (AU-rich element) (ARE) which is derived from the human GM-CSF
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gene (Xu et al., 1997) and is cloned into the /3-globin intron, approximately 120
nt downstream of the SD exon/intron junction. The presence of the ARE
directly downstream of the poly(A) trap's SD should potentially eliminate
any neomycin resistant clones that arise from the stabilisation of the neo
mRNA transcript (via SD read-through) by cryptic poly(A) signal sites that
reside within the splice donor's /3-globin intron or intergenic mouse genomic
regions thus resulting in the reduction of 'background' vector integrations.
4.1.2 Characterisation of the 5'triple reporter fusion
4.1.2.1 The triple fusion proteins possess the potential to be efficient
reporters of endogenous gene expression
Reporter expression analysis of neomycin and hygromycin resistant
gene trap clones containing the egfpflgeo and egfpffhygro respectively suggests
that the individual components of the fusion proteins can function properly.
The percentage of reporter expressing, hygroR clones was found to be higher
than the one obtained for the neoR clones (Table 3.1). This is likely to reflect
the fact that a higher level of endogenous trapped gene expression is
required for activation of the egfpphygro gene and subsequent hygromycin
resistance compared to egfpftgeo and hence a greater number of hygroR clones
are expected to be positive for reporter expression.
A wide variety of lacZ/egfp expression profiles of differing intensity
and cell distribution were observed in both neomycin and hygromycin
resistant clones indicating that our vectors can disrupt distinct loci of
different transcriptional activity states (Figures 3.4-3.8). Overall, flow
cytometry appears to be a more sensitive means of detecting fluorescence
(both as a function of fluorescence distribution and intensity) compared to
microscopy (Figure 3.10). Detection of eGFP expression by fluorescence
microscopy was possible only in the case of clones that were also found by
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flow cytometry to express high levels of eGFP. However, even the highest
eGFP expressors appeared to be only moderately bright under microscopy
and the use of a more efficient fluorescent marker (e.g. "Venus"; Nagai et al.,
2002) as an alternative to eGFP might be the best option for future vector
designs.
In general, we observed a correlation between eGFP expression and (3-
galactosidase activity; clones characterized by high lacZ expression were also
found by flow cytometry/fluorescence microscopy to contain the highest
fractions of fluorescent cell populations (Figure 3.10). X-gal staining of eGFP
positive clones and subsequent analysis by microscopy demonstrated that (3-
galactosidase activity correlates well with eGFP expression both in terms of
cellular distribution and intensity (Figure 3.11).
Approximately half of the X-gal positive clones were found to be
negative for eGFP expression (Table 3.1). In the case of clones characterized
by lower levels of lacZ expression the lack of fluorescence could be attributed
to the fact that the eGFP reporter is less sensitive compared to lacZ as it is
detected without enzymatic amplification and therefore requires higher
expression for detection (>30,000 molecules/cell for the bright mutants;
Whitney et al., 1998). However, some of the eGFP negative clones were
found to express high levels of [3-galactosidase and should theoretically
possess detectable fluorescent cell populations.
A more likely explanation for the absence of eGFP expression in lacZ
positive clones might be the loss of fluorescence due to protein misfolding or
steric hindrance. It should be noted that we attempted to address this
problem by inserting a glycine-based linker on both termini of the eGFP
protein. However, the large size of the triple fusion protein combined with
any N-terminal additions of endogenous trapped protein may still promote
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susceptibility to structural obstructions. Alternatively the integrity of the
protein's structure may be affected by the conditions of its local
microenvironment such as pH and hence certain localizations of the fusion
protein within a cell (potentially facilitated by 'trapped' localization signals)
would result in reduction or loss of fluorescence. This 'structural alteration'
model as a causative agent for the loss of fluorescence activity is supported
by previous reports showing that variations in eGFP fluorescence are due to
difference in structure rather than protein levels (Li et al., 1997). The
development of a folding-enhanced GFP variant, called 'superfolder' GFP
has been recently reported (Pedelacq et al., 2006). This shows increased
resistance to fusion partner misfolding and chemical denaturants while
exhibiting improved folding kinetics. 'Superfolder' GFP might prove an ideal
candidate reporter for future gene trap vector design studies.
Interestingly, we also identified two clones that were lacZ positive but
possessed a surprisingly high proportion of fluorescent cells (Figure 3.12).
These clones might represent vector integrations that give rise to fusion
proteins which have a detrimental effect on the enzymatic activity of (3-
galactosidase. It has been demonstrated that genes which encode secretory
and membrane-spanning proteins cannot be tagged by conventional j3geo
gene trap vectors (Skarnes et al., 1995). This led to the development of
specialized vector designs targeting this specific class of genes (Skarnes et al.,
1995; De-Zolt et al., 2006). 5'RACE PCR analysis of the lacZ negative, eGFP
positive clone FI3-17 revealed that vector integration occurred within the
erdrl locus which encodes a protein that was shown to localize in the inner
side of the cytoplasmic membrane and is likely to be secreted (Dormer et al.
2004). Hence gene trap clone H3-17 probably represents a gene trap event in
which the trapped gene's expression is being detected through the
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expression of the egfp but not the lacZ component of the reporter triple
fusion. This finding supports the idea that the eg/p-containing triple reporter
fusion within our vectors enables the identification of gene trap events into
genes whose entrapment cannot be detected with (3gal-based constructs. To
test this hypothesis further examination of clone H3-17 is required. This
could be done, for example, through the use of an anti-|3gal antibody and
subsequent analysis by immunofluorescence which would enable the
detection of the subcellular localization of the egfp(3hygro fusion protein.
4.1.2.2 Molecular analysis of gene trap clones provides evidence for the
occurrence of complex vector integration events
A small number of gene trap clones containing both the egfpj3geo and
egfpfihygro fusion were analysed by 5'RACE analysis. The results of this
preliminary 'molecular screen' suggest that the En-2 splice acceptor junction
included within the vectors was utilized in the predicted manner. In three
cases (clones H3-10, H3-17 and 1B2) vector insertion occurred within
transcriptional units (Fbxol5, erdrl and "expressed sequence AI506816") in
the right orientation and is predicted to give rise to a chimaeric protein that is
translated from an ATG present in the trapped sequence and consists of an
endogenous N-terminal portion and the vector's reporter protein. Of the
three gene trap events, the most likely to induce a null mutation is the
disruption of the Fbxol5 locus. The latter is a target of the pluripotency
transcription factor Oct3/4, and its F-box-containing protein product is
predominantly expressed in undifferentiated ES cells (Tokuzawa et al., 2003).
The vector in this instance (as indicated by RACE product H3-10-1)
integrated within the gene's first intron and the resulting fusion protein is
theoretically translated in the same frame as the endogenous protein
containing only 8 of the 517 aminoacids encoded by the affected gene.
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We also identified an alternatively spliced Fbxol5 fusion transcript
(H3-10-2) which probably represents a previously unidentified 5'UTR exon
located upstream of the gene's reported first exon. This transcript has been
trapped by other gene trap groups (SIGTR gene trap cell line RRF222) and its
authenticity was confirmed by RT-PCR. The regions homologous to
transcripts H3-10-1 and H3-10-2 were located 547 and 109 bp respectively
downstream of an 18-bp enhancer element which is activated by Oct3/4 and
Sox2 and is required for ES cell-specific expression of Fbxol5 (Tokuzawa et
al., 2003). Targeting of the Fbxol5 exons 3-7 which code for the F-box was not
associated with any overt developmental defects (Tokuzawa et al., 2003).
However, we speculate that the severity of the Fbxol5 mutation introduced
by the gene trap event in clone F13-10 is likely to be greater than the lesion
generated by Tokuzawa et al. since a larger portion of the FBX015 protein is
disrupted and vector integration might also interfere with the function of the
Fbxol5 enhancer. This hypothesis can be tested by generating mutant mice
using gene trap ES cell clone H3-10.
The majority of the rest of the cloned 5'RACE products were
indicative of vector insertions within 5' and 3'UTR regions of genes (H3-1,
Dido; 5C1, Ubc; 1B3, Bat2d) and non-protein coding loci (5B1, Rnul7d; 1A1,
Gas5). The common feature shared by these RACE transcripts was the lack of
ATG codons within the trapped sequences combined with the presence of
stop codons in the same frame as the triple fusion's ATG-less coding
sequence (Appendix 3). Hence these RACE transcripts are incompatible with
the translation of the vector's reporter protein despite the fact that they were
all obtained from clones which were strongly positive for lacZ and egfp
expression. Southern blot analysis of four representative hygromycin
resistant clones suggests that multiple vector integration took place in all
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cases (Figure 3.17). It is therefore likely that reporter expression in clones that
gave rise to stop codon-containing 5'RACE products might be facilitated by
independent, translation-compatible gene trap events that occurred within
the same clones. Indeed, two of the clones examined by Southern blotting
(H3-1 and H3-10) were also found to generate stop-codon containing 5'RACE
products.
The results of the Southern blot analysis might also be indicative of
more complex insertional events such as vector/flanking DNA
rearrangements and concatemer formation. These are commonly occurring
events during electroporation (Friendrich and Soriano, 1991; Niwa et al.,
1993; Forrester et al., 1996; Neilan and Barsh, 1999) and further optimisation
of the electroporation conditions will be required to address this issue.
Moreover, Southern blot analysis of the clones using probes that are specific
to different segments of the vector and restriction enzymes that cut at
defined sites within mouse genomic sequences flanking the site of vector
integration would be useful for elucidating the exact nature of the integration
events. Additionally, analysis of the gene trap clones using fluorescence in
situ hybridization (FISH) together with a gene trap vector-specific probe
could be employed for mapping the vector insertions and consequently
reveal whether multiple vector integrations took place within distinct
chromosomes or as concatemers within the same locus.
A less likely explanation for the isolation of stop codon-containing
5'RACE transcripts from reporter-expressing gene trap clones involves the
initiation of reporter protein translation downstream of the stop codons and
at a codon other than ATG. The existence of mRNAs whose translation starts
exclusively at a non-AUG codon has been previously reported. The
translational regulator p97 which initiates solely at a GUG codon is such an
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example (Imataka et al., 1997). A GUG codon is present in our vector's
reporter sequence and is the first codon of the egfp gene directly downstream
of the stretch of glycines (Figure 3.1). This codon could theoretically serve as
a translational initiation signal in a fashion similar to p97. Other codons have
also been demonstrated to facilitate initiation of protein synthesis. The AGG
and GUC codons, for example, have been shown to successfully initiate
protein synthesis in vitro (Drabkin and Rajbhandary, 1998). Both of these
codons are present in our stop codon-containing cloned 5'RACE products;
GTC is the third codon in the translated splice acceptor exonic sequence
(Figure 3.1) while an AGG codon was generated in all cases from the in
frame splicing of the last two bases (AG) of the upstream endogenous
trapped sequences and the first G base present into the vector's splice
acceptor coding leader sequence (see Appendix 3). It should be noted that
similar 5' RACE products that include in frame stop codons have also been
obtained by other gene trap groups that employ ATG-less, figeo-type gene
trap vectors and therefore identification/selection of the corresponding
clones was, theoretically, dependent on active translation of the jSgeo reporter
(e.g. SIGTR cell lines AJ0170, AJ0182, AM0414, AR0145). Many of these
transcripts are indicative of vector insertions within non-protein-coding
transcriptional units (e.g. Rnu22, Rnu87, Mmu-mir-350 and 28S rRNA).
4.1.3 Characterisation of the 3'poly (A) trap cassette
4.1.3.1 3' RACE analysis reveals a high proportion of SD read-through
events
Processing of pre-messenger RNAs (pre-mRNAs) transcribed by RNA
polymerase II (Pol II) begins with the capping of their 5' end. This involves
the removal of the 5' triphosphate of the pre-mRNA and the addition of
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guanosine monophosphate which is subsequently methylated to produce
m7GpppN (for a review see Shatkin and Manley, 2000). The 5' cap serves as a
binding site for the heterodimeric nuclear cap binding complex (CBC) (Visa
et al., 1996). Both the 5' cap and CBC mark the 5' end of the transcript's first
exon. Capping is followed by splicing during which introns are removed and
exons are ligated together through the action of a multi-component
ribonucleoprotein (RNP) complex called the spliceosome. A 5' splice site is
usually characterised by the consensus sequence _2AG*GUPuAGU+6 (the star
indicates the exon-intron junction) and defines the 5' boundary of most
introns (Goldstrohm et al., 2001). The 3' end of introns is defined by the
branch point/polypyrimidine tract which are located several basepairs
downstream of the 5' splice site and close to the 3' splice site (~
4NPyAG*PuN+2). The 3' splice site, in turn, marks the upstream boundary of
the next exon in the transcript. Internal exons are located upstream of 5'splice
sites while 3' terminal exons are characterised by the presence of a
polyadenylation signal.
The spliceosome's components "associate in a step-wise manner with
pre-mRNA" (Tazi et al., 2005); 5'site recognition occurs through base-pairing
with UlsnRNP and is influenced and stabilised by several General Splicing
Factors (GSFs) that are members of the SR (serine-arginine rich) family of
proteins (Kohtz et al., 1994). In 5'exons 5'splice site recognition is enhanced
by the interaction of the splicing machinery with the CBC at the cap
structure. This interaction defines the first exon of the transcript (Figure 4.1a)
(Robberson et al., 1990). Splicing Factor 1 (SF1) then binds to the branch point
(Arning et al., 1996; Berglund et al., 1997) within the adjacent intron and
interacts with the 65 kDa subunit of the heterodimeric factor U2AF which



























Figure 4.1 Protein-protein interactions across exons and introns mark the splice sites in
pre-messenger RNAs. (a) Early in the life of a nascent pre-messenger RNA, the cap-binding
complex (CBC) interacts with factors assembled on the 50 splice site (indicated by the highly
conserved GU dinucleotide).(b) At a later time (t), once the 30 splice site has emerged from
the elongating RNAPII, cross intron interactions can be seen. U1 snRNP components, U1-
70K protein (70K) and Prp40/FBP11, can interact with SF1 and U2AF on the branch point
(BP), polypyrimidine tract (Py) and 30 splice site (indicated by the highly conserved AG
dinucleotide). (c) At an even later time one of two scenarios are possible: a new downstream
50 splice site defines an internal exon or a downstream polyadenylation signal (pA) defines a
terminal exon. In both cases cross-exon interactions are noted (Figure obtained from
Goldstrohm et al., 2001).
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subunit of U2AF binds the invariable AG dinucleotide at the intron's 3' end
(Guth et al., 1999; Wu et al., 1999). Hence the UlsnRNP complex at the
5'splice site and the SF1-U2AF complex at the branch point/polypyrimidine
tract/3'splice site mark the borders of the intron. Furthermore, these
complexes interact with each other either directly (Bedford et al., 1998) or
indirectly via SR proteins (Wu and Maniatis, 1993) (Figure 4.1b). The SF-1-
U2AF complex also interacts via SR proteins (Wu and Maniatis, 1993) with
the UlsnRNP/GSF complex at the next downstream 5'splice site (Figure 4.1c)
and this association defines the intervening exon as an internal one
(Robberson et al., 1990). Additionally, exon definition is influenced by the
interaction of SR proteins with exonic splicing enhancers (ESEs) which are
cis-acting sequence elements that facilitate the inclusion of an exon
(Blencowe, 2000). 3'terminal exons are defined by the interaction of the
3'splice site factors with the protein complexes that recognise and bind to the
cleavage and poly(A) signals (Figure 4.1c) (Niwa et al., 1990; Niwa and
Berget, 1991; Vagner, 2000).
Splice site recognition is then followed by the ATP-dependent binding
of U2snRNP to the branch point and spliceosome assembly is completed
through the employment of the tri-RNP U4-U5-U6 (Tazi et al., 2005).
Dissociation of the U1 and U4 snRNPs through the action of DExD/H box
proteins renders the spliceosome catalytically active. This state is
accompanied by several spliceosome rearrangements that involve the U2, U5
and U6 snRNPs and which eventually trigger via two frans-esterification
steps intron excision and ligation of the adjacent exons (Tazi et al., 2005;
Goldstrohm et al., 2001).
A high proportion of neomycin resistant clones carrying
predominantly insertions with the Hindlll/Mfel-digested pEHygro2neoSD2
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(-ARE) construct gave rise to 3' RACE products in which no SD use took
place. The majority of these products consisted of unspliced figlobin SD
sequence that included various portions of the ftglobin intron 2 and a cryptic
poly(A) signal followed by a stretch of A's. The generation of such
transcripts provides an interesting insight into the mechanisms of splice site
recognition and exon definition; in these cases the consensus flglobin exon
2/intron 2 junction is ignored by the splicing machinery and the retained
intronic segment is recognized as part of a terminal exon as the transcript's
3'end formation occurs via the employment of cryptic poly(A) signal sites
residing within the intron. This might be due to the fact that the sequence
elements (branch point, polypyrimidine tract and 3'splice site) that define the
intron's 3' boundary are removed upon Mfel digestion. This would, in turn,
limit the access of the 3'splice site factors (SF-1, U2AF and SR proteins)
required for the recognition of the figlobin intron's 5'and 3' boundaries and
lead to increased levels of impairment of the consensus exon/intron splice
junction. It should be noted proper SD use still occurs as evidenced by the
generation of a small number of properly spliced 3'RACE transcripts (Table
3.3) but at a lower level. In this case the efficient employment of the figlobin
SD might depend on the sequence context of endogenous intronic sequences
that are present downstream of the vector's integration site; these sequences
might potentially function as recognition sites for docking of the appropriate
factors that facilitate 3'splice site recognition.
4.1.3.2 Inclusion of the ARE enhances the performance of the flglobin
SD
Comparison of the 3'RACE results obtained from clones
electroporated with the + and -ARE versions of vector pEHygro2neoSD2
(N=45 and 43 respectively) indicates that the inclusion of the ARE improves
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the efficiency of the figlobin SD. We observed a reduction (approximately 1.7-
fold) in the number of neomycin resistant clones compared to the number
obtained when the construct without the ARE was used. This result could
potentially reflect a reduction in the fraction of clones that acquired
neomycin resistance through read-through events and employment of
cryptic poly(A) signal sites and therefore a decrease in the 'background'.
3'RACE PCR analysis further supports this hypothesis; the percentage of
3'RACE products from pEHygro2neoSD2 (+ARE)-containing clones that are
indicative of vector read-through was considerably reduced (approximately
4.3-fold; Table 3.3) compared to RACE transcripts from -ARE clones. This
reduction in 'background' was accompanied with an enhancement in the
performance of the vector's rabbit figlobin splice donor as in the 77% (7-fold
increase compared to the -ARE vector) of the clones examined the splice
donor's splice junction was used in the predicted manner (Table 3.3).
We postulate that the presence of the ARE within the splice donor's
figlobin intron results in the degradation of mRNA species arising from read-
through events. In the majority of the -ARE vector-containing clones these
read-through transcripts probably become stabilised through the
employment of cryptic poly(A) signal sites present within the SD intron (see
also previous section 4.1.3.1). Indeed, the presence of such poly(A) addition
motifs was observed in most of the RACE products that represented read-
through events and these transcripts were also found to include a poly(A)
tail. A further clue comes from the fact that the 3'RACE products obtained
from pEHygro2neoSD2+ARE-electroporated clones and in which read-
through was observed contained only a small portion of the ARE sequence,
probably as a result of the element's destabilisation occurring in these cases.
This implies that degradation of the ARE sequence is linked to an increase in
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the incidence of read-through events. An experimental setting which also
includes electroporation with a vector which is identical to vector
pEHygro2neoSD2 (+ARE) but contains a scrambled sequence cloned into the
figlobin SD instead of the ARE would be an ideal control for assessing
whether the improvement in the SD function is indeed specifically linked to
the presence of the destabilising element.
It would also be interesting to test whether this positive effect exerted
by the ARE is SD sequence-specific i.e. restricted only to an enhancement in
the performance of the specific figlobin splice donor used in this study or
whether it could also improve the performance of other splice donor
sequences. A study involving the testing of the RET poly(A) trap vector
which incorporates a similar ARE in conjunction with the mouse hprt exon
8/intron 8 SD also indicated that this sequence element might have a positive
effect on a poly(A) trap vector's performance; it was shown that a reduction
(2-fold) in the number of drug-selected, +ARE vector-containing clones
occurred compared to those containing the -ARE vector (Ishida and Ledder,
1999). However, the above comparison was not combined with 3'RACE data
and hence our study is to our knowledge the first demonstration of the fact
that an mRNA destabilising element can enhance the efficiency of a poly(A)
trap vector's SD.
4.1.3.3 Gene trapping efficiency of pEHygro2neoSD2 (+/-ARE) vectors is
similar to other poly(A) trap vectors
A big proportion of the properly spliced 3'RACE products derived
from clones electroporated with vectors pEHygro2neoSD2 and
pEHygro2neoSD2 (+ARE) contained a poly(A) signal site and a poly(A) tail.
This suggests that our vectors functioned appropriately as poly(A) trap
vectors. BLAST analysis of the transcripts shows that our vectors target genes
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at a comparable rate to other poly(A) trap vectors; 40% of the trapped
sequences matched exons of known genes and EST transcripts (this
percentage was found to be 49.5% by Matsuda et al., 2004 and 48% by
Osipovich et al., 2005) (Figure 3.21).
22% of the RACE products were found to be homologous to ab-initio
predicted GENSCAN transcripts and many of them had a splicing pattern
i.e. different segments of their sequence were found to be homologous to
different adjacent genomic regions indicating the trapping of different exons.
Moreover, one transcript (2%) did not align with any known/predicted
transcript but also exhibited a splicing pattern. Some of these RACE products
could represent artefacts/splicing to sequences capable of functioning as
cryptic 3'exons. However, it is likely that at least a fraction of them
corresponds to genuine, novel functional genes. This speculation is
supported by the fact that many of the sequences belonging to this group
were found to be highly conserved between different species. Furthermore,
Matsuda et al (2004) employed similar poly(A) trapped sequences (i.e. not
found to be homologous to any known genes/ESTs) for the construction of
DNA arrays and showed that some of them were indeed expressed. Further
assessment of these transcripts is required (for example by analysing their
expression by RT-PCR/m situ hybridisation in different
tissues/developmental stages) in order to elucidate whether they correspond
to previously unidentified genes.
A considerable proportion (30%) of the 3'RACE products
corresponded to a sequence from the 3'LTR of the ETn family of
retrotransposon elements. This sequence appears to be a trapping target for
other poly (A) trap vectors too. ETn elements were first discovered and
characterised in 1980s (Brulet et al., 1983; Brulet et al., 1985). They represent a
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family of middle repetitive sequences which are transcribed during early
mouse embryogenesis in ES and embryonic carcinoma (EC) cell lines (Brulet
et al., 1985) and possess retrotransposon-like properties (Mager and
Freeman, 2000; Baust et al., 2003). We speculate that the high fraction of
vector integrations within these elements might be attributed to the presence
of a potent splice acceptor and poly(A) signal site in the 3'LTR of this highly
dispersed in the mouse genome (200 copies; Tanaka and Ishihara, 2001)
family of sequences, which facilitates splicing events between the vector's
splice donor and the ETn LTR's splice acceptor. Interestingly, a significant
number of germline and somatic cell mutations in mouse cell lines have been
reported to be caused by insertions of ETn elements into genes (Baust et al.,
2002; Baust et al., 2003) and in many cases the loss of gene function was due
to aberrant transcripts as a result of ETn-induced alternative splicing.
Furthermore, some functional genes have been shown to contain ETn LTR
sequences within their 3'UTR (an example was reported by Tsuiji et al., 2002)
and hence a proportion of the ETn LTR integrations might represent
insertional events within transcriptional units that have incorporated these
repetitive elements in their structure by transposition.
4.1.3.4 Poly(A) trapping using the pEHygro2neoSD2 constructs appears
to be immune to NMD
Examination of the vector insertion sites within transcripts with well
documented exon/intron structure indicates that our vector does not appear
to suffer from the bias exhibited by other poly(A) trap vectors to integrate
within the last intron of their target genes. However, a greater number of
clones must be analysed in order to confirm this observation. It is also
essential to demonstrate by Southern blotting and the use of a neo-specific
probe that the 3'RACE transcripts we obtained result from single vector
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integrations as it is possible that neomycin resistance of the clones analysed
arises from different, independent insertion events if more than one vector
copies are present within the same clones. Data from a preliminary Southern
blot analysis (using an EGFP-specific probe) of four neomycin resistant
clones suggest that in some cases multiple vector integrations might have
occurred (Figure 3.26 and Section 4.1.3.6). However, analysis of the neomycin
resistant clone 3C4 yielded a single band, a finding that could be indicative
of a single vector insertion. 3'RACE analysis of the same clone resulted in an
NMD-resistant transcript that represents an insertion event into the first
intron of the Cds2 gene (13 exons in total) (Tables 3.5 and 3.6). This suggests
that the neomycin resistance of this clone is generated by an "unbiased
splicing event" stemming from a single vector integration within the Cds2
locus.
Another piece of evidence that indicates that poly(A) trapping using
the pEHygro2neoSD2 vectors is not subject to NMD is the fact that we
successfully generated through 3'RACE PCR bona fide neo fusion transcripts
derived from clones electroporated with vectors pEHygro2neoSD2 and
pEHygro2neoSD2 (+ARE); these fusion products should, theoretically, have
been degraded by NMD since the termination codon (TC) of the
pEHygro2neoSD2 vector's neo coding sequence is located 362 bp upstream of
the splice donor's splice junction, a distance that significantly exceeds the "60
nt from the last exon-exon junction" limit for evasion of NMD and would
therefore be recognised as a potentially premature termination codon.
The reasons behind the potentially unbiased insertional behaviour of
our vectors are unknown. We speculate that the 'distance-relative-to-a-
downstream-exon-exon-junction' rule for eliciting NMD might be broken
due to the presence of a sequence or sequences located downstream of the
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neo's termination codon (TC) and within the rabbit figlobin SD used. The
existence of such stabilising elements that confer resistance to NMD has been
reported for the general control norepressible (GCN4) and yeast AP-1 (YAP-
1) mRNAs of S. cerevisiae (Maquat et al., 2004; Ruiz-Echevarria and Peltz,
2000). More interestingly, nonsense mutations engineered to introduce
premature termination codons (PTCs) within the human figlobin exon 1 have
been shown to unexpectedly fail to elicit NMD, even though intron 1 is more
than 55-60 nt downstream (Romao et al., 2000). Alternatively, additional,
unidentified czs-acting sequence determinants that facilitate NMD might
exist and their presence in the human figlobin gene has been speculated
(Danckwardt et al., 2002). It is likely that such sequence elements reside in
the portion of the rabbit figlobin exon 2 that was deleted in our vector's splice
donor since the latter contains only the last 29 nt of exon 2. A further piece of
evidence that points to a potential link between the specific rabbit /3-globin
splice donor used in our study and NMD immunity comes from the fact that
some cases of (3-thalassemia are associated with nonsense mutations that
introduce PTCs within the human ftglobin gene but do not activate an NMD
response resulting in the accumulation of abnormal, stable NMD-resistant
transcripts (Lapoumeroulie et al., 1986; Hall and Thein, 1994). It might be
useful to test the insertional behaviour of different mutated versions of our
ftglobin SD in order to determine whether the presence or absence of any
sequence elements is associated with resistance to NMD. Furthermore, the
employment of different splice donor controls in a poly(A) trapping context
could provide an insight into whether immunity to NMD is indeed linked to
the specific pglobin SD incorporated in our poly(A) trap vector.
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4.1.3.5 The pEHygro2neoSD2 (+/-ARE) poly (A) trap vectors possess the
potential to capture developmentally regulated genes
Many of the known genes trapped by our poly(A) trap vectors have
been reported to be developmentally regulated with different functions and
expression profiles, indicating that the pEHygro2neoSD2 constructs could be
potentially used as tools for entraping this class of genes. RT-PCR expression
analysis and data from published reports/EST databases showed that all of
the known trapped genes are expressed in undifferentiated ES cells. Clearly,
a larger number of clones need to be analysed in order to determine whether
our poly(A) trap vectors disrupt genes that are not expressed in
undifferentiated ES cells. 7/8 of our trapped genes have already been
captured by SA-type vectors indicating that both poly(A)- and promoter-type
gene trap strategies roughly target the same fraction of the mouse genome.
However, one of the pEHygro2neoSD2-trapped genes (Phlda2) has only been
previously trapped through the use of a poly(A) trap vector employed by
another gene trap group (CMHD).
4.1.3.6 Poly(A) trap vectors can disrupt genes that are not accessible to
entrapment by other gene trap vectors
To further test whether poly(A) trap vectors target a set of genes that
cannot be trapped by SA-based gene trap constructs we examined all gene
targets of poly(A) trap vectors within the IGTC database. We found that, to
date, poly(A) trap vectors have trapped 1025 genes which correspond to 6.2%
mouse genome coverage (the total number of IGTC-trapped ENSEMBL
genes, to date, is 6644 representing 40.36% of genome coverage). Half of
these genes (513 or 50%) have been trapped exclusively by means of poly(A)
trapping (Figure 3.23a). However, analysis of the vector integration sites for
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180 of the 513 poly(A) trapping-specific genes that contain more than two
exons and whose exon/intron structures are well defined revealed that the
majority of vector insertions (approximately 75%) occurred within the 3'-
most intron of the genes (Figure 3.25). Many of the poly(A) trap-specific
genes are lineage- and tissue-restricted and have not been shown to be
expressed in ES cells (based on expression data obtained from the Mouse
Genome Informatics website: http://www.informatics.jax.org/). Interestingly,
a proportion (27/513) of the genes mutated exclusively by poly(A) trapping
(e.g. Phlda2, Wdr74, Rhox6, Rab3gapl) appear to be expressed in
undifferentiated ES cells. These observations suggest that a fraction of mouse
genes can only be disrupted through the use of poly(A) trap constructs. The
differences in the integrational preferences between poly(A) trap and
conventional gene trap vectors are likely to reflect the differences in their
basic design; drug selection in poly(A) trap vectors is driven by a constitutive
promoter and depends on the proper functioning of a SD sequence and
'capture' of a downstream poly(A) signal while the activation of the
reporter/selector gene in SA-type vectors relies on the function of a SA
sequence and the activity of upstream endogenous regulatory/promoter
elements. These differences also indicate that the combined employment of
both trapping systems might be beneficial for mutating different,
complementary fractions of the mouse genome.
4.1.3.7 Clones trapped by the pEHygro2neoSD2 vectors do not show
reporter expression
No [3-galactosidase positive or hygromycin resistant gene trap cell
lines were detected after analysis of reporter expression by X-gal staining or
switch to hygromycin selection of neor, pEHygro2neoSD2 (+ARE)-
electroporated clones. This finding does not agree with previous studies
161
demonstrating that a fraction of poly(A)-trapped clones (2.8-22.7%
depending on the study) always exhibit (3-galactosidase activity in the
presence of LIF (Yoshida et al., 1995; Salminen et al., 1998; Flirashima et alv
2004). Southern blot analysis of four neomycin resistant clones using an
EGFP-specific probe indicates that complex vector insertional events might
have taken events (Figure 3.26). These events might be associated with
vector/DNA rearrangements as well as vector deletions and they are likely to
negatively affect the functionality of the 5'reporter cassette and therefore be
the cause for the lack of reporter expression.
The generation of 3'RACE products consisting of a sequence that is
homologous to the neo coding sequence followed by mouse genomic
sequences of different length and chromosomal origin (Sections 3.3.2 and
3.3.3) might also indicate a propensity towards 3'vector deletions. It is likely
that these 3'RACE sequences are derived from clones in which the
introduced plasmid vector was subjected to degradation by exonucleases
resulting in the deletion of the poly(A) trap component's SD while the
integrity of the upstream neo gene remained unaffected. We postulate that
this increased sensitivity to degradation exhibited by our vectors is linked to
a reduced structural integrity induced by their double digestion with
FFindlll/Mfel prior to electroporation into ES cells. Further optimisation of
the electroporation protocol might be beneficial in addressing the issue of
multiple and complex insertional events. Furthermore, the construction of a
retroviral version of vector pEHygro2neoSD2 (+ARE) is also underway since




Our overview of gene targets of poly(A) trap vectors indicates that
poly(A) trapping may enable the disruption of genes that cannot be trapped
by other means. However, the biased insertional behaviour of poly(A) trap
constructs compromises their mutagenic capacity.
Our results suggest that the pEHygro2neoSD2 (+/-ARE) vectors are
not biased towards integrations into the last introns of their target genes and
therefore can be the ideal vehicles for poly(A) trapping experiments. They
could also constitute the basis for the design of the 'optimal' poly(A) trap
vector. The 5'cassette of such a vector would ideally include a strong
consensus SA sequence such as the widely used mouse En-2 SA, which is
present in our constructs, or the intron 2/exon 3 splice junction from the
human Bcl-2 gene. The latter is considered to be relatively resistant to
alternative splicing and it has been shown to function efficiently in a poly(A)
trapping context (Ishida and Ledder, 1999). The 5'cassette would also include
an easily assayable and sensitive 5'reporter gene such as a fluorescent marker
(e.g. Venus) to allow monitoring of trapped gene activity in living cells. The
reporter could be fused, for example, to a drug resistance marker such as
puromycin or hygromycin. This coupling would be particularly useful for
lineage selection and purification of trapped cell populations. The inclusion
of an IRES sequence upstream of the vector's reporter/selector gene would
also be beneficial as it would alleviate the requirement for an in-frame
translational fusion between the reporter and the trapped endogenous
polypeptide. An alternative route to achieve multicistronic expression of
different reporter proteins (e.g. Venus and puromycin/hygromycin) could
involve the employment of viral "2A peptides" such as the T2A peptide from
the insect virus Thosea asigna (TaV) (Donnelly et al., 2001) that would link the
reporter and selector genes (Szymczak et al., 2004; Bill Skarnes, personal
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communication). Preliminary data indicate that this approach increases
reporter sensitivity and efficiency in a gene/targeted trapping context (Bill
Skarnes, personal communication).
The 3'cassette of the 'optimal' poly(A) would consist of a promoter-
driven neomycin resistance gene linked to a downstream efficient SD. Such a
cassette should be characterized by an unbiased insertional behaviour and
the (5-actin promoter-neo-[3globin exon 2/intron 2 SD (+ARE) cassette
incorporated in our vectors could potentially meet this criterion.
Alternatively, the poly(A) trap cassette (RNA polymerase II promoter-neo-
IRES-hprt exon 8/intron8 SD) of the UPATrap poly(A) trap vector could be
employed as it has been shown to facilitate unbiased poly(A) trapping that is
not subject to NMD (Shigeoka et al., 2005). The best method for introducing
this 'optimal' poly(A) trap vector into ES cells would be via retroviral
infection since this approach ensures the insertion of single, intact vector
copies.
A highly efficient poly(A) trap vector could be then employed in
large-scale mutagenesis projects and in conjunction with conventional SA-
and promoter-type vectors. This combination of trapping strategies might
prove to be the best route for improving the trapping rate of new loci
(poly(A) trapping can be potentially used for the disruption of non-protein
coding transcriptional units such as microRNAs, an important class of genes
that cannot be captured through the use of SA-based constructs) and
eventually achieving genome saturation. Moreover, the 'optimal' poly(A)
trap vector would be the ideal tool for conducting expression/induction gene
trap screens (e.g. through the use of the OP9 co-culture system for induction
of haematopoietic differentiation) to identify developmentally regulated
genes whose expression is induced upon in vitro differentiation. Another
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potential use could involve the adoption of the poly(A) trap vector in a
"targeted trapping" context through the addition of homology arms (Friedel
et al., 2005); this approach would theoretically allow the targeting of loci that
are expressed at levels below the threshold (1% of the transferrin receptor
gene) required for disruption through the use of a SA-type vector. However,
it is important to establish that poly(A) trap vectors can function as effective
mutagens and hence a thorough characterisation of their mutagenic capacity















0 i i i i | i i i i | i i i i | i i i i | i i i i | i ii i | i i i i | i i i i | ii i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 8 0
3' TTCGAACCTTAAGTACCCTTCTCCTTGGCTTTCATACAAAAAGTCTACAAGAAAGAGTCTTTATCCTCAAACGCCTCCAA
° I En-2 SA intron




5 LSPI PFLFRFYTK I NKRLFLLKRLN
o
6 LKSNMPLPVSL I NKLHEKES I PTQPPQ
5' GGAGTGTGTGTTGTAGGACACGAACCCCAGGGTGGAGGAGACTGGAGGACAGAGCCCTCTTTCCCAGGGAGGGAAGGAGG
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 160
3' CCTCACACACAACATCCTGTGCTTGGGGTCCCACCTCCTCTGACCTCCTGTCTCGGGAGAAAGGGTCCCTCCCTTCCTCC









o i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | 2 40
3' TCTCAAACTCTAGGCGAGGCCTTCAGCCCCAAGTCCAAACTCGTCCGGTCCGGAGAGGGCACCAGAGCGGGAGAACAGGA
0 En-2 SA intfon
1 ESLRSAPEVGVQV AGQASPVVSPSCP
2 RV DPLRKSGFRFEQARPLPWSRPLVL
3 EFE I RSGSRGSGLSRPGLSRGLALLS





o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 320
3' TCTTCGGAGTGACCGGTCCACATTCGGTCCAGCACCCACGGCTCGGGACGAGGGAGTAGGAGTCGTACCTACACTTCTCC
0 En-2 SA intron
1 RSLTGQV ARSWVPSPAPSSSAWM RG
2 EASLARCKPGRGCRALLPHPQHGCEE
3 KPHWPGVSQVVGAEPCSL I LSMDVKR
4 FG.QGPTLWTTPASGQERMRLMSTFL
5 LLRVPWTYALDHTGLGAGEDEAH I HLP
o
6 SAESALHLGPRPHRARSG G CPHSSS
5' ACTGTATGGCGTGCGGGTGTGTGTGACCGTGGGTACACTTAAAACACCGGGTTTTGGATCTGCACTGTCCCGGATGTCCT
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4 00
3' TGACATACCGCACGCCCACACACACTGGCACCCATGTGAATTTTGTGGCCCAAAACCTAGACGTGACAGGGCCTACAGGA
° En-2 SA intron
1 LYGVRVCVTVGTLKTPGFGSALSRMS
2 DCMACGCV PWVHLKHRVLDLHCPGCP
3 TVWRAGVCDRGYT NTGFWI CTVPDVL
4 VTHRAPTHSRPYV. FVPNQ IQVTGSTR
5 SYPTRTHTVTPVSLVGPKPDASDR I DE
o
6 Q I AHPHTHGHTCKFCRTKSRCQGPHG
5' CTGGTGCTCAAAGACCCTTTTGGGTTTGCCCTTTGGTAAGAGCGCCGGGATCTACTTGTCTGGAGGCCAGGGAGTCCTCA
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4 80
3' GACCACGAGTTTCTGGGAAAACCCAAACGGGAAACCATTCTCGCGGCCCTAGATGAACAGACCTCCGGTCCCTCAGGAGT
0 En-2 SA intron
1 SGAQRPFWVCPLVRAPGSTCLEARESS
2 LVLKDPFGFALW. ERRDLLVWRPGSPQ
3 WCSKTL LGLPFGKSAG I YLSGGQGVL
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5' GCCGAGGCTTGCCGCCCCTGACTGCACTGCACTGAGTAGTGGATGGGAGAGTCTGGTACCGCACTGCCGGTTTCCTCCAC
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 560
3' CGGCTCCGAACGGCGGGGACTGACGTGACGTGACTCATCACCTACCCTCTCAGACCATGGCGTGACGGCCAAAGGAGGTG
° En-2 SA intron








o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i [ 64 0
3' GTAGGGGCGTCGCGTCCCGTCACGTAAGGCAGGACCGACGCTTCCCCCTACCAGCCCGGAAGAGGTCGGAGAAGGCGAAG
0 En-2 SA intron
1 i paaqgsafrpgceggwsgllqplpl
2 pspqrravhsvlaakgdgrafssl frf
3 hprsagqc i pswlrrgmvgpspassas





o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7 20
3' ATCGCTTCCCCGGAACTACCTTCCCGGGCGTACAGAGGTTTCAACTAAGTACGAAGAACGTGTCTCTTTCTGGTCTTTCT




4 lspak i spgahrwlqnmsraclfvlff
5 afpgqhfpgcteltsehkkclslgsl
o
6 rlprsplarmdgfn i .aeqvsfswfs
5' AGGTCTCAAGTTTTAGCCGGTAGCCCGGATGGCCTTTTCCTGCACGGCACCATATGAACCTTGTGACCCTGACTTTGAGA
o i i i i | i i i i | i i i i | i i i i | i i i i | i m i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 8 00
3' TCCAGAGTTCAAAATCGGCCATCGGGCCTACCGGAAAAGGACGTGCCGTGGTATACTTGGAACACTGGGACTGAAACTCT









o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | ii i i | 880
3' GGGGAGATTGGGTTCCGGGGATGGTGAAATGGGAAAGGGAAACTTCCGAAAGGGTGTGGTGGGAGGTGTGAAGGGGTTTG









o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | ii i i | i i i i | ii ii | ii ii | ii i i | ii ii I ii ii | 960
3' TGACGGTTGATACATCCTCCTTCCCCAACCCTGATTGTCTTCTTGGGCAACACCCCTTCGACAACCCTCCCAGTGAAATA




4 sgv i yssptpvlllvrqpsatpltvkh
5 qwshllfpnpsvssgttpfsnppds
o
6 val tpplpqs.cffgnhplqqsp k i
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pEHygroneoSD2 (+ARE)
5' GTTCTTGCCCAAGGTCAGTTGGGTGGCCTGCTTCTGATGAGGTGGTCCCAAGGTCTGGGGTAGAAGGTGAGAGGGACAGG
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | M i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1040
3' CAAGAACGGGTTCCAGTCAACCCACCGGACGAAGACTACTCCACCAGGGTTCCAGACCCCATCTTCCACTCTCCCTGTCC
° En-2 SA intron
1 VLAQGQLGGLLLMRWSQGLG KVRGTG
2 FLPKVSWVACF GGPKVWGRR EGQ
3 CSCPRSVGWPASDEVVPRSGVEGERDR
4 EQGLDTPHGAESSTTGLDPTSPSLSL




o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1120
3' GGTGGTTCCAGTCGGGGGGGGGGGATAGGGTATCCTCGGTCCAGGGAGAGGACCTGTCCTTCTGACTTCCCCTCTACGGT
0 En-2 SA intron
1 HQGQPPPP I P EPGPSPGQED RGDA
2 ATKVSPPPLS HRSQVPLLDRKTEGEMP
3 PPRSAPPPYP I GARSLSWTGRLKGRCQ
4 GGLDAGGG GMPALDREQVPLSFPLHW
5 WWP GGGG I GYSGPGEGPCSSQLPSAL
o
6 VLTLGGGRDWL LWTGRRS L FVSPS I G
5' GAGACTCAGTGAAGCCTGGGGTACCCTATTGGAGTCCTTCAAGGAAACAAACTTGGCCTCACCAGGCCTCAGCCTTGGCT
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i ii | i i i i | i i i i | 1200
3' CTCTGAGTCACTTCGGACCCCATGGGATAACCTCAGGAAGTTCCTTTGTTTGAACCGGAGTGGTCCGGAGTCGGAACCGA
0 En-2 SA intron
1 RDSVKPGVPYWSPSRKQTWPHQASALA
2 ETQ SLGYP I GVLQGNKLGLTRPQPWL
3 RLSEAWGTLLESFKETNLASPGLSLG
4 LSLSAQPVRNSDKLSVFKAEGPRLRPE




o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1280
3' GGAGGACCCTTGAGATGACGGGAACCCTAGGGAACATCAACACCCAATGTATCCTTCCCCTGCCTAAGGGGAACTGACCG
0 En-2 SA intron
1 PPGNSTALG I PCSCGLFIRKGTDSP LA
2 LLGTLLPLGSLVVVGY IGRGR I PLDW




6 RRPVRSGKPDRTTTP MPLPR I GRSQS
5' TAGCCTACTCTTTTCTTCAGTCTTCTCCATCTCCTCTCACCGTTCTCTCGACCCTTTCCCTAGGATAGACTTGGAAAAAG
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |-1 i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 13 60
3' ATCGGATGAGAAAAGAAGTCAGAAGAGGTAGAGGAGAGTGGCAAGAGAGCTGGGAAAGGGATCCTATCTGAACCTTTTTC
0 En-2 SA intron




5 LRSKEETKEMEE RERSGKGL I SKSFS
o
6 A EKR DEGDGRVTREVRERPYVQFF
5' ATAAGGGGAGAAAAACAAATGCAAACGAGGCCAGAAAGATTTTGGCTGGGCATTCCTTCCGCTAGCTTTTATTGGGATCC
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | 1440
3' TATTCCCCTCTTTTTGTTTACGTTTGCTCCGGTCTTTCTAAAACCGACCCGTAAGGAAGGCGATCGAAAATAACCCTAGG
0 En-2 SA intron
1 DKGRKTNANEARK I LAGFISFR LLLGS
2 I RGEKQMQTRPERFWLG I PSASFYWDP
3 GEKNKCKRGQKDFGWAFLPLAFIG I
4 YPSFFLHLRPWFSKPQANRGSAK I P I G
5 LPLFVFAFSALF I KAPCEKR SKNPD
o
6 I LPSFC ICVLGSLNQSPMGEALK.QSG
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5' CCTAGTTTGTGATAGGCCTTTTAGCTACATCTGCCAATCCATCTCATTTTCACACACACACACACCACTTTCCTTCTGGT
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1520
3' GGATCAAACACTATCCGGAAAATCGATGTAGACGGTTAGGTAGAGTAAAAGTGTGTGTGTGTGTGGTGAAAGGAAGACCA
° En-2 SA intron
1 PSL. AF LHLP I HL I FTHTHTTFLLV
2 LVCDRPFSY ICQS I SFSHTHTPLSFW
3 P FV IGLLATSANPSHFHTHTHHFPSG
4 NT I PRKAVDALGD K .VCVCWKGEP




o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1600
3' GTCACCCGTGTACAGGTCGGGGGTTGTGAACATACCGGAACCGCCCCAGTAGGGGGGGGGTGGGGGTCATAGACGTTGGA
0 En-2 SA intron
1 SGHMSSPQHLYGLGGV I PPPPPVSAT
2 SVGTCPAPNTCMALAGSSPPHPQYLQP
3 QWAHVQPPTLVWPWRGHPPPTPS ICNL
4 HACTWGGVSTHGQRP GGGVGL I QLR
5 LPCMDLGWCKYPRPPTMGGGGGTDAVE
o
6 TPVHGAGLVQ I AKAPDDGGWGWYRCG
5' CAAGCTAGCTTGGGTGCGTTGGTTGTGGATAAGTAGCTAGACTCCAGCAACCAGTAACCTCTGCCCTTTCTCCTCCATGA
0 iiii|iii i | i i i i | i i i i | i i ii | i M i | i i i i i i i i i | i i i i | i i ii |i i i i |iii i | i i i i | i i i i | i i i i | i i i i | 1680
3' GTTCGATCGAACCCACGCAACCAACACCTATTCATCGATCTGAGGTCGTTGGTCATTGGAGACGGGAAAGAGGAGGTACT
° En-2 SA intron
1 SS LGCVGCG VARLQQPVTSALSPP
2 QASLGALVVDK LDSSNQ. PLPFLLHD
3 KLAWVRWLWI SS TPATSNLCPFSSM







o i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i I i i i i I i i i i | i i i i I i i i i | 1760
3' GTTGGTCCAGGGTCCAGGGCTTTTGGTTTCTTCTTCTTGCGTCTAGACCTCCTCCTCCTCCTCCTCCTCCTCCTCCTCCT




















o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 1920
3' TTTGCCGGTGTTCAAGTCGCACAGGCCGCTCCCGCTCCCGCTACGGTGGATGCCGTTCGACTGGGACTTCAAGTAGACGT
0 EGFP
1 TATSSACPARARAMPPTAS P SSSA
2 KRPQVQRVRRGRGRCHLRQADPEVHLH




6 LRGCT RTRRPRPRHWRRCASGST RC
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:>EHygroneoSD2 (+ARE)
5' CCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCC
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i M | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 2000
3' GGTGGCCGTTCGACGGGCACGGGACCGGGTGGGAGCACTGGTGGGACTGGATGCCGCACGTCACGAAGTCGGCGATGGGG
° EGFP
1 PPASCPCPGPPS PP PTACSASAATP
2 HRQAARALAHPRDHPD LRRAVLQP L P
3 TTGKLPVPWPTLVTTLTYGVQCFSRYP














6 GCSAARSR TRWARLSRGPACWRR P
5' CGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCG
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 2160
3' GCTGCCGTTGATGTTCTGGGCGCGGCTCCACTTCAAGCTCCCGCTGTGGGACCACTTGGCGTAGCTCGACTTCCCGTAGC
° EGFP
1 TTATTRPAPR SSRATPW. TASS RAS
2 RRQLQDPRRGEVRGRHPGEPHRAEGHR






0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 2240
3' TGAAGTTCCTCCTGCCGTTGTAGGACCCCGTGTTCGACCTCATGTTGATGTTGTCGGTGTTGCAGATATAGTACCGGCTG
° EGFP
1 TSRRTATSWGTSWSTTTTATTS I SWPT
2 LQGGRQHPGAQAGVQLQQPQRLYHGR
3 DFKEDGN I LGHKLEYNYNSHNVYIMAD
4 KLSSPLMRPCLSSYL LLWLT. I M A S
5 VELLVAVDQPVLQLVVVVAVVD I DHGV
o
6 S PPRCCGPACAPTCSCCGCRRY PRC
5' AAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTA





3 KQKNG i KVN FK I RHN I EDGSVQLADHY
4 LCFFPMLTFKL I RWLMSSPLTCSASW.
5 LLLVADLHVELDAVVDLVAAHLEGVVV
o
6 ASSRC PSS SGGCCRPRCRAARRGS
5' CCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCA
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 2400
3' GGTCGTCTTGTGGGGGTAGCCGCTGCCGGGGCACGACGACGGGCTGTTGGTGATGGACTCGTGGGTCAGGCGGGACTCGT
0 EGFP
1 TSRTPPSATAPCCCPTTTT APSPP A
2 PAEHPHRRRPRAAARQPLPEHPVRPEQ
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5' AAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAG
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 2480
3' TTCTGGGGTTGCTCTTCGCGCTAGTGTACCAGGACGACCTCAAGCACTGGCGGCGGCCCTAGTGAGAGCCGTACCTGCTC
0 EGFP
KTPTRSA I TWSCWSS PPPGSLSAWTS
RPQREARSHGPAGVRDRRRDHSRHGR
KDPNEKRDHMVLLEFVTAAG I TLGMDE
SGLSFRS MTRSSNTVAAP I VRPMSS














i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | II II | i i i i | i i i i | i i i i | 2 64 0
ACCCTTTTGGGACCGCAATGGGTTGAATTAGCGGAACGTCGTGTAGGGGGAAAGCGGTCGACCGCATTATCGCTTCTCCG
lacZ
LGKPWRYPT SPCSTSPFRQLA R R G
WENPGVTQLNRLAAHPPFASWRNSEEA
GKTLALPNL I ALQH I PLSPAGV I AKR









PAP I ALPNSCAA MANGALPGFRHQKR
AG I ARGL LQAAQ I AFPAKGPKRCWFR
GCRDGKGVTACGSHR I ASQRTEPVLLP
RVSRGEWCNRLRFPSHRKAQNGAGSAT
Bae I' Bae I
TGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCAGATGCACGGTTAC





CRKAGWSA I FLRP I LSSSPQTGRCTVT
HRFAPQLA I KRLG I SDDDG VPLHVTV
AP FSAPTRDEQPRYQRRGRLSASARNR
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5' GATGCGCCCATCTACACCAACGTAACCTATCCCATTACGGTCAATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGTTG




DAP I YTNVTYP I TVNPPFVPTENPTGC
MRPSTPT P I PLRS I RRL FPRR I RRV




















WRMSGI FRDVSLLHKPTTQ I SDFHVA

















FYAPEKTASR .WCCVGVTAV IWK I R I
K AGSFVAERHHHQTPTVAT I QF I L IH
KVRRL FGGRPSPAANSHRCNDPLDPY
NKRAPSFRRAT I TSRQLSPL RSS S I
GTGGCGGATGAGCGGCATTTTCCGTGACGTCTCGTTGCTGCATAAACCGACTACACAAATCAGCGATTTCCATGTTGCCA
I I i i | I I i i | I I i i | I I i i | I i m | I I i i | I I i i | I i i 11 I I i i | I I i i | I I i i | I I i i | I I i i | I I i i | I I i i | I I i i |
CACCGCCTACTCGCCGTAAAAGGCACTGCAGAGCAACGACGTATTTGGCTGATGTGTTTAGTCGCTAAAGGTACAACGGT
3200
HR I LPMKRSTENSCLGVVC I LSKWTAV
CTCGCTTTAATGATGATTTCAGCCGCGCTGTACTGGAGGCTGAAGTTCAGATGTGCGGCGAGTTGCGTGACTACCTACGG
■ ' ' ' I ' ' ■ ' I ' ' ' i I ' i i ' I ' ' ' H ' ' ♦ ' I ' i ' i I ' i 1 i I ' ' i ' I i i ' i I i i i i I i i ' i I i i i ' I ' i ' ' I ' i ' ' H i t i |
GAGCGAAATTACTACTAAAGTCGGCGCGACATGACCTCCGACTTCAAGTCTACACGCCGCTCAACGCACTGATGGATGCC
iacZ
SL. FQPRCTGG SSDVRRVA LPT
TRFNDDFSRAVLEAEVQMCGELRDYLR
LALMM I SAALYWRLKFRCAASCVTTYG
SAKI I I EAASYQLSFNLHAALQTVV P
ES HHN GRQVPPQLESTRRTAHSGVP
3280





o i i i i | i i i i | i i ii | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 3360
3' CATTGTCAAAGAAATACCGTCCCACTTTGCGTCCAGCGGTCGCCGTGGCGCGGAAAGCCGCCACTTTAATAGCTACTCGC
gnsffmag nagrqrhrafrr n y r .a
vtvslwqgetqvasgtapfgge i ider
qflygrvkrrspaaprlsavklsms
ycnr pltfrldgaagrreatfnd i lt
llkk i aphfaprwrcrakrrh f rha
tvtekhcpsvctalpvagkpps i issr
TGGTGGTTATGCCGATCGCGTCACACTACGTCTGAACGTCGAAAACCCGAAACTGTGGAGCGCCGAAATCCCGAATCTCT





vvvmp iashyv tsktrncgapksr i s
ttigiadc. tqvdfvrfqpagfdr i e
hhnhrdr vvdsrrfgsvtsrrfgsdr
pp asrtvsrrftsfgfshlas i gfr
ATCGTGCGGTGGTTGAACTGCACACCGCCGACGGCACGCTGATTGAAGCAGAAGCCTGCGATGTCGGTTTCCGCGAGGTG






i trhnfqvggvarqnfcfga i dtealh
dh ppqvacrrrcasql l lrrhrngrpa
rattsscvaspvs i sasaqstpkrst
CGGATTGAAAATGGTCTGCTGCTGCTGAACGGCAAGCCGTTGCTGATTCGAGGCGTTAACCGTCACGAGCATCATCCTCT
i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | i i i i i i i i i | 3 600
GCCTAACTTTTACCAGACGACGACGACTTGCCGTTCGGCAACGACTAAGCTCCGCAATTGGCAGTGCTCGTAGTAGGAGA
ad kwsaaaerqavadsrr psrasss
r i engllllngkpll i rgvnrhehhpl
glkmvccc tasrc fealtvts i i l








cmvrswmsrrwcr i sc srttltpca
mtldh i llrhhl i dqqhllvvkvgha
ahdp phasspapygassascs rras
cp tmsscv i tcs i rs 1 fcflklatrq
GTTCGCATTATCCGAACCATCCGCTGTGGTACACGCTGTGCGACCGCTACGGCCTGTATGTGGTGGATGAAGCCAATATT





vr i i rt i rcgtrcatatacmwwmkp i l
trm i rvmrqpvrqavavaq i hh i fgin
nandsgdattcatrgsrgthpphlwyq
ec gfwgshyvshsr pryttssal i
Saturday, October 14, 2006 1:32 PM Page 9 of 27
>EHygroneoSD2 (+ARE)
5' GAAACCCACGGCATGGTGCCAATGAATCGTCTGACCGATGATCCGCGCTGGCTACCGGCGATGAGCGAACGCGTAACGCG






4 FGVAHHWH I TQG I I RAP RRHAFAYRS
5 fgrcpa lsddsrhdasavpssrvrla
o




o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 3920
3' TTACCACGTCGCGCTAGCATTAGTGGGCTCACACTAGTAGACCAGCGACCCCTTACTTAGTCCGGTGCCGCGATTAGTGC
0 lacZ
1 ngaars specdhlvage irprr.sr
2 MVQRDRNHPSV I IWSLGNESGHGANH
3 EWCSA IV I TRV SSGRWGMNQATAL I T
4 HH LA I T I VRTHDDPRQP I F AVAS I V
5 fpaardydgshs rtapsh i lgrr dr
o
6 I TCRSRL .GLT IMQDSPFSDPWPAL S
5' ACGCGCTGTATCGCTGGATCAAATCTGTCGATCCTTCCCGCCCGGTGCAGTATGAAGGCGGCGGAGCCGACACCACGGCC





3 TRC I AGSNLS I LPARCSMKAAEPTPRP
4 VRQ I APDFRD I RGARHL I FAASGVGRG
5 RATDSS. I QRDKGGPATH'LRRLRCWPW
3
6 ASYRQ I LDTSGERGTCYSPPPASVVA
-y ACCGATATTATTTGCCCGATGTACGCGCGCGTGGATGAAGACCAGCCCTTCCCGGCTGTGCCGAAATGGTCCATCAAAAA
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4080
3' TGGCTATAATAAACGGGCTACATGCGCGCGCACCTACTTCTGGTCGGGAAGGGCCGACACGGCTTTACCAGGTAGTTTTT
s
1 HRYYLPDVRARG . RPALPGCAEMVHQK
2 t d i i cpmyarvdedqpfpavpkws i kk
3 P I LFARCTRAWMKTSPSRLCRNGPSK
4 GINNARHVRAHI FVLGERSHRFPGDFF
5 RY KGSTRARPHLGARGPQAS I TW. F
5
3 VSI I QG I YARTSSSWGKGATGFHDML F
3' ATGGCTTTCGCTACCTGGAGAGACGCGCCCGCTGATCCTTTGCGAATACGCCCACGCGATGGGTAACAGTCTTGGCGGTT
3 i i i i | i i i i | i i i i | i I i i | i i i i | i i i i [ i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4160
3' TACCGAAAGCGATGGACCTCTCTGCGCGGGCGACTAGGAAACGCTTATGCGGGTGCGCTACCCATTGTCAGAACCGCCAA
3 iacZ
1 MAFATWRDAPADPLR I RPRDG QSWRF
2 WLSLPGETRPL I LCEYAHAMGNSLGG
3 NGFRYLERRAR SFANTPTRWVTVLAV
4 p kr rslrarqdkafvgvrhtvtkat
5 I AKAVQLSAGASGKR I RGRSPYCDQRN
3
3 HSESGPSVRGS I RQSYAWA I PLLRPPK
5' TCGCTAAATACTGGCAGGCGTTTCGTCAGTATCCCCGTTTACAGGGCGGCTTCGTCTGGGACTGGGTGGATCAGTCGCTG
3 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4240
3' AGCGATTTATGACCGTCCGCAAAGCAGTCATAGGGGCAAATGTCCCGCCGAAGCAGACCCTGACCCACCTAGTCAGCGAC
^ iacZ
1 R. I LAGVSSVSPFTGRLRLGLGGSVA
2 FAKYWQAFRQYPRLQGGFVWDWVDQSL
3 SLNTGRRFVS I PVYRAASSGTGWI SR
t ESFVPLRKTL IGT LAAEDPVPH I LRQ
5 R. I SAPTEDTDGNVPRSRRPSPPDTAS
3
3 ALYQCANR YGRKCPPKTQSQTS DS
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ATTAAATATGATGAAAACGGCAACCCGTGGTCGGCTTACGGCGGTGATTTTGGCGATACGCCGAACGATCGCCAGTTCTG
i i i i 1 i i i i | M i i | i i i i | i i i i | i i i i | i it i| i i i i | ii i i | i i i i | i i i i | i i i i | i i i i | i i i i | M i i | i i i i | 4 320
TAATTTATACTACTTTTGCCGTTGGGCACCAGCCGAATGCCGCCACTAAAACCGCTATGCGGCTTGCTAGCGGTCAAGAC
lacZ —
D. I KRQPVVGLRR F WRYAERSPVL
I KYDENGNPWSAYGGD FGDTPNDRQFC
LNMMKTATRGRLTAV I LAIRRTIASS














i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4 4 80
AGGCAAATAGGCCCGTTTGGTAGCTTCACTGGTCGCTTATGGACAAGGCAGTATCGCTATTGCTCGAGGACGTGACCTAC
PF I RANHRSDQR I PVPS R RAPALD
FRLSGQT I EVTSEYLFRHSDNELLHWM
SVYPGKPSK PANTCSV IAI TSSCTGW
ET GPLGDFHGAFVQETMA IVLEQVPH
GN I RAFWRLSWR I GTGDYRYRAGASSP
RKDPCVMSTVLSYRNR LSLSSRCQI
GTGGCGCTGGATGGTAAGCCGCTGGCAAGCGGTGAAGTGCCTCTGGATGTCGCTCCACAAGGTAAACAGTTGATTGAACT
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | 4 560
CACCGCGACCTACCATTCGGCGACCGTTCGCCACTTCACGGAGACCTACAGCGAGGTGTTCCATTTGTCAACTAACTTGA
lacZ
GGAGW AAGKR SASGCRSTR TVD T
VALDGKPLASGEVPLDVAPQGKQL I EL
WRWMVSRWQAVKC LWMS L HKVNS LN
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5' GCCATCCCGCATCTGACCACCAGCGAAATGGATTTTTGCATCGAGCTGGGTAATAAGCGTTGGCAATTTAACCGCCAGTC
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i ii | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 4800
3' CGGTAGGGCGTAGACTGGTGGTCGCTTTACCTAAAAACGTAGCTCGACCCATTATTCGCAACCGTTAAATTGGCGGTCAG
RHPASDHQRNGFLHRAG A L A I .PPV
A I PHLTTSEMDFC I ELGNKRWQFNRQS
PSR I PPAKWI FASSWV I SVGNLTAS
GDRMQGGAFH I KADLQT I LTPLKVAL
WGADSWWRFPNKCRAPYYANA I G G T
AMGCRVVLS I SKQMSSPLLRQCNLRWD
AGGCTTTCTTTCACAGATGTGGATTGGCGATAAAAAACAACTGCTGACGCCGCTGCGCGATCAGTTCACCCGTGCACCGC





QAFFHRCGLA I KNNC R R C A I SSPVHR
AKK LHPNA I FFLQQRRQA I LEGTCR
LSEKVSTSQRYFVVASAAARDT G H V A
PKREC I H i PSL FCSSVGSRS NVRAGS
TGGATAACGACATTGGCGTAAGTGAAGCGACCCGCATTGACCCTAACGCCTGGGTCGAACGCTGGAAGGCGGCGGGCCAT
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | 4 960
ACCTATTGCTGTAACCGCATTCACTTCGCTGGGCGTAACTGGGATTGCGGACCCAGCTTGCGACCTTCCGCCGCCCGGTA
lacZ
G RHWRK SDPH P RLGRTLEGGGP
LDND I GVSEATR I DPNAWVERWKAAGH










TRPKQRCCSARQ I HLLMRC LRPLTR
VLGFCRQQLARC I CKS I RHQNRGSVRP
GPRLLTTATCPLYVQQHPAS SRERT
WASAANNCHVASVSASATS I V V A AH
GCAGCATCAGGGGAAAACCTTATTTATCAGCCGGAAAACCTACCGGATTGATGGTAGTGGTCAAATGGCGATTACCGTTG
i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 5120
CGTCGTAGTCCCCTTTTGGAATAAATAGTCGGCCTTTTGGATGGCCTAACTACCATCACCAGTTTACCGCTAATGGCAAC
[acZ
AASGENL I YQPENLPD W.WSNGDYR
QHQGKTL F I SRKTYR I DGSGQMA I TV
GS I RGKPYLSAGKPTGLMVVVKWRLPL
LMLPFG KDAP FGVPN I TTTLHRNGN
AADPSFRI GSFRGSQHYHDFPS RQ
CC PFVKN I LRFV R I SPLP IAIVTS
ATGTTGAAGTGGCGAGCGATACACCGCATCCGGCGCGGATTGGCCTGAACTGCCAGCTGGCGCAGGTAGCAGAGCGGGTA
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i 1 i i i i I i i i i | i i i i I i i i i | i i i i i i i i i | i i i i I i i i i | 5200
TACAACTTCACCGCTCGCTATGTGGCGTAGGCCGCGCCTAACCGGACTTGACGGTCGACCGCGTCCATCGTCTCGCCCAT
iacZ
C SGE'RYT ASGADWPE L PAGAGSRAG
DVEVASDTPHPAR I GLNCQLAQVAERV
ML KWRA I HR I RRGLA TASWRR QSG
I N FHRA I CRMRRPNAQVALQRLYCLPY
HQLPSRYVADPASQGSSGAPAPLLAPL
TSTALSVGCGAR I PRFQWSACT ASRT
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5' AACTGGCTCGGATTAGGGCCGCAAGAAAACTATCCCGACCGCCTTACTGCCGCCTGTTTTGACCGCTGGGATCTGCCATT
o i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 5280
3' TTGACCGAGCCTAATCCCGGCGTTCTTTTGATAGGGCTGGCGGAATGACGGCGGACAAAACTGGCGACCCTAGACGGTAA
° lacZ
KLAR I RAARKLSRPPYCRL F . PLGSA I
NWLGLGPQENYPDRLTAACFDRWDLPL
TGSD GRKKT I PTALLPPVLTAG I CH
VPES PRLFV I GVAKSGGTKVAP IQWQ









CQTC I PRTSSRAKTVCAAGRAN IMAH
VH IGRVDERAFVTQAAPRAFQI IAW
TLCTYGTRRGSRFRDASRSAR I SNHGV
DSMYVGYTKGLS FPRRQPVRSN F PGC
ACCAGTGGCGCGGCGACTTCCAGTTCAACATCAGCCGCTACAGTCAACAGCAACTGATGGAAACCAGCCATCGCCATCTG




HQWRGD FQFN I SRYSQQQLMETSHRH L
TSGAATSSSTSAATVNSN .WKPA I A I C
VLPAAVELEVDAAVTLLLQHFGAMAMQ
GTARRSGT C GSCDVAVSPFWGDGDA
WHRPSKWNLMLR L CCS I SVLWRWR
CTGCACGCGGAAGAAGGCACATGGCTGAATATCGACGGTTTCCATATGGGGATTGGTGGCGACGACTCCTGGAGCCCGTC
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 5520
GACGTGCGCCTTCTTCCGTGTACCGACTTATAGCTGCCAAAGGTATACCCCTAACCACCGCTGCTGAGGACCTCGGGCAG
———
AARGRRHMAEY.RR FPYGDWWRRL L EPV
LHAEEGTWLN I DGFHMG I GGDDSWSPS
CTRKKAHG. I STVS IWGLVATTPGAR
QVRFFACPQIDVTEMHPNTAVVGPAR
ARPL LCMASYRRNGYPSQHRRSRSGT
SCASSPVHSF I SPKWI P I PPSSEQLGD
Blp I
AGTATCGGCGGAATTCCAGCTGAGCGCCGGTCGCTACCATTACCAGTTGGTCTGGTGTCAGGGGATCCCCCGGGGatccg
i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 5 600
TCATAGCCGCCTTAAGGTCGACTCGCGGCCAGCGATGGTAATGGTCAACCAGACCACAGTCCCCTAGGGGGCCCCtaggc
jacZ
S I GG I PAERRSLPLPVGLVSGDPPG I R
VSAEFQLSAGRYHYQLVWCQG I PRGS
QYRRNSS APVAT I TSWSGVRGSPGDP
YRRFELQAGTAVMVLQDPTLPDGPSG
L I PP I GASRRDSGNGTPRTDPSGGP I R
TDASNWSLAPR .W.WNTQH P I GRPDA
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PshA\
ccaccatggctaaaAATTCGAGCTCGGTACCCGGGGATCCAGCCGCCACCATGAAAAAGCCTGAACTCACCGCGACGTCT













PPWL K I RARYPG I QPPP KSLNSPRRL
GGHSF I RARYGP IWGGGHFLRFEGRRR
WWP FNSSPVRPDLRWWS FAQV RSTQ
VMAL FELETGPSGAAVMFFGSSVAVD
GTCGAGAAGTTTCTGATCGAAAAGTTCGACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTT








TSFNR I SFNSLTESR I CSESPSSDRAK
CAGCTTCGATGTAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTACAAAGATCGTTATGTTT





SASM EGVDMSCG I AAPMVSTK 1 VMF









SALC IGRAPDSGSA HWG IQREPDL L
YRHFASAALP I PEVLD I GEFSESLTYC
I GTLHRPRSRFRKCLTLGNSARA P I A













0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 6080
3' CCGGTACCTACGCTAGCGACGCCGGCTAGAATCGGTCTGCTCGCCCAAGCCGGGTAAGCCTGGCGTTCCTTAGCCAGTTA
° Hygro
1 GHGCDRCGRS PDERVRP I RTARNRS I
2 AMDA I AAADLSQTSGFGPFGPQG I GQ
3 RPWMRSLRP I LARRAGSAHSDRKESVN
4 GH I RDSRGI KALRAPEAWESRLSDTL
5 PWPHSRQPRD .GSSRTRGMRVALFRD I
o
6 AMSA I AAASRLWVLPNPGNPGCP I P Y
5' ACACTACATGGCGTGATTTCATATGCGCGATTGCTGATCCCCATGTGTATCACTGGCAAACTGTGATGGACGACACCGTC
0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 6160
3' TGTGATGTACCGCACTAAAGTATACGCGCTAACGACTAGGGGTACACATAGTGACCGTTTGACACTACCTGCTGTGGCAG
a Hygro
1 HYMA FHMRDC SPCVSLANCDGRHR
2 YTTWRDF I CA I ADPHVYHWQTVMDDTV
3 TLHGV I SYARLL I PMC I TGKL .WTTPS
4 VSCPT I EYARNS IGMH I VPLSHHVVGD
5 C.MAHN. I RSQQDGHTDSAFQSPRCR
5
3 VVHRSKMHA I ASGWTY QCVT I SSVT
5' AGTGCGTCCGTCGCGCAGGCTCTCGATGAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGC














DFGSNNVLTDNGR I TAV I DWSEAMFG
R I SAPTMS RTMAA QRSLTGARRCSG
I EAGV I DQRV I AAYCRDNVPALRHEP
PN RSWCHGSPCHGC L L P QSSRPSTRP
SKPEL LTRVSLPRMVATMSQLSA I NPS
ATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTGGCTTGTATGGAGCAGCAGACGCGCTACTTCGAG








EWYSTALMKKQLGHNAQ I SCCVR KS
CGGAGGCATCCGGAGCTTGCAGGATCGCCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATCAGAG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 64 80
GCCTCCGTAGGCCTCGAACGTCCTAGCGGCGCCGAGGCCCGCATATACGAGGCGTAACCAGAACTGGTTGAGATAGTCTC
Hygro
AEASGACR I AAAPGVYAPHWS PTLSE
RRHPELAGSPRLRAYMLR I GLDQLYQS
GG I RSLQDRRGSGR I CSALVLTNS I R
PPMRLKCSRRPEPR I HEANTKVLE I LA
SADPAQL I AAAGPTYAGCQDQGVRDS
RLCGSSAPDGRSRAY I SRMPRSWS .L
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CTTGGTTGACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCGACGCAATCGTCCGATCCGGAGCCGGGACTG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i [ i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 6560
GAACCAACTGCCGTTAAAGCTACTACGTCGAACCCGCGTCCCAGCTACGCTGCGTTAGCAGGCTAGGCCTCGGCCCTGAC
Hygro
LG RQFR CSLGAGSMRRNRP I RSRDC
LVDGN FDDAAWAQGRCDA I VRSGAGT
AWLTA I SMMQLGRRVDATQSSDPEPGL
QNVAIEI I CSPRLTSAVCDDSGSGPS
SPQRCNRHHLKPAPD I RRLRG I RLRSQ
KTSPLKSSAAQACPRHSA I TRDPAPVT
TCGGGCGTACACAAATCGCCCGCAGAAGCGCGGCCGTCTGGACCGATGGCTGTGTAGAAGTACTCGCCGATAGTGGAAAC




VGRTQ I ARRSAAVWTDGCVEV LADSGN
SGVHKSPAEARPSGPMAV . KYSP I VET





i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
GCTGCGGGGTCGTGAGCAGGCTCCCGTTTCCTTATCTCATCTACGGCTGGCTTGTTCTCGACTAAAGCTCTTGCGGAGTC








i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
GGTCGTTGAGCGCGCTCGGATCGTTCCTAGGAACGTCTTTAACTACTAGATAATTTGTTATTTCTACAGGTGATTTTACC
PATRASLAR I LAE I DDL LNNKDVH NG
QQLARA QGSLQKLM I Y T I KMSTKM
ASNSREPSKDPCRN .SIKQ.RCPLKW
LLERSGLLSGQLFQHD I LCYLHGSFH
GAVRALRAL I RAS I SSRNFLLSTW. FP
6800
WCSARA CPDKCFN I I . .VI FIDVL IS
AAGTTTTTCCTGTCATACTTTGTTAAGAAGGGTGAGAACAGAGTACCTACATTTTGAATGGAAGGATTGGAGCTACGGGG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
TTCAAAAAGGACAGTATGAAACAATTCTTCCCACTCTTGTCTCATGGATGTAAAACTTACCTTCCTAACCTCGATGCCCC
SFSCHTLLRRVRTEYLHFEWKDWSYG
EVFPV I LC EG EQSTY I LNGR I GATG
KFFLSYFVKKGENRVPTF MEGLELRG
FNKRDYKTL FPSFLTGVNQ I SPNSSRP
LKEQ VKNLLTLVSYRCKSHFSQL PP
6880
TKGTMSQ SPHSCLV MKFPL I PAVP
GTGGGGGTGGGGTGGGATTAGATAAATGCCTGCTCTTTACTGAAGGCTCTTTACTATTGCTTTATGATAATGTTTCATAG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
CACCCCCACCCCACCCTAATCTATTTACGGACGAGAAATGACTTCCGAGAAATGATAACGAAATACTATTACAAAGTATC
GGGGVGLDKCLLFTEGSLLLLYDNVS
VGVGWD. I NACSLLKALYYCFM IMFHR
WGWGG I R MPALY RL FT I AL C F I
HPHPP I LY I GAR QLSKV I AKHYHKMP
PPPTPNS LHRSKVSPEKSNS SLTEY
6960
TPTPHS. I FAQEKSFAR. Q K I I IN.L
GTTGGATATCATAATTTAAACAAGCAAAACCAAATTAAGGGCCAGCTCATTCCTCCCACTCATGATCTATAGATCTATAG
i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i [ i i i i | i i i i | i i i i |
CAACCTATAGTATTAAATTTGTTCGTTTTGGTTTAATTCCCGGTCGAGTAAGGAGGGTGAGTACTAGATATCTAGATATC
VGYHNLNKQNQ I KGQL I PPTHDL I Y R
L D I I I TSKTKLRASSFLPLM I YRS I
GWIS. FKQAKPN .GPAHSSHS S IDL
Q I DYNLCAFGF PGA EEWEHD I SRY
TPY LKFLCFWI LPWSMGGV SRY I L
7040
V N N D I
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5' ATCTCTCGTGGGATCATTGTTTTTCTCTTGATTCCCACTTTGTGGTTCTAAGTACTGTGGTTTCCAAATGTGTCAGTTTC










0 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7200
3' TATCGGACTTCTTGCTCTAGTCGTCGGAGACAAGGTGTATGTGAAGTAAGAGTCATAACAAAACGGTTCAAGATTAAGGT
1 HSLKNE I SSLCSTYTSFSVLFCQVL I P
2 I A .RTRSAASVPHTLHSQYCFAKF FH
3 PEERDQQPLFHIHFI LS IVLPSSNS
4 YGSSRS CGRNWMCKMRL I TKGLELEM
5 LRFFS I LLRQEVYVENETNNQWTR I G
3
3 MAQLVLDAAETGCVS E YQKALN NW
5' TCAGAAGCTCCCGGCGCGTGATCCAGCTCACTCCCCTGTTGATTGTGTGTTATGGTGCAGAGTCCAGCCACTGTTTGTCC
3 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i M | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7280
3' AGTCTTCGAGGGCCGCGCACTAGGTCGAGTGAGGGGACAACTAACACACAATACCACGTCTCAGGTCGGTGACAAACAGG
1 SEAPGA SSSLPC LCVMVQSPATVCP
2 QKLPARDPAHSPVDCVLWCRVQPL FV
3 I RSSRRV IQLTPLL IVCYGAESSHCLS
» LLERRT IWSVGRN I TH PASDLWQKD




3 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7360
J' TCACCCCAGAGACTGGACGGAAGGACATCGAGAACCTCAGTAAGACCGGAGGGGGAGGGGGTTCGGGTGTGTTTTTTGGT
I VGSLTCLPVALGV I LASPSPKPTQKT









3 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | 7440
3' TGTGTGTCTAGATTACTTTTATTTCTAGAAAATAACCTAGCCCCGCGCGGGGTCGAACCCGACGTCCAGGACGTCTAGAC
1 NTQI K RSF I GSGRAPAWAAGPADL
2 THRSNENKDL L LDRGAPQLGLQVLQ I C
3 HTDLMKIKI FYWIGARPSLGCRSCRS
i CVSR I F I F I K Q I PARGLKPQLDQLDA
5 VCI HFYLDK I PDPRAGAQAAPGASR
3




3 i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7520
j, GTCTTTAAGCGGAAGACGTCCTCGCATGTCTTGGGTCCCGGGACCGTGGGCACGTCTGGGACCGGGTGGGGTGGACCCGC
3 | beta-actin P
I QKFAFCRSVQNPGPWHPCRPWPTPPGR
I RNSPSAGAYRTQGPGTRADPGPPHLG
3 AE I RL LQERTEPRALAPVQTLAHPTWA






































i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 7 84 0
TTCCTCCCCTCTCCCCCATTTTTTTACGACGTGACACGCCGCTTCGGCCACTCACTCGCCGCGCCCCGGTTAGTCGCACG
RRGEGVKKCCTVRRSR VSGAGP I SV
KGGERG KNAALCGEAGE AARGQSAC
KEGRGGKKMLHCAAKPVSERRGANQRA












GNRFNGK I ARAAAAAG . LVWRRSAGGG
RESLQRKHSSRGRRRG I FGL PAVRWW
V V
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CGCCGAGACCGCGTCCGCCCCGCGAGCACAGAGCCTCGCCTTTGCCGATCCTCTAGAGTCGAGATCCGCCGCCACCAtga
i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i ii i | i i i i | i i i i | 8000
GCGGCTCTGGCGCAGGCGGGGCGCTCGTGTCTCGGAGCGGAAACGGCTAGGAGATCTCAGCTCTAGGCGGCGGTGGTact
beta-actin P ^>|
1 RRDRVRPASTEPRLCRSSRVE I RRHHD
2 AETASAPRAQSLAFADPLESRSAATM
3 PPRPRPPREHRASPLP I L SRDPPPP





i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | 8080
aacttgttctacctaacgtgcgtccaagaggccggcgaacccacctctccgataagccgatactgacccgtgttgtctgt
Neo
TRWI ARRFSGRLGGEA I RL LGTTD
I EQDGLHAGSPAAWVERLFGYDWAQQT
LNKMDCTQVLRPLGWRGYSAMTGHNRQ
NFL I SQVCTRRGSPHLP EA IVPCLLC
QVLH 1 ARLNEPRKPPSA I RSHSPVVSL
SCSPNCAPEGAAQTSLSNP SQACCV
atcggctgctctgatgccgccgtgttccggctgtcagcgcaggggcgcccggttctttttgtcaagaccgacctgtccgg




I GCSDAAVFRLSAQGRPVL FVKTDL SG
SAALMPPCSGCQRRGARFFLSRPTCP




i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i I i i i i | i i i i [ i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | 82 4 0
acgggacttacttgacgtcctgctccgtcgcgccgatagcaccgaccggtgctgcccgcaaggaacgcgtcgacacgagc
Neo
CPE TAGRGSAA I VAGHDGRS LRSCAR
ALNELQDEAARLSWLATTGVPCAAVL
VP MNCRTRQRGYRGWPRRAFLAQLCS




i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | 8320
tgcaacagtgacttcgcccttccctgaccgacgataacccgcttcacggccccgtcctagaggacagtagagtggaacga
Neo




RQ QLPFPSAA I PRLAPAPDGTMEGQE
TTVSAPLSQSSNPSTGPCSRRDD RA
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v cctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcccattcgacca
s i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i M i | i i i i | i i i i | i i i i | i i i i | i i i i | 8400
3' ggacggctctttcataggtagtaccgactacgttacgccgccgacgtatgcgaactaggccgatggacgggtaagctggt
i Neo
1 SCRES I HHG CNAAAAYA SGYLP I RP
PAEKVS I MADAMRRLHTLDPATCPFDH
LPRKYPSWLMQCGGC I RL I RLPAHST
RGLFYGDHS I CHPPQMRK I RSGAWEVV
QRSL IW. PQH LAAAAYAQDP RGMRG
0 GAS FTDMMASA I RRSCVSSGAVQGNSW
Bsa Al
i' ccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaagagc




! QAKHR I ERARTRMEAGLVDQDDLDEE




i WAFCRMSRARVR I SAPRTS SSRSSSC
, Sph I
atcaggggctcgcgccagccgaactgttcgccaggctcaaggcgcgcatgcccgacggcgaggatctcgtcgtgacccat





l I RGSRQPNCSPGSRRACPTAR I SS PM








: GMGDACR I SWWK I CGRFSGF I DCGRLG
I AWAMPAEYHGGKFAAAFLDSSTVAGW
AHA I GASY PPFNAAAKRSEDVTAPQT
, CPRHRGF IMTSFKRGSKQI .RSHGAP
i
> PMPSAQR IDHHF IQPRKEPNMSQPRSP
tgtggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgct
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | 8720
acaccgcctggcgatagtcctgtatcgcaaccgatgggcactataacgacttctcgaaccgccgcttacccgactggcga
i Neo
CGGPLSGHSVGYP YC RAWRRMG PL
; VADRYQD I ALATRD I AEELGGEWADR
I VWRTA I RT RWLPV I LLKSLAANGLTA
t HRVA I LVYRQSGT I NSFLKAAFPSVA
HPPGSDPCLTP GHYQQLAQRR I PQGS
>
3 TASR. SMANAVRS I ASSSPPSHASRK
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tcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgaGCG




FLVLYG I AAPDSQR IAFYRLLDEFF .A
SSCFTVSPLP IRSASPS I AFLTSSSER






i i i i | i i i i | i i i i | i i i i | i i i i | i ii i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
CCTGAGACCCCAAGCTTTACTGGCTGGTTCGCTGCGGGTTGGACGGTAGTGCTCTAAAGCTAAGGTGGCGGCGGAAGATA
GTLGFEMTDQATPNLPSRDFDSTAAFY
GLWGSK PTKRRPTCHHE I S I PPPPSM




PSQPEFHGVLRRGVQW S I E I GGGGE I
GAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTT
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
CTTTCCAACCCGAAGCCTTAGCAAAAGGCCCTGCGGCCGACCTACTAGGAGGTCGCGCCCCTAGAGTACGACCTCAAGAA
ERLGFG IVFRDAGWMI LQRGDLMLEFF
KGWASESFSGTPAG SSSAG I SCWSS
KVGLRNRFPGRRLDDPPARGSHAGVL
FTPSRFRKGPRRSSSGGARPD APTR
SLNPKP I TKRSAPQ I IRWRPSRMSSNK
8960
Q N E P
Nru I
v H I H Q
CGCCCACCCCGGGCTCGATCCCCTCGCGAGTTGGTTCAGCTGCTGCCTGAGGCTGGACGACCTCGCGGAGTTCTACCGGC
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
GCGGGTGGGGCCCGAGCTAGGGGAGCGCTCAACCAAGTCGACGACGGACTCCGACCTGCTGGAGCGCCTCAAGATGGCCG
AHPGLDPLASWFSCCLRLDDLAEFYR







i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
TCACGTTTAGGCAGCCGTAGGTCCTTTGGTCGTCGCCGATAGGCGCGTAGGTACGGGGGCTTGACGTCCTCACCCCTCCG






I D M G G
San Dl
ACGATGGCCGCTTTGGTCCCGGATCCTGAGAACTTCAGGGtgagtttggggacccttgattgttctttctttttcgctat
i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i |
TGCTACCGGCGAAACCAGGGCCTAGGACTCTTGAAGTCCCactcaaacccctgggaactaacaagaaagaaaaagcgata
Ev brtafltemnSDwrtlt ^>1 betaglobin SD intron
TMAALVPDPENFRVSLGTLDCSFFFA I
RWPLWSRI LRTSG VWGPL IVLSFSL
HDGRFGPGS ELQGEFGDP LFFLFRY
SPRKPGPDQSS PSNPSGQNNKRKR
V I AAKTGSGSFKLTLKPVRSQEKKKA I
9200
RHGSQDR I RLVEPHTQPGK I TREKESN
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">' tgtaaaattcatgttatatggagggggcaaagttttcagggtgttgtttagaatgggaagatgtcccttgtatcacTAAT
j i i i i | i i i i | i i M | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i M i | i i i i | i i i i | i i i i | 9280
i' acattttaagtacaatatacctcccccgtttcaaaagtcccacaacaaatcttacccttctacagggaacatagtgATTA
beta qlobin SD intron
i vkfmlygggkvfrvlfrmgrcplyh.
> l nscymegakfsgcclewedvpc i tn
3 ck i hv iwrgqsfqgvv ngkmslvsl i
} q l i tihlpclk.ptt.fpfidrtdsi
5 tfnmnypppltkltnnl i plhgky y
J
3 yfeh. i spafnephqkshsstgq i vl
ATTTATATATTTATATTTTAAAATATTTATTTATTTATTTATTTAAcatggaccctcatgataattttgtttctttcact
> i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 9360
TAAATATATAAATATAAAATTTTATAAATAAATAAATAAATAAATTgtacctgggagtactattaaaacaaagaaagtga
beta qlobin SD intron
ARE
yly i y i lkyl f i yl fnmdphdnfvsft
! iyifif.niylfiyltwtlmi ilfl l
i • fiylyfkifiylfi .hgps. .fcffh
, niykyklini .kni cpgehynqkk k
i kyi ikfykni knlmsg.slktekv
i i inin.fi .kni .kvhvrmi iknres
ttctactctgttgacaaccattgtctcctcttattttcttttcattttctgtaactttttcgttaaactttagcttgcat
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 9440
aagatgagacaactgttggtaacagaggagaataaaagaaaagtaaaagacattgaaaaagcaatttgaaatcgaacgta
beta globin SD intron
fysvdnhclllfsfhfl lfr tlac i
stlltt i vssyflf i fcnffvkl la
fllc .qplspl i ffsfsvtfslnfslh
rsqqcgndgr i kkenetvken fklkc
k etslwqrrknek kryskr . vkaqm
evrnvvmtee krkmkqlkktls san
ttgtaacgaatttttaaattcacttttgtttatttgtcagattgtaagtactttctctaatcacttttttttcaaggcaa
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | 952 0
aacattgcttaaaaatttaagtgaaaacaaataaacagtctaacattcatgaaagagattagtgaaaaaaaagttccgtt
beta globin SD Intron
cneflnsllficqivstfsnhfffka
fvtnf. ihfclfvrl .vlsl i tffsrq
l r i fkftfvylsdckyfl sl ffqgn
kyriklnvkt.kdsqlykr.dskk.pl
qlsnkfeskniq. i tlvkel kkklai
tvfk. i kqkn tlnytserivkkelc
Mfe I Psi I
tcagggtatattatattgtacttcagcacagttttagagaacaattgttataattaaatgataaggtagaatatttctgc
i i i i | i i i i | i i i i | i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | 9600
agtcccatataatataacatgaagtcgtgtcaaaatctcttgttaacaatattaatttactattccatcttataaagacg
beta globin SD intron
i rvyy i vlqhsfreql l lndkveyfc
sgyi i lyfstvlenncyn .m i r n i sa
qgilyctsaqf.rtivi ik. .grifl
p i nyqveacn lviti i lhypl inrc
lty. i ts clklscnnyn fsltsykq
dpyi inyklvtksflq. l i ilyfiea
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I I LAGVEI FLLVETTTSWSSSCLSLY
YKFWLAWKYSYW. KQLHPGHHPAFLF
H INSGWRGN I L IGRNNY I LVI I LPFSL
I FEPQRPFIRIPLFL MRTMMRGKEK
MY I RAPTS I NKNTSVVVDQDDDQRER
YLNQSAHFYE .QYFCSCGP .GAKRKI
tggttacaatgatatacactgtttgagatgaggataaaatactctgagtccaaaccgggcccctctgctaaccatgttca
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
accaatgttactatatgtgacaaactctactcctattttatgagactcaggtttggcccggggagacgattggtacaagt
beta globin SD intron
GYND I HCLR G NTLSPNRAPLLTMF
MVTMI YTV.DEDKI L .VQTGPLC. PCS
WLQ YTLFEMR I KYSESKPGPSANHVH
HNCHYVSNS I L I FYESDLGPGEALWT
P LS I CQKLHPYFVRLGFRAGRSVMNM
9680
5' atataaattctggctggcgtggaaatattcttattggtagaaacaactacatcctggtcatcatcctgcctttctcttta
3 I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I | I I I I |
3' tatatttaagaccgaccgcacctttataagaataaccatctttgttgatgtaggaccagtagtaggacggaaagagaaat
3 y S beta globin SD intron
9760
TV I I YVTQSSSL I SQTWVPGRQ GHE
tgccttcttctttttcctacagCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTTCCCC
i i i i | i i i i | i i i i | i i i i | 1 1 i i | i 1 1 i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
acggaagaagaaaaaggatgtcGAGGACCCGTTGCACGACCAACAACACGACAGAGTAGTAAAACCGTTTCTTAAAGGGG
beta giobin exon 3 fragment :>beta globin SD intron ^
MPSS F SYSSWATCWL LCCL I I LAKNFP
CL L L FPT APGQRAGCCAVSSFWQR I SP
AFFFFLQLLGNVLVVVLSHHFGKEFP
AKKKKRCSRPLTSTTTSD .KPLSNGR






i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
AATTAATTCTCGAGCTTAAGCATTAGTACCAGTATCGACAAAGGACACACTTTAACAATAGGCGAGTGTTAAGGTGTGTT
I pol^>
L I KSSNS SWS L FPV NCYPLT I PHN
LRAR I RNHGHSCFLCE I V I RSQFHT
LN ELEFV I M V I AVSCVKLLSAHNSTQ
L SSSNT IMTMATEQTFNNDA LEVC
K I LLEFEYDHDYSNGTHFQ.GSVIGCL
9920
NLAR I RL P LQKRHS I TIRECNWVV
CATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCAC
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i [ i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |
GTATGCTCGGCCTTCGTATTTCACATTTCGGACCCCACGGATTACTCACTCGATTGAGTGTAATTAACGCAACGCGAGTG
I RAGS I KCKAWGA VS.LTLIALRS
TYEPEA SVKPGVPN E ANSH LRCAH
HTSRKHKV . SLGCLMSELTH I NCVALT
CVLRFCLTYLRPHR I LSSV.MLQTASV










GAKWDPFRDHWSC H I PWRAPLPPKR
10080
QGSELRSVQRALQMLSDALARPSATQT
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ATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTC




YWALFRFLAH LAALGRSAAASG I SSL




i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 10240
TTTCCGCCATTATGCCAATAGGTGTCTTAGTCCCCTATTGCGTCCTTTCTTGTACACTCGTTTTCCGGTCGTTTTCCGGT
K A V I RLSTESGDNAGKNM AKGQQKA
QRR YGYPQNQG I TQERTCEQKASKRP
KGGNTV I HR I RG RRKEHVSKRPAKGQ
LPPLVT I W L I LPYRLFSCTLLLGAFPW
FAT I RNDVSDPSLAPFFMHAFPWCFAL
LRYYP GCF P IVCSLVHSCFALLLG
GGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i| i i i i | i i i i | 10320
CCTTGGCATTTTTCCGGCGCAACGACCGCAAAAAGGTATCCGAGGCGGGGGGACTGCTCGTAGTGTTTTTAGCTGCGAGT
RNRKKAALLAFFHRLRPPDEHHKNRRS
GTVKRPRCWR FS IGSAPLTS I TK I D A Q









KSEVAKPDRT I K I PGVSPWKLPRALSC




i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 10480
AGGCTGGGACGGCGAATGGCCTATGGACAGGCGGAAAGAGGGAAGCCCTTCGCACCGCGAAAGAGTATCGAGTGCGACAT
PTLPLTGYLSAFLPSGSVALSHSSRC
FRPCRLPDTCPPFSLREAWRFL I A H A V
SDPAAYR I PVRLSPFGKRGAFS LTL













i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 10640
AATAGGCCATTGATAGCAGAACTCAGGTTGGGCCATTCTGTGCTGAATAGCGGTGACCGTCGTCGGTGACCATTGTCCTA
LSGNYRLESNPVRHDLSPLAAATGNR I
YPVT I VLSPTR DTTYRHWQQPLVTG
L IR. LSS VQPGKTRL IATGSSHW.QD
I RYSDDQTWGPLVRS I AVPL LWQYCS
KDPL RRSDLGTLCSKDGSAAAVPLL I
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CAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAAT
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 11280
GTCGTTATTTGGTCGGTCGGCCTTCCCGGCTCGCGTCTTCACCAGGACGTTGAAATAGGCGGAGGTAGGTCAGATAATTA
SA INQPAGRAERRSGPATLSAS IQS I N
QQ. TSQPEGPSAEVVLQLYPPPSSL L I
SNKPASRKGRAQKWSCN F I RLHPVY
LLLGALRFPRACFHDQLK I RRWGT N
A I FWGAP LASR L L PGAVKDAEMWD I L
CYVLWGSPGLASTTRCS GGGDLRN I
TGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGT
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 11360
ACAACGGCCCTTCGATCTCATTCATCAAGCGGTCAATTATCAAACGCGTTGCAACAACGGTAACGATGTCCGTAGCACCA
CCREARVSSSPVNSLRNVVA I A T G I VV
VAGKLE V V R Q L I VCATLLPL LQASW
LLPGS SK FAS FAQRCCHCYRHRG








VTLVVWYGF IQLRFPT I KASYM I PHVV








QKSG. LLRSSDRCQK VGRSV I THGY
CFLP SRRDESRQ FYTPRLT I V P P
LFATLEKPGG I TTLLLNAATNDSMT I
AFFRNAGETRRDNDSTLQGCH E H N H
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATT
i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i |i i i i | i ii i | i i i i | i i i i | i i i i | 11600
CGTCGTGACGTATTAAGAGAATGACAGTACGGTAGGCATTCTACGAAAAGACACTGACCACTCATGAGTTGGTTCAGTAA
AALHNSLTVMPSVRCFSVTGEYSTKSF
QHCI I LLLSCHP.DAFL LVSTQPSH
GSTA. FSYCHA I RKMLFCDW. VLNQV I
LVAYNE Q AMRL I SKQSQHTSLWTM
AASCLERVTMGDTLHKETVPSYEVLDN
CCQM I RKSDHWGYSAKRHSTLV GL E
CTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTT
i i i i I i i i i | i i i i I i i i i | i i i i I i ' i i | i i i i 1 i i i i | i i i i I i i i i | i i i i h i i i | i i i i I i i i i | i i . i I i i i i | 11680
GACTCTTATCACATACGCCGCTGGCTCAACGAGAACGGGCCGCAGTTATGCCCTATTATGGCGCGGTGTATCGTCTTGAA
E CMRRPSCSCPAS I RDNTAPHSRT
SENSVCGDRVALARRQYG 1 IPRHIAEL
LR IVYAATELLLPGVNTG YRAT Q N F
RL I TYAAVSNSKGPTLVPYYRAVYCFK
QSYH I RRGLQEQGAD I RSLVAGCLLVK
SFLTHPSRTARARR . YP I IGRWMASS
TAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 11760
ATTTTCACGAGTAGTAACCTTTTGCAAGAAGCCCCGCTTTTGAGAGTTCCTAGAATGGCGACAACTCTAGGTCAAGCTAC
LKVL I I GKRSSGRKLSR I LPLLRSSSM
KCSSLENVLRGENSQGSYRC DPVRC
KSAHHWKTF FGAKTLKDLTAVE I QFD
LLA. QFVNKPAFVRLSRVATS IWNST
FTSMMPFREEPRFSEL I KGSNLDLE I
FHEDNSFTRRPSFE PD RQQSGTRH
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TAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCA




VTHSCTQL I FS! FYFHQRFWVSKNRKA




i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 11920
TTTACGGCGTTTTTTCCCTTATTCCCGCTGTGCCTTTACAACTTATGAGTATGAGAAGGAAAAAGTTATAATAACTTCGT
NAAKKG I RATRKC ILILFLFQYY.S
KMPQKRE GRHGNVEYSYSSFFN I I E A
KCRKKGNKGDTEMLNTHTLPFS I LLKH
FHRLFPFLPSVS INFV VRGKE I NNFC
FAAFFP I LAVRFHQ I SMSKRK Y QLM
I GCFLSYPRCPFTSYEYEEKKL I ISA
TTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACA
i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 12000
AAATAGTCCCAATAACAGAGTACTCGCCTATGTATAAACTTACATAAATCTTTTTATTTGTTTATCCCCAAGGCGCGTGT
I YQGYCLMSGY I FEC I KNKQ I GVPRT
F I RV IVS ADTYLNVFRK INK .GFRAH
LSGLLSHERIH I MYLEK TNRGSAH
KDPNND SR I C I Q I YKSFYVFLPEACM
P QRMLPYMNSH I FFLC I PTGRV
N I LT I TEHASVYKFTNLF I FLYPNRAC
TTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAG
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 12080
AAAGGGGCTTTTCACGGTGGACTGCAGATTCTTTGGTAATAATAGTACTGTAATTGGATATTTTTATCCGCATAGTGCTC
FPRKVPPDV . ET I I IMTLTYKNRR I TR
FPEKCHLTSKKPL LS H P I K I GVSR
I SPKSAT RLRNHYYHD I NL K AYHE
EGFLAVQRRLFW. SMLRYFYAY S
NGRFTGGST SVM I IMVNV.LFLRIVL
KGSFHWRVDLFGNNDHC G I FIPTDRP
GCCCTTTCGTCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTC
















QLR I GPASLGTLAR RTNAPTPAPKV I
GCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCG
i i i i | i i i i [ i i i i I i i i i | i i i i I i i i i | i i i i I i i i i | i i i i I i i M | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 12320
CGCCGTAGTCTCGTCTAACATGACTCTCACGTGGTATACGCCACACTTTATGGCGTGTCTACGCATTCCTCTTTTATGGC
AASEQ I VLRVHHMRCE I PHRCVRRKYR
RHQSRLY ECT I CGVKYRTDA GENT
CG I RADCTESAPYAV NTAQMRKEK I P
PMLASQVSLAGYATHFVAC I RLSF I G
AADSC I TSLTCWI RHS IGCLHTLLFYR
RC L LNYQSHVMHPTFYRVSAYPSFVA
iturday, October 14, 2006 1:33 PM
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CATCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGC
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | ii i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | 12400
GTAGTCCGCGGTAAGCGGTAAGTCCGACGCGTTGACAACCCTTCCCGCTAGCCACGCCCGGAGAAGCGATAATGCGGTCG
I RRHSPFRLRNCWEGRSVRASSLLRQ
A S G A I RHSGCATVGKGDRCGPLRYYAS
HQAPFA I QAAQL LGRA I GAGIFA1 T P A








GERGMCCKA I KLGNARVFPVTTL ND

















































Sequences of primers used for sequencing of vector






































































Detailed Analysis of 5'Race Sequence Tags






Chromosome Position: 4 (-): 131624739-131625709 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
*Sequence in red represents the region of homology to the BLAST hits
Accession: AK076188
Description: Mus musculus 18 days pregnant adult female placenta and
extra embryonic tissue cDNA, RIKEN full-length enriched library,
clone:3830421G02 product: Mus musculus RNA transcript from U17 small
nucleolar RNA host gene, full insert sequence
% Match: 95 (70/73 bp)
Accession: BC100513
Description: Mus musculus RNA, U17d small nucleolar, mRNA (cDNA
clone IMAGE:30918832)
% Match: 95 (70/73 bp)
Accession: AJ006837
Description: Mus musculus RNA transcript from U17 small nucleolar RNA
host gene
% Match: 95 (70/73 bp)
Gene Information
Official Symbol: Rnul7d and Name: RNA, U17d small nucleolar [Mus
musculus]
Other Aliases: U17HG
Chromosome: 4; Location: 4 D2.3
GenelD: 399101
172
Function: No protein-coding potential. Transcript serves as a vehicle for the
biogenesis of small nucleolar RNAs (snoRNAs) of the H/ACA-box class
(Pelczar and Filipowicz, 1998).
Predicted translation:
CT CTC TAG GCG TCG CTC TCT TGG TGT GCT TGT TCT TGA CCC
L * A S LSWCAC S* P
GGT CAA TGA TTT CAG GTA CTT TGT TGA TGG AGG TCC CAG GTC
GQ* FQ V L C * W RSQV
CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA GGA GGA
PKTKEEERRSGGGG
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GTG AGC
GGGGGGGGGGGGV S
AAG GGC GAG GAG CTG
K G E E L
Sequence in black: RACE product sequence and predicted translation
Sequence in pink: Vector's En-2 splice acceptor exon
Sequence in blue: stretch of glycines
Sequence in green: beginning of egfp coding region
173





Chromosome Position: 5 (+): 125679658-125679689 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: BC008661
Description: Mus musculus ubiquitin C, mRNA (cDNA clone IMAGE:
3598724), complete cds
% Match: 93 (30/32)
Accession: AF285161
Description: Mus musculus cell-line C3H/He polyubiquitin C (Ubc) gene,
complete cds
% Match: 93 (30/32)
Gene Information
Official Symbol: Ubc and Name: ubiquitin C [Mus musculus]
Other Aliases: 2700054004Rik, AI194771, TI-225
Other Designations: polyubiquitin C
Chromosome: 5; Location: 5 64.0 cM
GenelD: 22190
Function: Ubiquitin protein serves as a tag in the selective proteolysis of
abnormal/foreign proteins by the 26S proteasome. Gene contains multiple
tandem ubiquitin coding regions and the resulting protein is processed to
ubiquitin monomers.
Predicted translation:
CTG CTG TGT GAG GAC TGC CGC CAC CAC CGC TGG TCC CAG GTC
L L C E D C R H H R W S Q V
CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA GGA GGA
P K T K E E E R R S G G G G
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GTG AGC
G G G G G G G G G G G G V S
AAG GGC GAG GAG CTG
K G E E L
174






Chromosome Position: 1 (+):164513366-164513464 bp (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: XM_917352
Description: PREDICTED: Mus musculus BAT2 domain containing 1,
transcript variant 9 (Bat2d), mRNA
% Match: 100 (76/76)
Accession: XM_001002638
Description: PREDICTED: Mus musculus BAT2 domain containing 1,
transcript variant 12 (Bat2d), mRNA
% Match: 100 (76/76)
Accession: BC099612
Description: Mus musculus BAT2 domain containing 1, mRNA (cDNA
clone IMAGE: 3417702), partial cds
% Match: 100 (76/76)
Gene Information
Official Symbol: Bat2d and Name: BAT2 domain containing 1 [Mus
musculus]
Other Aliases: 1810043M20Rik, 9630039I18Rik/ A630006J20, Bat2dl,
E130112L15Rik/ mKIAA1096




TGA ACA GTG TTG TGT ATC AGA AAC AGT TCC AGT CAG CCC CCG
* T V L C I R N S S S Q P P
CCA CAG TGC GCA TGG CAC AGC CGT TTC CTG CAC AGT TTG CAC
P Q C A W H S R F L H S L H
ccc AGG TCC CAG GTC CCG AAA ACC AAA GAA GAA GAA CGC AGA
p R S Q V P K T K E E E R R
TCT GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA
s G G G G G G G G G G G G G
GGA GGA GGA GTG AGC AAG GGC GAG GAG CTG
G G G V S K G E E L
175
Sequence in orange: Upstream endogenous sequence from Bat2d exon 21
176






Chromosome Position: 1 (+): 162871843-162872481 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: BC059726
Description: Mus musculus growth arrest specific 5, mRNA (cDNA clone
IMAGE: 6582586)
% Match: 96 (79/82)
Gene Information
Official Symbol: Gas5 and Name: growth arrest specific 5 [Mus musculus]
Other Aliases: Gas-5, MGC6251
Chromosome: 1; Location: 1 H2.1
GenelD: 14455
Function: No protein-coding potential. Locus transcribes snoRNAs (class
box C/D)-similar to Rnul7d (see RACE tag 5B1 above).
Predicted translation:
TTC GGA GCT GTG CGN CAT TCT GAG CAG GAA TGG CAA TGT GGA
F G A V R H S E Q E W Q C G
CCT CCG TGA TGG GAC ATC TTG TGG GAT CTC ACA GCC AGG TCC
P P * W D I L W D L T A R S
CAG GTC CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA
Q V P K T K E E E R R S G G
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA
G G G G G G G G G G G G G G
GTG AGC AAG GGC GAG GAG CTG
177







Chromosome Position: 3 (-): 108083536-108083657 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: AC079042
Description: Mus musculus strain C57BL/6J chromosome 3 clone rp23-313f7,
complete sequence
% Match: 100 (121/121)
Accession: BY727029
Description: BY727029 RIKEN full-length enriched, adult male corpora
quadrigemina Mus musculus cDNA clone B230112L17 5', mRNA sequence.
% Match: matched 89% identity over 60% length (last 73 bp) of the 1A6
sequence tag.
Predicted translation:
GGT CCC TGG AGG AGA GAG CAA GGA AGG AGA GGA AGA GTT TTT
G P W R R E Q G R R G R V F
TTA CCA TGC TTT GGA GGG AGA AGA ACC CGG CAG CCA TGT GAG
L P C F G G R R T R Q P C E
GTC TCT GGA GGA GCT GGA GCC TGT GGC CAC TAT TAC AGG TCC
V S G G A G A C G H Y Y R S
CAG GTC CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA
Q V P K T K E E E R R S G G
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA
G G G G G G G G G G G G G G
GTG AGC AAG GGC GAG GAG CTG
V S K G E E L
178






Chromosome Position: 5 (-): 23222939-23224488 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: XM_001000526
Description: PREDICTED: Mus musculus expressed sequence AI506816
(AI506816), mRNA
% Match: matched 91% identity over 83% length (first 48 bp) of the 1B2
sequence tag.
Accession: AK157274
Description: Mus musculus activated spleen cDNA, RIKEN full-length
enriched library, clone: F830209B14 product: unclassifiable, full insert
% Match: matched 91% identity over 83% length (first 48 bp) of the 1B2
sequence tag.
Accession: AK151523
Description: Mus musculus bone marrow macrophage cDNA, RIKEN full-
length enriched library, clone:I830031F13 product:unclassifiable, full
% Match: matched 91% identity over 83% length (first 48 bp) of the 1B2
sequence tag.
Gene Information
Official Symbol: AI506816 and Name: expressed sequence AI506816 [Mus
musculus]




TTC CGC CGC GGC CCG TTC CTG ATG AGT GCT GTG ATC CAG GAT GAT CTG GCT
F R R G P F L Met S A V I Q D D L A
ccc AGG TCC CAG GTC CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA
p R S Q V P K T K E E E R R S G G
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GTG AGC AAG
G G G G G G G G G G G G G G V S K
GGC GAG GAG CTG
G E E L
179







Chromosome Position: 18 (+): 85091512-85115585 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: NM_015798
Description: Mus musculus F-box protein 15 (Fbxol5), mRNA
% Match: 98 (135/137)
Accession: AK166599
Description: Mus musculus morula whole body morula cDNA, RIKEN full-
length enriched library, clone: I0C0032P13 product: F-box only protein
% Match: 98 (135/137)
Accession: AK163224
Description: Mus musculus 2 cells egg cDNA, RIKEN full-length enriched
library, clone:B020003D24 product:F-box only protein 15, full insert
% Match: 98 (135/137)
Gene Information
Official Symbol: Fbxol5 and Name: F-box protein 15 [Mus musculus]
Other Aliases: AU019763, Fbxl5, ecat3
Other Designations: F-box only protein 15
Chromosome: 18; Location: 18 E4
GenelD: 50764
Function: Involved in phospohorylation-dependent ubiquitination through
binding to E3 ubiquitin protein ligases called SCFs. Shown to be a target for
Oct3/4.
Predicted translation:
GTT GGA ATC TGC TTC TAC AGA AGA CCA GCT GAA ACA AAT AGC
VGICFYRRPAETNS
TTC GTG GGA CTG AGC ACA ACT ACT AGA TTC TTG GAC TTC CGT
180
FVGLSTTTRFLDFR
TCA CAG CTG CCA ATT GTT GGG AGT ACA ATA ATG GAG GAG TCG
SQLPIVGSTI Met EES
GAA TTG GAG ATG TCC CAG GTC CCG AAA ACC AAA GAA GAA GAA
E L E Met SQVPKTKEEE
GAA CGC AGA TCT GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA
ERRSGGGGGGGGGG
GGA GGA GGA GGA GGA GGA GTG AGC AAG GGC GAG GAG CTG
GGGGGGVSKGEEL
181





Chromosome Position: 18 (+): 85068799-85069929 (Ensembl v39)
Top BLAST hits(NCBI BLASTN):
Accession: AC134545
Description: Mus musculus BAC clone RP24-470H2 from chromosome 18,
complete sequence
% Match: 96 (30/31)
Predicted translation:
AC TGC CTC ACC CCA CTT TGA GGA CTT GTA AGG TCC CAG GTC
CLTPL*GLVRSQV
CCG AAA ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA GGA GGA
PKTKEEERRSGGGG
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GTG AGC
GGGGGGGGGGGGV S
AAG GGC GAG GAG CTG
K G E E L
182






Chromosome Position: 2 (-): 180638399-180638481 (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: AK036185
Description: Mus musculus 16 days neonate cerebellum cDNA, RIKEN full-
length enriched library, clone: 9630044K06 product: unclassifiable, full insert
sequence
% Match: 92 (78/84)
Accession: AK036185
Description: Mus musculus 12 days embryo spinal ganglion cDNA, RIKEN
full-length enriched library, clone: D130048F08 product: unclassifiable, full
insert sequence
% Match: 92 (78/84)
Gene Information
Official Symbol: Didol and Name: death inducer-obliterator 1 [Mus
musculus]
Other Aliases: 6720461J16Rik, C530043I07, D130048F08Rik, DIO-1, Datfl,
Dido2, Dido3, mKIAA0333
Other Designations: death inducer-obliterator-2; death inducer-obliterator-3
Chromosome: 2; Location: 2 H4
GenelD: 23856
Function: Three isoforms described (Futterer et al., 2005). One of them was
shown to be involved in apoptosis (Garcia-Domingo et al., 1999). Exact role
of the other two is unknown. Targeting of a segment common to all three
isoforms was associated with a myelodysplastic/myeloproliferative
(MDS/MPD)-type disease (Futterer et al., 2005).
Predicted translation:
TAA GAC CAG TTT AGC AGA TCT GTC AGA CAC AAT GAC CAC AGT
* DQF SRSV RHNDH S
GGC AGT CTC TTA ACT CCA TAG CTC TAC CCG AAG CTA TCC AGG
183
G S L L T P *
TCC CAG GTC CCG AAA ACC AAA
S Q V P K T K
GGA GGA GGA GGA GGA GGA GGA
G G G G G G G
GGA GTG AGC AAG GGC GAG GAG
G V S K G E E
L Y P K L S R
GAA GAA GAA CGC AGA TCT GGA
E E E R R S G
GGA GGA GGA GGA GGA GGA GGA










Chromosome Position: Multiple (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Accession: BC085274
Description: Mus musculus similar to glyceraldehyde-3-phosphate
dehydrogenase, mRNA (cDNA clone MGC:103192 IMAGE:6530979),
complete cds
% Match: 100 (71/71)
Accession: BC083065
Description: Mus musculus glyceraldehyde-3-phosphate dehydrogenase,
mRNA (cDNA clone MGC:103190 IMAGE:5371133), complete cds
% Match: 100 (71/71)
Accession: NG_005470
Description: Mus musculus glyceraldehyde-3-phosphate dehydrogenase
pseudogene (LOC654475) on chromosome 4
% Match: 100 (71/71)
Accession: NG_005467
Description: Mus musculus glyceraldehyde-3-phosphate dehydrogenase
pseudogene (LOC654475) on chromosome 5
% Match: 100 (71/71)
Accession: NG_005469
Description: Mus musculus glyceraldehyde-3-phosphate dehydrogenase
pseudogene (LOC654475) on chromosome X
% Match: 100 (71/71)
Accession: NG_005233
Description: Mus musculus glyceraldehyde-3-phosphate dehydrogenase
pseudogene (LOC433921) on chromosome 5
% Match: 100 (71/71)
185
Predicted translation:
TCT CTG CTC CTC CCT GTT CCA
S L L L P V P
GCA GTG CCA GCC TCG TCC CGT
A V P A S S R
TGT GAA CGG TCC CAG GTC CCG
C E R S Q V P
AGA TCT GGA GGA GGA GGA GGA
R S G G G G G
GGA GGA GGA GGA GTG AGC AAG
G G G G V S K
GAG ACA GCC GCA TCT TCT TGT
E T A A S S C
AGA CAA AAT GGT GAA GGT CGG
R Q N G E G R
AAA ACC AAA GAA GAA GAA CGC
K T K E E E R
GGA GGA GGA GGA GGA GGA GGA
G G G G G G G
GGC GAG GAG CTG
G E E L
186











Top BLAST hits (NCBI BLASTN):
Accession: BC058113
Description: Mus musculus erythroid differentiation regulator 1, mRNA
(cDNA clone MGC:69587 IMAGE:6820436)/ complete cds
% Match: two regions of homology-one showed 97% identity over the first
120 bp of the sequence tag (117/120) and the other 86% identity over the last
117 bp of the sequence tag (101/117).
Gene Information
Interim Symbol: Erdrl and Name: erythroid differentiation regulator 1
[Mus musculus]
Other Aliases: MGC5764, edr
Chromosome: Un
GenelD: 170942
Function: Induction of haemoglobin synthesis, cell survival and growth
control (Dormer et al., 2004).
Predicted translation:
CG'T CCG CCA GTC ACG GCC GCC GCC CCC AGC GAC GTC ACC CAC
R P P V T A A A P S D V T H
GCG CGC AGA AGC GGA CGC CGC GGT CAA GAT GTC TCT GCC ATG
A R R S G R R G Q D V S A Met
CCC ACG GGA CGC ACG GAC GCA CGG ACG GAC TCC ACA CCG GTC
P T G R T D A R T D S T P V
ACT GCC GCC GCC CAC AGT GAT GTC ACC CAC GAA AGC ACA CAC
T A A A H S D V T H E S T H
GTA GAA GCG GAC GCC GTG GTC AAG ATG TCT CTG CCA TCC CCA
V E A D A V V K Met S L P S P
CAG GAC GGA CGG ACG GAC TCC ACA AGG TCC CAG GTC CCG AAA
Q D G R T D S T R S Q V P K
ACC AAA GAA GAA GAA CGC AGA TCT GGA GGA GGA GGA GGA GGA
T K E E E R R S G G G G G G
GGA GGA GGA GGA GGA GGA GGA GGA GGA GGA GTG AGC AAG GGC
G G G G G G G G G G V S K G
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Flow cytometry profiles of some of the gene trap clones analysed by
5'RACE PCR and whose expression profile is not shown in Chapter 3
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Flow cytometry profiles of some of the gene trap clones analysed by
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3'Race Sequence tag Analysis and Integration details for clones
characterised by proper SD Function









Chromosome Position: Multiple (Ensembl v39)
Top BLAST hits (NCBI BLASTN):
Multiple high homology hits on different chromosomes
Hits are related to a sequence from 3'LTR of mouse ETn transposon
Accession: Y17106
Description: Mus musculus transposon ETn, SELH/L3A strain











Chromosome Position: 7 (-): 131206322 -131206403
Top BLAST hits (NCBI BLASTN):
Accession: BC019141
Description: Mus musculus pleckstrin homology-like domain, family A,
member 2, mRNA (cDNA clone MGC: 29089 IMAGE: 5042041), complete cds
% Match: 98 (257/260)
Accession: NM_009434
191
Description: Mus musculus pleckstrin homology-like domain, family A,
member 2 (Phlda2), mRNA
% Match: 98 (257/260)
Hit on exon 2 of Phlda2 (2 exons in total)
DNA(contigs) < AC023246.20
3 Blast hits
gEnsembl trans. <-Phida2Erisepcl knouri trans
Gene trap orientation relative to gene's transcription: +
Gene Information
Official Symbol: Phlda2 and Name: pleckstrin homology-like domain,
family A, member 2 [Mus musculus]
Other Aliases: Ipl, Tssc3
Other Designations: tumor-suppressing subchromosomal transferable
fragment 3












Chromosome Position: 5 (-): 105647255-105647507
Top BLAST hits (NCBI BLASTN):
Accession: AC159996
Description: Mus musculus chromosome 5, clone RP23-46J11, complete
sequence
% Match: 99 (243/244)
BLAST hit (opposite orientation) within a region located on intron 21-22 of







- Reverse strand H
Conservation (USCS genome server): Region homologous to the RACE









Chromosome Position (UCSC genome server): 6 (+): 10067072-10067099
(region in red) and 6(+): 10081909-10081943 (region in blue)
Top BLAST hits (NCBI BLASTN):
Accession: AC144519
Description: Mus musculus BAC clone RP24-325A1 from chromosome 6,
complete sequence
% Match: Two regions (shown in red and blue on the RACE tag) of
homology-each is homologous to two different regions on chromosome 6-
red: 96% (27/28)-blue: 88% (30/34)
No transcript present in the region
Conservation (USCS genome server): Mouse chromosome regions 6:
10067072 - 10067152 and 10081856 - 10081943 are highly conserved between
mouse and rat
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5) CLONES: 1, 6, 7, 30, 32, 33, 35







Same as clones N2 and N29 (see above)
6) CLONE 2









Chromosome position (USCS genome server): 10 (-): 84292973-84293223
Top BLAST hits (NCBI BLASTN):
Accession: AY102010
Description: Mus musculus winged-helix transcription factor RFX4 variant 3
(Rfx4) mRNA, complete cds, alternatively spliced
% Match: 100 (148/148)
Accession: AY342003
Description: Mus musculus regulatory factor X 4 variant (Rfx4) mRNA
% Match: 100 (148/148)
RACE tag is homologous to exon 11 of Rfx4 gene (18 exons in total)-note
nomology also spans flanking intronic sequence which was found to be
conserved between many different species (USCS genome server).
Q90453J10USE ->





g Blast hits ■■■
□ Unigene
Length -«4| 4.25 Kb Rewrse strand —I
Gene trap orientation relative to gene's transcription: -
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Gene Information
Official Symbol: Rfx4 and Name: regulatory factor X, 4 (influences HLA
class II expression) [Mus musculus]
Other Aliases: 4933412G19Rik, NYD-splO
Other Designations: regulatory factor X, 4; winged-helix transcription
factor RFX4
Chromosome: 10; Location: 10 CI
GenelD: 71137
7) CLONE 4









Chromosome position (USCS genome server): 18 (-): 34232342-34232573
Top BLAST hits (NCBI BLASTN):
Accession: AC114003
Description: Mus musculus chromosome 18 clone RP23-174C24, complete
sequence
% Match: 95 (221/231)
Hit within intron of a predicted transcript (Genscan ID:
GENSCAN000000402318)
Length I—Forviard strand 4.23 Kb
l I l I I I I I l
DNA(contigs)
g Blast hits ■■■
a Genscan < GENSCAN00000402318
Conservation (USCS genome server): Mouse chromosome region 18:
34232342-34232573 is highly conserved between mouse, rat, human and dog
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8) CLONE 5

















Chromosome position (USCS genome server): 12 (+): 85954074-85959476
Top BLAST hits (NCBI BLASTN):
Accession: BC055465
Description: Mus musculus YLP motif containing 1, mRNA (cDNA clone
IMAGE:3992501), complete cds
% Match: Three regions of homology (shown in blue, red and green)-blue:
100% (110/110), red: 99% (160/161), green: 85% (164/191)
Accession: NM_178363
Description: Mus musculus YLP motif containing 1 (Ylpml), mRNA
% Match: Three regions of homology (shown in blue, red and green)-blue:
100% (110/110), red: 99% (160/161), green: 85% (164/191)
RACE tag is homologous to exons 21 and 22 of Ylpml gene (22 exons in total)
y hnsembl trans. ~ I
Ylpml >
Ensembl Known Protein Coding
j-j Blast hits ■
I | I I | | |
DNA(contigs)
pi Genscan
Gene trap orientation relative to gene's transcription: +
Gene Information
Official Symbol: Ylpml and Name: YLP motif containing 1 [Mus musculus]
Other Aliases: A930013E17Rik, AI851834, ZAP, Zap3
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Chromosome Position (UCSC genome server): ll(-): 53983451-53983810
Top BLAST hits (NCBI BLASTN):
Accession: AF441733
Description: Mus musculus clone RP23-225M6 45S pre-ribosomal RNA
gene, partial sequence; and intergenic spacer, partial sequence
% Match: 98 (388/391)
Accession: BK000964
Description: TPA_exp: Mus musculus ribosomal DNA, complete repeating
unit
% Match: 98 (388/391)
Trapped sequence corresponds to a repeat
10) CLONE 11







Chromosome Position (UCSC genome server): 19 (+): 7303181-7303348
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Top BLAST hits (NCBI BLASTN):
Accession: AC140307
Description: Mus musculus BAC clone RP23-389D15 from chromosome 19,
complete sequence
% Match: 100 (167/167)
Top BLAST hits (NCBI BLASTN-mouse EST):
Accession: AI506879
Description: vl56e06.xl Stratagene mouse skin (#937313) Mus musculus
cDNA clone IMAGE: 976258 3', mRNA sequence.
% Match: 100 (167/167)
Accession: AA562649
Description: vl56e06.rl Stratagene mouse skin (#937313) Mus musculus
cDNA clone IMAGE: 976258 5', mRNA sequence.
% Match: 99 (166/167)
Homology (Opposite orientation) with intronic area (1st intron) of known
transcript Natll (Ensembl transcript ID: ENSMUST00000025675; 9 exons in
total)
g Blast hits
DNA(contigs) AC 140307.3 >
< Nat11
Ensembl Known Protein Coding
i—i Fn*a=mhl franc
Conservation (USCS genome server): Mouse chromosome region 19:
7303181-7303348 is conserved between mouse, rat and human
Gene trap orientation relative to gene's transcription: -
11) CLONE 12








Chromosome Position (UCSC genome server): 11 (+): 97461499-97461582
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Top BLAST hits (NCBI BLASTN):
Accession: AK155239
Description: Mus musculus NOD-derived CDllc +ve dendritic cells cDNA,
RIKEN full-length enriched library, clone: F630210K12 product:
unclassifiable, full insert sequence
% Match: 98 (51/52) (Region in red)
Accession: AK052674
Description: Mus musculus 0 day neonate kidney cDNA, RIKEN full-length
enriched library, clone: D630020N09 product: unclassifiable, full insert
sequence
% Match: 98 (51/52) (Region in red)
Conservation (USCS genome server): Mouse chromosome region 11:
97461499-97461582 is conserved between mouse, rat and human
12) CLONE 13











Chromosome Position (UCSC genome server): 4 (-): 85492307- 85492647
Top BLAST hits (NCBI BLASTN):
Accession: AL929448
Description: Mouse DNA sequence from clone RP23-313G2 on chromosome
4, complete sequence
% Match: 98 (319/324)
No known transcripts present in the region
Hit adjacent to ab-initio Genscan transcript GENSCAN00000391247
199
DNA(contigs)
g Genscan < GENSCAN0000039124T
Ab-initio Genscan trans
Conservation (USCS genome server): Mouse chromosome region 4:
85492307-85492493 is conserved between mouse, rat, human and dog.
13) CLONE 16


















Chromosome Position (UCSC genome server): 4 (-): 135144032-135145175
Top BLAST hits (NCBI BLASTN):
Accession: BC006598
Description: Mus musculus proline-rich nuclear receptor coactivator 2,
mRNA (cDNA clone MGC:11707 IMAGE:3965195), complete cds
% Match: 93 (660/705)
Accession: AK077403
Description: Mus musculus 6 days neonate head cDNA, RIKEN full-length
enriched library, clone: 5430438M09 product:similar to PROLINE-RICH
NUCLEAR RECEPTOR COACTIVATOR 2 [Homo sapiens], full insert
sequence
% Match: 93 (660/705)
RACE tag homologous to exons 2 and 3 of Pnrc2 gene (3 exons in total)
200
□ Blast hits






Ensembl Known Protein Coding
< Pnnc2-002
Known Protein coding
Gene trap orientation relative to gene's transcription: +
Gene Information
Official Symbol: Pnrc2 and Name: proline-rich nuclear receptor coactivator
2 [Mus musculus]
Other Aliases: 0610011E17Rik, D4Bwg0593e, MGC11707
Chromosome: 4; Location: 4 66.7 cM
GenelD: 52830
14) CLONE 19











Chromosome Position (UCSC genome server): 8 (-): 25504433-25507388
Top BLAST hits (NCBI BLASTN):
Accession: AC117207
Description: Mus musculus BAC clone RP23-278A7 from 8, complete
sequence
% Match: three regions of homology (shown in blue, green and red)-blue:
100% (96/96), red: 95% (129/135), green: 100% (146/146)
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BLAST hits homologous (opposite orientation) to areas within an intronic















Ensembl Known Protein Coding
AC 117207.5 >
< GENSCAN00000375108
Conservation (USCS genome server): Mouse chromosome region 8:
25504433-25504653 is conserved between mouse and rat. Mouse
chromosome regions 8: 25505335-25505774 and 25505843-25506091 are
conserved between mouse, rat, human and dog. Mouse chromosome region
25506446-25507388 is conserved between mouse, rat and dog.
15) CLONE 22











Chromosome Position (UCSC genome server): 3 (+): 127531848-127532209
Top BLAST hits (NCBI BLASTN):
Accession: AC113952
Description: Mus musculus chromosome 3, clone RP24-166J20, complete
sequence
% Match: 93 (336/360)
202
BLAST hit homologous (opposite orientation) to intronic region within
D3Wsul61e gene (last intron-5 exons in total).
ONA(contigs)
, Blast hits
g Ensembl trans. < D3Wsu161e
Ensembl Known Protein Coding
Conservation (USCS genome server): Mouse chromosome region 3:
127531848-127532083 is conserved between mouse, human and dog.
16) CLONE 23









Chromosome Position (UCSC genome server): 12 (-): 87314170-87314228
Top BLAST hits (NCBI BLASTN):
Accession: AC145163
Description: Mus musculus BAC clone RP24-238C5 from chromosome 12,
complete sequence
% Match: Two regions of homology (shown in blue and red)-blue, 84%
(45/53); red, 100% (58/58)
BLAST hit is homologous (opposite orientation) to intronic area (1st intron)













Conservation (USCS genome server): Mouse chromosome region 12:



















Chromosome Position (UCSC genome server): 4 (-): 134109536-134110066
Top BLAST hits (NCBI BLASTN):
Accession: BC037192
Description: Mus musculus transmembrane protein 57, mRNA (cDNA clone
IMAGE: 4480906), with apparent retained intron
% Match: 99 (507/509)
RACE tag is homologous to second exon of Tmem57 gene (11 exons in total)-

















Gene trap orientation relative to gene's transcription: +
Gene Information
Official Symbol: Tmem57 and Name: transmembrane protein 57 [Mus
musculus]
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Other Aliases: 1110007C24Rik, 9230118A01Rik, AI317300, AI606104, C61
Other Designations: macoilin
Chromosome: 4; Location: 4 65.69 cM
GenelD: 66146
18) CLONE 29







Chromosome Position (UCSC genome server): 3 (-): 32897106-32897254
Top BLAST hits (NCBI BLASTN):
Accession: AC111140
Description: Mus musculus chromosome 3, clone RP23-369L16, complete
sequence
% Match: 92 (125/135)
RACE tag homologous to a repeat sequence (RLTR9E-int; information from
USCS RepeatMasker software).
19) CLONE 34












Chromosome Position (UCSC genome server): 14 (+): 99191588-99192276
Top BLAST hits (NCBI BLASTN):
Accession: AC125446
Description: Mus musculus chromosome 14, clone RP24-501J23, complete
sequence
% Match: 100 (345/345)
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BLAST hit within intron of ab-initio transcript GENSCAN00000376976







AC 125+46 12 >
-4.34 Kb- - Reverse strand-
Conservation (USCS genome server): Mouse chromosome region 14:
99191588- 99192276 is conserved between mouse and rat. Also partially
conserved between mouse, rat and dog.
20) CLONE 44







Chromosome Position (UCSC genome server): 6 (-): 122271468-122271613
Top BLAST hits (NCBI BLASTN):
Accession: AC153579
Description: Mus musculus 6 BAC RP23-21F2 (Roswell Park Cancer
Institute (C57BL/6J Female) Mouse BAC Library) complete sequence
% Match: 92 (135/146)
RACE tag homologous to ab-initio transcript GENSCAN00000381797
s Genscan GENSCAN00000381797 >
Ab-initio Genscan trans
DNA(contigs) AC 153579 10 >
y Blast hits
Length 4.14 Kb Reverse strand-
Conservation (USCS genome server): Mouse chromosome region 6:
122271468-122271529 is partially conserved between mouse, rat, human and
dog. Chromosome region 6: 122271530- 122271578 is well conserved between



















Chromosome Position (UCSC genome server): 7 (-): 73417549-73429433
Top BLAST hits (NCBI BLASTN):
Accession: AK140938
Description: Mus musculus 16 days embryo head cDNA, RIKEN full-length
enriched library, clone: C130076G01 product: unclassifiable, full insert
sequence
% Match: 100 (543/543)
Accession: AK007604
Description: Mus musculus 10 day old male pancreas cDNA, RIKEN full-
length enriched library, clone: 1810026B05 product: unclassifiable, full insert
sequence
% Match: 100 (430/430)
RACE tag homologous to exons 2-4




















Gene trap orientation relative to gene's transcription: +
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22) CLONE 2D4














Chromosome Position (UCSC genome server): 12 (-): 114556604-
114588772
Top BLAST hits (NCBI BLASTN):
Accession: AJ851868
Description: Mus musculus immunoglobulin heavy chain locus constant
region and partial variable region, strain 129/Sv
% Match: 91 (424/461)
Accession: AY169677
Description: Mus musculus clone VG2J2.8 immunoglobulin heavy chain
variable region precursor, gene, partial cds
% Match: 96 (269/279)
Accession: XM_903470
Description: PREDICTED: Mus musculus similar to Ig heavy chain V-I
region HG3 precursor (LOC630342), mRNA
% Match: 96 (238/247)
RACE tag is homologous to exon of EST transcript
ENSMUSESTT00003717556-also homologous to similar to Ig heavy chain V-I





g Ensembl trans. < XR_004918.1




[Z] Genscan < GENSCAN00000400079
Ab-initio Genscan trans
Gene trap orientation relative to gene's transcription: +
23) CLONE 2A5







Chromosome Position (UCSC genome server): 6 (-): 122763428-122763463
Top BLAST hits (NCBI BLASTN):
Accession: AC163108
Description: Mus musculus BAC clone RP23-46L17 from chromosome 6,
complete sequence
% Match: 100 (31/31 )-sequence in red
Top BLAST hits (NCBI BLASTN-mouse EST):
Accession: BF019192
Description: uy02c04.yl McCarrey Eddy spermatocytes Mus musculus
cDNA clone IMAGE: 3656838 5' similar to SW:GTR3_MOUSE P32037
GLUCOSE TRANSPORTER TYPE 3, BRAIN. ;mRNA sequence.
% Match: 100 (31/31)-sequence in red
BLAST hit is linked to a Slc2a3 gene-homologous to a region upstream of the






< Slc2a3 < ENSMUST00000095496




Ensembl Known Protein Coding
Ml —

















Gene trap orientation relative to gene's transcription: +
Conservation (USCS genome server): Mouse chromosome region 6:
122763428 - 122763463 is conserved between mouse, rat, human and dog.
24) CLONE 2C1













Chromosome Position (UCSC genome server): 13 (+): 29240648-29240856
Top BLAST hits (NCBI BLASTN):
Accession: AL645746
Description: Mouse DNA sequence from clone RP23-153B6 on chromosome
13, complete sequence
% Match: 88 (121/136)-sequence in red





g Genscan < GENSCANQ000037049Q
Ab-initio Genscan trans
Conservation (USCS genome server): Mouse chromosome region 13:
29240648 - 29240757 is conserved between mouse, rat, human and dog.
Mouse chromosome region 13: 29240758 - 29240856 is conserved between










Chromosome Position (UCSC genome server): 18 (+): 42686907 -
42686997
Top BLAST hits (NCBI BLASTN):
Accession: BC040284
Description: Mus musculus transcription elongation regulator 1 (CA150),
mRNA (cDNA clone MGC: 36862 IMAGE: 4460736), complete cds
% Match: 98 (84/85)
Accession: BC039185
Description: Mus musculus transcription elongation regulator 1 (CA150),
mRNA (cDNA clone MGC: 28934 IMAGE: 3982736), complete cds
% Match: 98 (84/85)
Accession: AK150312
Description: Mus musculus bone marrow macrophage cDNA, RIKEN full-
length enriched library, clone: I830002K14 product: transcription elongation
regulator 1 (CA150), full insert sequence
% Match: 98 (84/85)














Gene trap orientation relative to gene's transcription: +
Gene information
Official Symbol: Tcergl and Name: transcription elongation regulator 1
(CA150) [Mus musculus]
Other Aliases: 2410022J09Rik, 2900090C16Rik, AI428505, CA150b, FBP 23,
Taf2s, cal50, pi44
Other Designations: TATA box binding protein (TBP)-associated factor,
RNA polymerase II, S, 150kD; coactivator of 150 kD; transcription factor
CA150b
Chromosome: 18; Location: 18 B3
GenelD: 56070
26) CLONE 3C4





















Chromosome Position (UCSC genome server): 2 (+): 131984686-131987634
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Top BLAST hits (NCBI BLASTN):
Accession: AK170888
Description: Mus musculus NOD-derived CDllc +ve dendritic cells cDNA,
RIKEN full-length enriched library, clone: F630207J03 product: CDP-
diacylglycerol synthase (phosphatidate cytidylyltransferase) 2, full insert
sequence
% Match: 99 (774/781)
Accession: AK050589
Description: Mus musculus 2 days neonate thymus thymic cells cDNA,
RIKEN full-length enriched library, clone: C920007D24 product: SIMILAR
TO CDP-DIACYLGLYCEROL SYNTHASE (PHOSPHATIDATE
CYTIDYLYLTRANSFERASE) 2 homolog [Mus musculus], full insert
sequence
% Match: 99 (519/520)
Accession: BC059776
Description: Mus musculus CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 2, mRNA (cDNA clone IMAGE: 6484748), complete cds
% Match: 99 (519/520)
















Ensembl Known Protein Coding
ALSOTTSS Z >
Gene trap orientation relative to gene's transcription: +
Gene Information
Official Symbol: Cds2 and Name: CDP-diacylglycerol synthase
(phosphatidate cytidylyltransferase) 2 [Mus musculus]
Other Aliases: 5730450N06Rik, 5730460C18Rik, AI854580, D2Wsul27e
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Other Designations: phosphatidate cytidylyltransferase 2
Chromosome: 2; Location: 2 73.0 cM
GenelD: 110911
27) CLONE 2C4
















Chromosome Position (UCSC genome server): 13 (-): 23550495-23550780
Top BLAST hits (NCBI BLASTN):
Accession: BC092138
Description: Mus musculus histone 1, H2bh, mRNA (cDNA clone MGC:
106612 IMAGE:30613720), complete cds
% Match: 77 (147/189)
Accession: NM_178197
Description: Mus musculus histone 1, H2bh (Histlh2bh), mRNA
% Match: 77 (147/189)
RACE product is homologous to the only exon of Histlh2bh gene
i — i
g Ensembl trans. Hist1h3b>
Ensembl Known Protein Coding










Ensembl Known Protein Coding
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Gene Information
Official Symbol: Histlh2bh and Name: histone 1, H2bh [Mus musculus]
















Chromosome Position (UCSC genome server): 7 (+): 43147752-43148093
Top BLAST hits (NCBI BLASTN):
Accession: AC165418
Description: Mus musculus chromosome 7, clone RP23-148M16, complete
sequence
% Match: 97 (335/342)
Top BLAST hits (NCBI BLASTN-mouse EST):
Accession: BY432161
Description: BY432161 RIKEN full-length enriched, pooled tissues, 16 days
embryo, etc. Mus musculus cDNA clone 1920118K02 3', mRNA sequence.
% Match: 97 (303/311)
BLAST hit is not related to any known transcript
Conservation (USCS genome server): Mouse chromosome region 7:
43147997M3148093 is conserved between mouse and human.
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29) CLONE 2A4












Chromosome Position (UCSC genome server): 10 (-): 69302407-69302804
Top BLAST hits (NCBI BLASTN):
Accession: AB057357
Description: Mus musculus gene for Ankyrin 3, partial cds
% Match: 99 (395/396)
Accession: AK013487
Description: Mus musculus adult male hippocampus cDNA, RIKEN full-
length enriched library, clone: 2900006A17 product:unclassifiable, full
% Match: 99 (261/263)
Top BLAST hits (NCBI BLASTN-mouse EST):
Accession: DV656129
Description: DS138B_H02 Eppig/Hampl oocyte Mus musculus cDNA clone
DS138B_H02 5', mRNA sequence.
% Match: 98 (324/328)
RACE product is homologous (in the opposite orientation to the gene's






Ensembl Known Protein Coding
Ank3 >
Ensembl Known Protein Coding
Ank3 >
Ensembl Known Protein Coding
Ank3 >





Conservation ((JSCS genome server): Mouse chromosome region 10:
69302577- 69302659 is conserved between mouse, rat and human.
Chromosome region 10: 69302660 - 69302804 is conserved between mouse,
rat, human and dog.
30) CLONE 1A4










Chromosome Position (UCSC genome server): 6 (-): 133985138-
133985316
Top BLAST hits (NCBI BLASTN):
Accession: AC145116
Description: Mus musculus BAC clone RP23-434H14 from 6, complete
sequence
% Match: 98 (163/166)
Trapped sequence corresponds to a repeat sequence (LINE class; information
from USCS RepeatMasker software).
31) CLONE 1D6










Chromosome Position (UCSC genome server): 14 (+): 99191627-99191862
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Top BLAST hits (NCBI BLASTN):
Accession: AC125446
Description: Mus musculus chromosome 14, clone RP24-501J23, complete
sequence
% Match: 80(118/146)
RACE tag homologous to intronic region of ab-initio GENSCAN transcript
GENSCAN00000376976
y Unigene i ■
g Genscan GENSCAN000M376977 > GENSCAN00000376976 >




g EST trans. < ENSMUSESTT00003716769
-I
Conservation (USCS genome server): Mouse chromosome region 14:
99191627 -99191676 is conserved between mouse and rat. Chromosome
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